EurekaMag Full Text Articles Chapter 55,027

Thon, J.N.; Italiano, J.E. 2010: Platelet formation. Seminars in Hematology 47(3): 220-226

Day, L.R. 1947: Platelet fragility in man. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 64(1): 109-111

Li, Z.; Nardi, M.A.; Wu, J.; Pan, R.; Zhang, W.; Karpatkin, S. 2008: Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin. Journal of Biological Chemistry 283(6): 3224-3230

Perakis, P.G.; Yunus, T.; Long, G.; Cheema, Z.F.; Hammond, R.; Shanley, C.J. 2012: Platelet function after cessation of chronic clopidogrel therapy. American Surgeon 78(1): 51-56

Yıldırım, Z.K.; Orhan, M.F.; Büyükavcı, M. 2011: Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(2): 98-101

Michels, M.; Alisjahbana, B.; De Groot, P.G.; Indrati, A.R.; Fijnheer, R.; Puspita, M.; Dewi, I.M.W.; van de Wijer, L.; de Boer, E.M.S.; Roest, M.; van der Ven, A.J.A.M.; de Mast, Q. 2014: Platelet function alterations in dengue are associated with plasma leakage. Thrombosis and Haemostasis 112(2): 352-362

Akin, M.; Polat, Y. 2012: Platelet function analyser (PFA)-100 closure time in the evaluation of non-steroidal anti-inflammatory drug-induced platelet dysfunction in children with bleeding symptoms. Blood Transfusion 10(4): 545-546

Görlinger, K.; Jambor, C.; Dirkmann, D.; Dusse, F.; Hanke, A.; Adamzik, M.; Hartmann, M.; Philipp, S.; Weber, A.-A.; Rahe-Meyer, N. 2008: Platelet function analysis with point-of-care methods. Herz 33(4): 297-305

Aydinalp, A.; Atar, I.; Altin, C.; Gülmez, O.ü; Atar, A.; Açikel, S.; Bozbaş, H.üs.; Yildirir, A.; Müderrisoğlu, H. 2010: Platelet function analysis with two different doses of aspirin. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 38(4): 239-243

Morris, A.; Aliprandi-Costa, B.; Brieger, D. 2010: Platelet function analysis: a comparison of methods. International Journal of Cardiology 145(1): 167-168

Oestreich, J.H.; Smyth, S.S.; Campbell, C.L. 2009: Platelet function analysis: at the edge of meaning. Thrombosis and Haemostasis 101(2): 217-219

Chang, Y.-W.; Liao, C.-H.; Day, Y.-J. 2009: Platelet function analyzer (PFA-100) offers higher sensitivity and specificity than thromboelastography (TEG) in detection of platelet dysfunction. Acta Anaesthesiologica Taiwanica: Official Journal of the Taiwan Society of Anesthesiologists 47(3): 110-117

Satchell, C.S.; Cotter, A.G.; O'Connor, E.F.; Peace, A.J.; Tedesco, A.F.; Clare, A.; Lambert, J.S.; Sheehan, G.J.; Kenny, D.; Mallon, P.W.G. 2010: Platelet function and HIV: a case-control study. Aids 24(5): 649-657

Ting, H.J.; Khasawneh, F.T. 2010: Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?. Journal of Biomedical Science 17(1): 24

Troxler, M.; Dickinson, K.; Homer-Vanniasinkam, S. 2007: Platelet function and antiplatelet therapy. British Journal of Surgery 94(6): 674-682

Angiolillo, D.J.; Ferreiro, J.é L.; Price, M.J.; Kirtane, A.J.; Stone, G.W. 2013: Platelet function and genetic testing. Journal of the American College of Cardiology 62(17 Suppl): S21-S31

Puig Domingo, M. 2014: Platelet function and hyperglycemia in acute coronary syndrome. Revista Espanola de Cardiologia 67(1): 3-5

Patti, G.; De Caterina, R.; Abbate, R.; Andreotti, F.; Biasucci, L.Marzio.; Calabrò, P.; Cioni, G.; Davì, G.; Di Sciascio, G.; Golia, E.; Golino, P.; Malatesta, G.; Mangiacapra, F.; Marcucci, R.; Nusca, A.; Parato, V.Maurizio.; Pengo, V.; Prisco, D.; Pulcinelli, F.; Renda, G.; Ricottini, E.; Ruggieri, B.; Santilli, F.; Sofi, F.; Zimarino, M. 2014: Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. European Heart Journal 35(33): 2213-223b

Taomoto, K.; Ohnishi, H.; Kuga, Y.; Nakashima, K.; Ichioka, T.; Kodama, Y.; Kubota, H.; Tominaga, T.; Hirose, T.; Hayashi, M.; Kinugasa, C.; Yamashita, T.; Yamamoto, J. 2010: Platelet function and spontaneous thrombolytic activity of patients with cerebral infarction assessed by the global thrombosis test. Pathophysiology of Haemostasis and Thrombosis 37(1): 43-48

Kaur, H.; Mutus, B. 2012: Platelet function and thymosin β4. Biological Chemistry 393(7): 595-598

Selim, M.H.; Molina, C.A. 2010: Platelet function assays in stroke management: more study is needed. Stroke 41(10): 2396-2397

Chandler, W.L. 2014: Platelet function assays--not all are created equal. Clinical Chemistry 60(12): 1469-1470

Picker, S.M.; Schneider, V.; Gathof, B.S. 2009: Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies. Transfusion 49(6): 1224-1232

Oscarsson, A.; Öster, S.; Fredrikson, M.; Lindahl, T.L.; Eintrei, C. 2011: Platelet function assessed by whole-blood aggregometry in patients undergoing non-cardiac surgery. European Journal of Anaesthesiology 28(5): 363-369

Liu, H.; Glenn, E.; Mehl, J.; Rosinia, F. 2014: Platelet function assessment for epidural catheter removal in patient receiving Plavix. Journal of Anaesthesiology Clinical Pharmacology 30(2): 290

Ware, J.; Corken, A.; Khetpal, R. 2013: Platelet function beyond hemostasis and thrombosis. Current Opinion in Hematology 20(5): 451-456

Gerrah, R.; Brill, A.; Varon, D. 2007: Platelet function changes in different cardiac surgery subgroups as evaluated with an innovative technology. Innovations 2(4): 176-183

Simon, D.; Kunicki, T.; Nugent, D. 2008: Platelet function defects. Haemophilia: the Official Journal of the World Federation of Hemophilia 14(6): 1240-1249

Mills, H.L.; Abdel-Baki, M.S.; Teruya, J.; Dietrich, J.E.; Shah, M.D.; Mahoney, D.; Yee, D.L.; Srivaths, L.V. 2014: Platelet function defects in adolescents with heavy menstrual bleeding. Haemophilia: the Official Journal of the World Federation of Hemophilia 20(2): 249-254

Kehara, H.; Takano, T.; Ohashi, N.; Terasaki, T.; Amano, J. 2014: Platelet function during cardiopulmonary bypass using multiple electrode aggregometry: comparison of centrifugal and roller pumps. Artificial Organs 38(11): 924-930

Gurbel, P.A.; Erlinge, D.; Ohman, E.M.; Neely, B.; Neely, M.; Goodman, S.G.; Huber, K.; Chan, M.Y.; Cornel, J.H.; Brown, E.; Zhou, C.; Jakubowski, J.A.; White, H.D.; Fox, K.A.A.; Prabhakaran, D.; Armstrong, P.W.; Tantry, U.S.; Roe, M.T. 2012: Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA 308(17): 1785-1794

Davi, G.; Belvedere, M.; Catalano, I.; Mogavero, A.; Perez, T.; Notarbartolo, A.; Strano, A. 1990: Platelet function during ticlopidine and eicosapentaenoic Acid administration in patients with coronary heart disease. Platelets 1(2): 81-84

Smout, J.; Dyker, A.; Cleanthis, M.; Ford, G.; Kesteven, P.; Stansby, G. 2009: Platelet function following acute cerebral ischemia. Angiology 60(3): 362-369

Bauer, K.A.; Gerson, W.; Wright, C.; Wang, J.; McNicol, E.; Lanier, R.K.; Kramer, W.; Carr, D.B. 2010: Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. Journal of Clinical Anesthesia 22(7): 510-518

Solomon, C.; Traintinger, S.; Ziegler, B.; Hanke, A.; Rahe-Meyer, N.; Voelckel, W.; Schöchl, H. 2011: Platelet function following trauma. a multiple electrode aggregometry study. Thrombosis and Haemostasis 106(2): 322-330

Núñez-Gil, I.án.J.; Bernardo, E.; Feltes, G.; Escaned, J.; Mejía-Rentería, H.án.D.; De Agustín, J.é A.; Vivas, D.; Nombela-Franco, L.; Jiménez-Quevedo, P.; Macaya, C.; Fernández-Ortiz, A. 2015: Platelet function in Takotsubo cardiomyopathy. Journal of Thrombosis and Thrombolysis 39(4): 452-458

Hackert, T.; Pfeil, D.; Hartwig, W.; Fritz, S.; Schneider, L.; Gebhard, M.-M.; Büchler, M.W.; Werner, J. 2007: Platelet function in acute experimental pancreatitis. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 11(4): 439-444

Fröbert, O.; Christensen, K.; Fahlman, A.; Brunberg, S.; Josefsson, J.; Särndahl, E.; Swenson, J.E.; Arnemo, J.M. 2010: Platelet function in brown bear (Ursus arctos) compared to man. Thrombosis Journal 8: 11

Kasperska-Zajac, A.; Brzoza, Z.; Rogala, B. 2008: Platelet function in cutaneous diseases. Platelets 19(5): 317-321

Kalbantner, K.; Meyer-Lindenberg, A.; Mischke, R. 2011: Platelet function in dogs with congenital portosystemic shunt. Veterinary Journal 188(2): 189-192

Alcelik, A.; Aktas, G.; Eroglu, M.; Tosun, M.; Savli, H.; Dikbas, O.; Zeyrek, A.; Yalcin, A. 2013: Platelet function in euthyroid patients undergoing thyroidectomy in women. European Review for Medical and Pharmacological Sciences 17(17): 2350-2353

Ferroni, P.; Vazzana, N.; Riondino, S.; Cuccurullo, C.; Guadagni, F.; Davì, G. 2012: Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxidants and Redox Signaling 17(10): 1447-1485

Sentürk, T. 2010: Platelet function in inflammatory diseases: insights from clinical studies. Inflammation and Allergy Drug Targets 9(5): 355-363

Tesfamariam, B. 2008: Platelet function in intravascular device implant-induced intimal injury. Cardiovascular Revascularization Medicine: Including Molecular Interventions 9(2): 78-87

Picker, S.M. 2013: Platelet function in ischemic heart disease. Journal of Cardiovascular Pharmacology 61(2): 166-174

Lohse, J.; Schweigel, J.; Naeke, A.; Lee-Kirsch, M.A.; Siegert, G.; Bergmann, S.; Kuhlisch, E.; Suttorp, M.; Knöfler, R. 2010: Platelet function in obese children and adolescents. Hamostaseologie 30(Suppl 1): S126-S132

Yu, J.; Jia, J.-p. 2009: Platelet function in patients with Alzheimer disease: analysis of 40 cases. Zhonghua Yi Xue Za Zhi 89(3): 183-186

Lisman, T.; Porte, R.J. 2012: Platelet function in patients with cirrhosis. Journal of Hepatology 56(4): 993

Kakouros, N.; Rade, J.J.; Kourliouros, A.; Resar, J.R. 2011: Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. International Journal of Endocrinology 2011: 742719

Ziegelstein, R.C.; Parakh, K.; Sakhuja, A.; Bhat, U. 2009: Platelet function in patients with major depression. Internal Medicine Journal 39(1): 38-43

Gasparyan, A.Y.; Stavropoulos-Kalinoglou, A.; Mikhailidis, D.P.; Douglas, K.M.J.; Kitas, G.D. 2011: Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatology International 31(2): 153-164

Gallandat Huet, R.C.G.; de Vries, A.J.; Cernak, V.; Lisman, T. 2012: Platelet function in stored heparinised autologous blood is not superior to in patient platelet function during routine cardiopulmonary bypass. Plos one 7(3): E33686

Gordge, M.P.; Neild, G.H. 1991: Platelet function in uraemia. Platelets 2(3): 115-123

Gandhi, C.D.; Bulsara, K.R.; Fifi, J.; Kass-Hout, T.; Grant, R.A.; Delgado Almandoz, J.E.; English, J.; Meyers, P.M.; Abruzzo, T.; Prestigiacomo, C.J.; Powers, C.J.; Lee, S.-K.; Albani, B.; Do, H.M.; Eskey, C.J.; Patsalides, A.; Hetts, S.; Hussain, M.S.; Ansari, S.A.; Hirsch, J.A.; Kelly, M.; Rasmussen, P.; Mack, W.; Pride, G.L.; Alexander, M.J.; Jayaraman, M.V. 2014: Platelet function inhibitors and platelet function testing in neurointerventional procedures. Journal of Neurointerventional Surgery 6(8): 567-577

Dichiara, J.; Bliden, K.P.; Tantry, U.S.; Chaganti, S.K.; Kreutz, R.P.; Gesheff, T.B.; Kreutz, Y.; Gurbel, P.A. 2007: Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients. Platelets 18(6): 414-423

Sairaku, A.; Nakano, Y.; Eno, S.; Hondo, T.; Matsuda, K.; Kisaka, T.; Kihara, Y. 2011: Platelet function measured using a whole blood aggregometer can predict bleeding events. Journal of Atherosclerosis and Thrombosis 18(1): 16-23

Tantry, U.S.; Jeong, Y.-H.; Navarese, E.P.; Gurbel, P.A. 2012: Platelet function measurement in elective percutaneous coronary intervention patients: exploring the concept of a P2Y₁₂ inhibitor therapeutic window. JACC. Cardiovascular Interventions 5(3): 290-292

Mahla, E.; Suarez, T.A.; Bliden, K.P.; Rehak, P.; Metzler, H.; Sequeira, A.J.; Cho, P.; Sell, J.; Fan, J.; Antonino, M.J.; Tantry, U.S.; Gurbel, P.A. 2012: Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. CIRCULATION. Cardiovascular Interventions 5(2): 261-269

Harper, A.R.; Price, M.J. 2013: Platelet function monitoring and clopidogrel. Current Cardiology Reports 15(1): 321

Xu, L.; Wang, L.; Yang, X.; Li, K.; Sun, H.; Zhang, D.; Wang, H.; Li, W.; Ni, Z.; Xia, K.; Liu, Y. 2014: Platelet function monitoring guided antiplatelet therapy in patients receiving high-risk coronary interventions. Chinese Medical Journal 127(19): 3364-3370

Aradi, D.án.; Komócsi, A.ás. 2012: Platelet function monitoring in patients on clopidogrel: what should we learn from GRAVITAS?. Platelets 23(3): 167-176

Zafar, M.U.; Santos-Gallego, C.; Vorchheimer, D.A.; Viles-Gonzalez, J.F.; Elmariah, S.; Giannarelli, C.; Sartori, S.; Small, D.S.; Jakubowski, J.A.; Fuster, V.; Badimon, J.J. 2013: Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. Journal of Thrombosis and Haemostasis: Jth 11(1): 100-106

Capranzano, P.; Tamburino, C.; Capodanno, D.; Miccichè, E.; D'Urso, L.; Calvi, V.; Angiolillo, D.J.; Tamburino, C. 2011: Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. Thrombosis and Haemostasis 106(6): 1149-1157

Zisman, E.; Erport, A.; Kohanovsky, E.; Ballagulah, M.; Cassel, A.; Quitt, M.; Pizov, R. 2010: Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. European Journal of Anaesthesiology 27(7): 617-623

May, J.A.; Fox, S.; Glenn, J.; Craxford, S.; Heptinstall, S. 2008: Platelet function reduces significantly during the morning. Platelets 19(7): 556-558

Angiolillo, D.J.; Alfonso, F. 2007: Platelet function testing and cardiovascular outcomes: steps forward in identifying the best predictive measure. Thrombosis and Haemostasis 98(4): 707-709

Collet, J.-P.; Montalescot, G. 2009: Platelet function testing and implications for clinical practice. Journal of Cardiovascular Pharmacology and Therapeutics 14(3): 157-169

Grove, E.L.; Hossain, R.; Storey, R.F. 2013: Platelet function testing and prediction of procedural bleeding risk. Thrombosis and Haemostasis 109(5): 817-824

Ferreiro, J.é L.; Sibbing, D.; Angiolillo, D.J. 2010: Platelet function testing and risk of bleeding complications. Thrombosis and Haemostasis 103(6): 1128-1135

Alberts, M.J. 2010: Platelet function testing for aspirin resistance is reasonable to do: yes!. Stroke 41(10): 2400-2401

Aradi, Dániel.; Collet, J-Philippe.; Mair, J.; Plebani, M.; Merkely, Béla.; Jaffe, A.S.; Möckel, M.; Giannitsis, E.; Thygesen, K.; ten Berg, J.M.; Mueller, C.; Storey, R.F.; Lindahl, B.; Huber, K. 2015: Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding?. Thrombosis and Haemostasis 113(2): 221-230

Grove, E.L.; Hvas, A.-M.; Kristensen, S.D. 2008: Platelet function testing in atherothrombotic disease: steps forward in managing resistance to antiplatelet therapy. Kardiologia Polska 66(4): 478-479

Rechner, A.R. 2011: Platelet function testing in clinical diagnostics. Hamostaseologie 31(2): 79-87

Angiolillo, D.J. 2009: Platelet function testing in clinical practice: are we ready for prime time?. Revista Espanola de Cardiologia 62(2): 113-116

Franchi, F.; Rollini, F.; Cho, J.R.; Ferrante, E.; Angiolillo, D.J. 2014: Platelet function testing in contemporary clinical and interventional practice. Current Treatment Options in Cardiovascular Medicine 16(5): 300

Mani, H.; Hellis, M.; Lindhoff-Last, E. 2011: Platelet function testing in hirudin and BAPA anticoagulated blood. Clinical Chemistry and Laboratory Medicine 49(3): 501-507

Rade, J.J. 2012: Platelet function testing in patients with coronary artery disease: is the Who and the When any clearer than the What and the What then?. Circulation 125(25): 3073-3075

Mahmud, E.; Ang, L. 2011: Platelet function testing in practice: a case study. Reviews in Cardiovascular Medicine 12(Suppl 1): S34-S39

Ho, S.-J.; Gemmell, R.; Brighton, T.A. 2008: Platelet function testing in uraemic patients. Hematology 13(1): 49-58

Sharma, R.K.; Erickson, S.W.; Sharma, R.; Voelker, D.J.; Reddy, H.K.; Dod, H.; Marsh, J.D. 2013: Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department. Vascular Health and Risk Management 9: 187-193

Mahla, E.; Raggam, R.; Toller, W. 2014: Platelet function testing to time surgery in patients on dual antiplatelet therapy?. Hamostaseologie 34(1): 40-45

Fritsma, G.A. 2007: Platelet function testing: aggregometry and lumiaggregometry. Clinical Laboratory Science: Journal of the American Society for Medical Technology 20(1): 32-37

Favaloro, E.J.; Mohammed, S. 2010: Platelet function testing: auditing local practice and broader implications. Clinical Laboratory Science: Journal of the American Society for Medical Technology 23(1): 21-31

Zeidan, A.M.; Kouides, P.A.; Tara, M.A.; Fricke, W.A. 2007: Platelet function testing: state of the art. Expert Review of Cardiovascular Therapy 5(5): 955-967

Stegnar, M. 2010: Platelet function tests and resistance to antiplatelet therapy. Srpski Arhiv Za Celokupno Lekarstvo 138(Suppl 1): 59-63

Breet, N.J.; van Werkum, J.W.; Bouman, H.J.; Ten Berg, J.ën.M.; Hackeng, C.M. 2010: Platelet function tests for the monitoring of P2Y12 inhibitors. Expert Opinion on Medical Diagnostics 4(3): 251-265

Choi, J.-L.; Li, S.; Han, J.-Y. 2014: Platelet function tests: a review of progresses in clinical application. Biomed Research International 2014: 456569

Reininger, A.J. 2009: Platelet function under high shear conditions. Hamostaseologie 29(1): 21

Tentzeris, I.; Siller-Matula, J.; Farhan, S.; Jarai, R.; Wojta, J.; Huber, K. 2011: Platelet function variability and non-genetic causes. Thrombosis and Haemostasis 105(Suppl 1): S60-S66

Bakry, R.; Sayed, D.; Galal, H.; Shaker, S. 2010: Platelet function, activation and apoptosis during and after apheresis. Therapeutic Apheresis and Dialysis: Official Peer-Reviewed Journal of the International Society for Apheresis the Japanese Society for Apheresis the Japanese Society for Dialysis Therapy 14(5): 457-464

De Gaetano, G.; Cerletti, C. 2007: Platelet function, antiplatelet therapy and clinical outcomes: to test or not to test?. Journal of Thrombosis and Haemostasis: Jth 5(9): 1835-1838

Mahla, E.; Höchtl, T.; Prüller, F.; Freynhofer, M.K.; Huber, K. 2012: Platelet function: new drugs, new assays : possible impacts on operative medicine?. Der Anaesthesist 61(6): 483-496

Afanas'eva, A.N.; Tuzikov, S.A.; Evtushenko, V.A.; Udut, V.V. 2008: Platelet functional status in patients with gastric cancer at combined treatment stages. Klinicheskaia Laboratornaia Diagnostika 6: 51-53

Mittal, A.; Aggarwal, K.C.; Saluja, S.; Aggarwal, A.; Sureka, B. 2013: Platelet functions and coagulation changes in Indian children with nephrotic syndrome. Journal of Clinical and Diagnostic Research: Jcdr 7(8): 1647-1650

Smyth, S.S.; McEver, R.P.; Weyrich, A.S.; Morrell, C.N.; Hoffman, M.R.; Arepally, G.M.; French, P.A.; Dauerman, H.L.; Becker, R.C.; Arepally, G.M.; Becker, R.C.; Bhatt, D.L.; Cho, J.; Dauerman, H.L.; Gretler, D.D.; Hoffman, M.R.; Horrow, J.; Kleiman, N.S.; Kocharian, R.; Lincoff, A.M.; Maya, J.; McEver, R.P.; Morrell, C.N.; Prats, J.; Rusconi, C.P.; Smyth, S.S.; Strony, J.; Sun, H.; Veltri, E.P.; Weyrich, A.S.; Wiviott, S.D.; Wood, J.P. 2009: Platelet functions beyond hemostasis. Journal of Thrombosis and Haemostasis: Jth 7(11): 1759-1766

French, P.A. 2009: Platelet functions beyond hemostasis, antiplatelet therapies in high-risk patient subgroups: the Fourth Annual Platelet Colloquium. Journal of thrombosis and thrombolysis 28(2): 252-254

Iancu, R.I.; Iancu, D.; Murărescu, D.; Nechifor, M.; Costuleanu, M. 2010: Platelet functions in acute and chronic experimentally induced hepatopathia. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 114(4): 1101-1106

Piskin, A.; Kaplan, S.; Aktaş, A.; Ayyildiz, M.; Raimondo, S.; Aliç, T.; Bozkurt, H.H.; Geuna, S. 2009: Platelet gel does not improve peripheral nerve regeneration: an electrophysiological, stereological, and electron microscopic study. Microsurgery 29(2): 144-153

Córdoba-Fernandez, A.; Rayo-Rosado, R.; Juarez-Jiménez, J.é M.ía. 2008: Platelet gel for the surgical treatment of onychocryptosis. Journal of the American Podiatric Medical Association 98(4): 296-301

Balbo, R.; Avonto, I.; Marenchino, D.; Maddalena, L.; Menardi, G.; Peano, G. 2010: Platelet gel for the treatment of traumatic loss of finger substance. Blood Transfusion 8(4): 255-259

Picardi, A.; Lanti, A.; Cudillo, L.; Cerretti, R.; Dentamaro, T.; De Angelis, G.; Ferraro, A.; Di Veroli, A.; Adorno, G.; Arcese, W. 2010: Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant. Transfusion 50(2): 501-506

Parazzi, V.; Lazzari, L.; Rebulla, P. 2010: Platelet gel from cord blood: a novel tool for tissue engineering. Platelets 21(7): 549-554

Dominijanni, A.; Cristofaro, M.G.; Brescia, A.; Giudice, M. 2012: Platelet gel in oral and maxillofacial surgery: a single-centre experience. Blood Transfusion 10(2): 200-204

Bernuzzi, G.; Tardito, S.; Bussolati, O.; Adorni, D.; Cantarelli, S.; Fagnoni, F.; Rossetti, A.; Azzarone, M.; Ficarelli, E.; Caleffi, E.; Gazzola, G.; Franchini, M. 2010: Platelet gel in the treatment of cutaneous ulcers: the experience of the Immunohaematology and Transfusion Centre of Parma. Blood Transfusion 8(4): 237-247

Chajchir, A. 2007: Platelet gel sealant use in rhytidectomy. Plastic and Reconstructive Surgery 120(3): 809

Krasna, M.; Domanović, D.; Tomsic, A.; Svajger, U.; Jeras, M. 2007: Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerologica Alpina Pannonica et Adriatica 16(3): 105-110

Mariconda, M.; Cozzolino, F.; Cozzolino, A.; D'Agostino, E.; Bove, A.; Milano, C. 2008: Platelet gel supplementation in long bone nonunions treated by external fixation. Journal of Orthopaedic Trauma 22(5): 342-345

Rughetti, A.; Giusti, I.; D'Ascenzo, S.; Leocata, P.; Carta, G.; Pavan, A.; Dell'Orso, L.; Dolo, V. 2008: Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells. Blood Transfusion 6(1): 12-17

Forni, F.; Marzagalli, M.; Tesei, P.; Grassi, A. 2013: Platelet gel: applications in dental regenerative surgery. Blood Transfusion 11(1): 102-107

Motovska, Z.; Kvasnicka, J.; Hajkova, J.; Kala, P.; Simek, S.; Bobcikova, P.; Petr, R.; Bilkova, D.; Poloczek, M.; Miklik, R.; Fischerova, M.; Maly, M.; Widimsky, P. 2010: Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial. Atherosclerosis 212(2): 548-552

Shi, Q.; Kuether, E.L.; Chen, Y.; Schroeder, J.A.; Fahs, S.A.; Montgomery, R.R. 2014: Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia a mice transplanted with genetically manipulated human cord blood stem cells. Blood 123(3): 395-403

Fang, J.; Jensen, E.S.; Boudreaux, M.K.; Du, L.M.; Hawkins, T.B.; Koukouritaki, S.B.; Cornetta, K.; Wilcox, D.A. 2011: Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs. Proceedings of the National Academy of Sciences of the United States of America 108(23): 9583-9588

Huang, E.; Zhu, W.; Dhundale, A.; Bahou, W.F.; Gnatenko, D.V. 2013: Platelet genetic biomarker quantification: comparison of fluorescent microspheres and PCR platforms. Thrombosis and Haemostasis 109(2): 337-346

Ouwehand, W.H. 2007: Platelet genomics and the risk of atherothrombosis. Journal of Thrombosis and Haemostasis: Jth 5(Suppl 1): 188-195

Bray, P.F. 2009: Platelet genomics beats the catch-22. Blood 114(7): 1286-1287

Motovska, Z.; Kvasnicka, J.; Widimsky, P.; Petr, R.; Hajkova, J.; Bobcikova, P.; Osmancik, P.; Odvodyova, D.; Katina, S. 2010: Platelet glycoprotein GP Vi 13254C allele is an independent risk factor of premature myocardial infarction. Thrombosis Research 125(2): E61-E64

Rivera-García, B.E.; Esparza-García, J.C.; Aceves-Chimal, J.L.; Leaños-Miranda, A.; Majluf-Cruz, A.; Isordia-Salas, I. 2013: Platelet glycoprotein IIIA PIA1/A2 polymorphism in young patients with ST elevation myocardial infarction and idiopathic ischemic stroke. Molecular and Cellular Biochemistry 384(1-2): 163-171

Addad, F.; Elalamy, I.; Chakroun, T.; Abderrazek, F.; Dridi, Z.; Hamdi, S.; Hassine, M.; Ben-Farhat, M.; Gerotziafas, G.; Hatmi, M.; Gamra, H. 2010: Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 21(7): 674-678

Verdoia, M.; Cassetti, E.; Schaffer, A.; Di Giovine, G.; De Luca, G. 2015: Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: a meta-analysis of cohort studies. Platelets 26(6): 530-535

Wang, B.-Y.; Tan, S.-J. 2014: Platelet glycoprotein IIIa gene polymorphism (Leu33Pro) and aspirin resistance in a very elderly Chinese population. Genetic Testing and Molecular Biomarkers 18(6): 389-393

Wu, J.-H.; Zhang, D.-W.; Cheng, X.-L.; Shi, H.; Fan, Y.-P. 2012: Platelet glycoprotein IIb HPA-3 a/b polymorphism is associated with native arteriovenous fistula thrombosis in chronic hemodialysis patients. Renal Failure 34(8): 960-963

Liu, Z.; Gao, M.; Han, Q.; Lou, S.; Fang, J. 2009: Platelet glycoprotein IIb/IIIa (HPA-1 and HPA-3) polymorphisms in patients with hemorrhagic fever with renal syndrome. Human Immunology 70(6): 452-456

Bosch, X.; Marrugat, J.; Sanchis, J. 2013: Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes. Cochrane Database of Systematic Reviews 10: Cd002130

Bosch, X.; Marrugat, J.; Sanchis, J. 2013: Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes. Cochrane Database of Systematic Reviews 11: Cd002130

Kumar, S.; Rajshekher, G.; Prabhakar, S. 2008: Platelet glycoprotein IIb/IIIa inhibitors in acute ischemic stroke. Neurology India 56(4): 399-404

Duan, H.; Cai, Y.; Sun, X. 2012: Platelet glycoprotein IIb/IIIa polymorphism HPA-3 b/b is associated with increased risk of ischemic stroke in patients under 60 years of age. Medical science monitor: international medical journal of experimental and clinical research 18(1): CR19-CR24

Roffi, M.; Mukherjee, D. 2008: Platelet glycoprotein IIb/IIIa receptor inhibitors--end of an era?. European Heart Journal 29(4): 429-431

Leesar, M.A. 2008: Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 71(7): 907-908

Zhang, J.; Huang, D.; Yang, J.; An, H.; Ojha, R.; Du, C.; Liu, R. 2012: Platelet glycoprotein IaC807T polymorphisms and ischemic stroke in young Chinese Han population. European Review for Medical and Pharmacological Sciences 16(12): 1691-1695

Geng, H.; Xu, G.; Ran, Y.; López, J.é A.; Peng, Y. 2011: Platelet glycoprotein Ib beta/IX mediates glycoprotein Ib alpha localization to membrane lipid domain critical for von Willebrand factor interaction at high shear. Journal of Biological Chemistry 286(24): 21315-21323

Corken, A.; Russell, S.; Dent, J.; Post, S.R.; Ware, J. 2014: Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arteriosclerosis Thrombosis and Vascular Biology 34(5): 996-1001

Yago, T.; Lou, J.; Wu, T.; Yang, J.; Miner, J.J.; Coburn, L.; López, J.é A.; Cruz, M.A.; Dong, J.-F.; McIntire, L.V.; McEver, R.P.; Zhu, C. 2008: Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. Journal of Clinical Investigation 118(9): 3195-3207

Soylu, A.; Tokaç, M.; Cora, T.ül.; Düzenli, M.A.; Acar, H. 2009: Platelet glycoprotein Ibalpha gene polymorphism and massive or submassive pulmonary embolism. Journal of Thrombosis and Thrombolysis 27(3): 259-266

Jilma-Stohlawetz, P.; Jilma, B.; Mannhalter, C.; Bencur, P.; Pabinger, I.; Vormittag, R.; Dunkler, D.; Panzer, S. 2007: Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease. Annals of Hematology 86(10): 719-725

Hu, J.; Mondal, N.K.; Sorensen, E.N.; Cai, L.; Fang, H.-B.; Griffith, B.P.; Wu, Z.J. 2014: Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 33(1): 71-79

Jung, S.M.; Moroi, M. 2008: Platelet glycoprotein VI. Advances in Experimental Medicine and Biology 640: 53-63

Bigalke, B.; Haap, M.; Stellos, K.; Geisler, T.; Seizer, P.; Kremmer, E.; Overkamp, D.; Gawaz, M. 2010: Platelet glycoprotein Vi (GPVI) for early identification of acute coronary syndrome in patients with chest pain. Thrombosis Research 125(5): E184-E189

Farndale, R.W. 2009: Platelet glycoprotein Vi as a mediator of metastasis. Journal of Thrombosis and Haemostasis: Jth 7(10): 1711-1712

Jain, S.; Russell, S.; Ware, J. 2009: Platelet glycoprotein Vi facilitates experimental lung metastasis in syngenic mouse models. Journal of Thrombosis and Haemostasis: Jth 7(10): 1713-1717

Weiss, D.; Neuner, B.; Gorzelniak, K.; Bremer, A.; Rudack, C.; Walter, M. 2014: Platelet glycoproteins and fibrinogen in recovery from idiopathic sudden hearing loss. Plos one 9(1): E86898

Fitch-Tewfik, J.L.; Flaumenhaft, R. 2013: Platelet granule exocytosis: a comparison with chromaffin cells. Frontiers in Endocrinology 4: 77

Ho-Tin-Noé, B.; Goerge, T.; Cifuni, S.M.; Duerschmied, D.; Wagner, D.D. 2008: Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Research 68(16): 6851-6858

Whiteheart, S.W. 2011: Platelet granules: surprise packages. Blood 118(5): 1190-1191

Ambrosi, A.; Sasaki, T.; Pumera, M. 2010: Platelet graphite nanofibers for electrochemical sensing and biosensing: the influence of graphene sheet orientation. Chemistry An Asian Journal 5(2): 266-271

Aghideh, A.N.; Kheirandish, M.; Abolghasemi, H.; Gharehbaghian, A. 2010: Platelet growth factors suppress ex vivo expansion and enhance differentiation of umbilical cord blood CD133+ stem cells to megakaryocyte progenitor cells. Growth Factors 28(6): 409-416

Berndt, M.C.; Andrews, R.K. 2013: Platelet hem-immunoreceptor tyrosine-based activation motif receptors: at least one required. Arteriosclerosis Thrombosis and Vascular Biology 33(5): 884-885

Kristensen, S.D.; Martin, J.F. 1991: Platelet heterogeneity and coronary artery thrombosis. Platelets 2(1): 11-17

Nakagawa, S.; Zhan, J.; Sun, W.; Ferreira, J.C.; Keiles, S.; Hambuch, T.; Kammesheidt, A.; Mark, B.L.; Schneider, A.; Gross, S.; Schreiber-Agus, N. 2012: Platelet hexosaminidase a enzyme assay effectively detects carriers missed by targeted DNA mutation analysis. Jimd Reports 6: 1-6

Sakamoto, H.; Wu, B.; Nagai, Y.; Tanaka, S.; Onodera, M.; Ogawa, T.; Ueno, M. 2011: Platelet high-density lipoprotein activates transferrin-derived phagocytosis activators, MAPPs, following thrombin digestion. Platelets 22(5): 371-379

Jurcuţ, C.; Jurcuţ, R.; Caraiola, S.; Niţescu, D.; Mihai, C.; Baicuş, A.; Copaci, I.; Predeţeanu, D.; Ginghina, C.; Tănăsescu, C. 2010: Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. Romanian Journal of Internal Medicine 48(1): 51-55

Albeiroti, S.; Ayasoufi, K.; Hill, D.R.; Shen, B.; de la Motte, C.A. 2015: Platelet hyaluronidase-2: an enzyme that translocates to the surface upon activation to function in extracellular matrix degradation. Blood 125(9): 1460-1469

Mac Mullan, P.A.; Peace, A.J.; Madigan, A.M.; Tedesco, A.F.; Kenny, D.; McCarthy, G.M. 2010: Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target. Rheumatology 49(2): 240-245

Ormezzano, O.; Polack, B.; Vanzetto, G.ér.; Sahnoun, M.; Machecourt, J. 2010: Platelet hyperactivity during exercise leading to iterative coronary stent thrombosis: clinical implications. Journal of Thrombosis and Thrombolysis 30(1): 105-108

Natarajan, A.; Zaman, A.G.; Marshall, S.M. 2008: Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Diabetes and Vascular Disease Research 5(2): 138-144

Mikhailidis, D.P.; Barradas, M.A.; Jeremy, J.Y. 1990: Platelet hyperactivity: a predictor of cardiac events and death from myocardial infarction. Platelets 1(4): 217-218

Fuchs, I.; Spiel, A.O.; Frossard, M.; Derhaschnig, U.; Riedmüller, E.; Jilma, B. 2010: Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy. Critical Care Medicine 38(6): 1423-1429

Razmara, M.; Hjemdahl, P.; Ostenson, C.-G.; Li, N. 2008: Platelet hyperprocoagulant activity in Type 2 diabetes mellitus: attenuation by glycoprotein IIb/IIIa inhibition. Journal of Thrombosis and Haemostasis: Jth 6(12): 2186-2192

Elvers, M.; Pozgaj, R.; Pleines, I.; May, F.; Kuijpers, M.J.E.; Heemskerk, J.M.W.; Yu, P.; Nieswandt, B. 2010: Platelet hyperreactivity and a prothrombotic phenotype in mice with a gain-of-function mutation in phospholipase Cgamma2. Journal of Thrombosis and Haemostasis: Jth 8(6): 1353-1363

Zhiliuk, V.I.; Levykh, A.É; Mamchur, V.I. 2012: Platelet hyperreactivity and antiaggregatory properties of nootropic drugs under conditions of alloxan-induced diabetes in rats. Eksperimental'naia i Klinicheskaia Farmakologiia 75(4): 38-41

Fontana, P.; de Moerloose, P.; Reny, J.-L. 2009: Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?. Journal of Thrombosis and Haemostasis: Jth 7(2): 363-364

Mayer, K.; Sibbing, D. 2012: Platelet hyperreactivity and stent thrombosis in patients undergoing coronary stenting. Current Vascular Pharmacology 10(5): 597-605

Dinda, A.K.; Kumar, R.; Saraya, A.K. 1992: Platelet hyperreactivity and vasculopathy in insulin dependent diabetes mellitus. Platelets 3(2): 83-86

Villegas Martínez, I.; de Gea García, J.H.; Escribano Soriano, J.B. 2009: Platelet hyperreactivity as most likely etiology of ischemic event in cystic fibrosis patients. Neurologia 24(4): 283

Kanaji, T.; Kanaji, S.; Montgomery, R.R.; Patel, S.B.; Newman, P.J. 2013: Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia. Blood 122(15): 2732-2742

Bochsen, L.; Rosengaard, L.B.; Nielsen, A.B.; Steinbrüchel, D.A.; Johansson, P.är.I. 2009: Platelet hyperreactivity in response to on- and off-pump coronary artery bypass grafting. Journal of Extra-Corporeal Technology 41(1): 15-19

Valiyaveettil, M.; Podrez, E.A. 2009: Platelet hyperreactivity, scavenger receptors and atherothrombosis. Journal of Thrombosis and Haemostasis: Jth 7(Suppl 1): 218-221

Bray, P.F. 2007: Platelet hyperreactivity: predictive and intrinsic properties. Hematology/Oncology Clinics of North America 21(4): 633

Plocharczyk, E.F.; O'Brien, S.H.; Crumbacher, J.L.; Kahwash, S.B. 2012: Platelet hyperreactivity: report of a case with catastrophic arterial thrombosis in a child. Laboratory Hematology: Official Publication of the International Society for Laboratory Hematology 18(4): 22-26

Pati, H.P.; Bhargava, V.L.; Saraya, A.K. 1990: Platelet hypoaggregation in iron deficiency anaemia: reversible with therapy. Platelets 1(2): 85-87

Egan, K.; Cooke, N.; Dunne, E.; Murphy, P.; Quinn, J.; Kenny, D. 2014: Platelet hyporeactivity in active myeloma. Thrombosis Research 134(3): 747-749

Anger, K.; Kempfert, J.ör.; Kostelka, M.; Mohr, F.-W.; Dhein, S. 2010: Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans. Pharmacology 85(4): 241-247

Garraud, O.; Cognasse, F. 2009: Platelet immunology and the immune response. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 16(2): 106-117

Speth, C.; Rambach, G.ün.; Lass-Flörl, C. 2014: Platelet immunology in fungal infections. Thrombosis and Haemostasis 112(4): 632-639

Boulaftali, Y.; Hess, P.R.; Kahn, M.L.; Bergmeier, W. 2014: Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circulation Research 114(7): 1174-1184

López, M.ón.L.; Kieling, C.O.; Uribe Cruz, C.; Osvaldt, A.; Ochs de Muñoz, G.; Meurer, L.; Silla, L.; Matte, U. 2014: Platelet increases survival in a model of 90% hepatectomy in rats. Liver International: Official Journal of the International Association for the Study of the Liver 34(7): 1049-1056

Wiwanitkit, V. 2013: Platelet indices and deep vein thrombosis. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 19(3): 341

Abdel-Razik, A.; Eldars, W.; Rizk, E. 2014: Platelet indices and inflammatory markers as diagnostic predictors for ascitic fluid infection. European Journal of Gastroenterology and Hepatology 26(12): 1342-1347

Lee, W.S.; Kim, T.-Y. 2010: Platelet indices are not suitable for screening of leukemia. Journal of Pediatric Hematology/Oncology 32(3): 251

Zhang, Z.; Xu, X.; Ni, H.; Deng, H. 2014: Platelet indices are novel predictors of hospital mortality in intensive care unit patients. Journal of Critical Care 29(5): 885.E1

Varol, E.; Ozaydin, M. 2013: Platelet indices can be influenced by many cardiovascular factors in patients with acute pulmonary embolism. Clinical Respiratory Journal 7(4): 419

Varol, E. 2014: Platelet indices evaluation in contrast-induced nephropathy: methodological drawbacks. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 25(8): 918

Wasiluk, A.; Dabrowska, M.; Osada, J.; Jasinska, E.; Laudanski, T.; Redzko, S. 2011: Platelet indices in SGA newborns. Advances in Medical Sciences 56(2): 361-365

Varol, E. 2014: Platelet indices in assessment of in hospital mortality in intensive care unit patients. Journal of Critical Care 29(5): 864

Costa, A.C.áu.; Ribeiro, B.; Costa, E.ís. 2007: Platelet indices in chronic alcoholic liver disease patients with thrombocytopenia. Arquivos de Gastroenterologia 44(3): 201-204

Jindal, S.; Gupta, S.; Gupta, R.; Kakkar, A.; Singh, H.V.; Gupta, K.; Singh, S. 2011: Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology 16(2): 86-89

Varol, E. 2014: Platelet indices in differential diagnosis of pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. European Journal of Internal Medicine 25(6): E82

Varol, E.; Icli, A.; Uysal, B.A.; Ozaydin, M. 2011: Platelet indices in patients with acute pulmonary embolism. Scandinavian Journal of Clinical and Laboratory Investigation 71(2): 163-167

Gîrleanu, I.; Trifan, A.; Cojocariu, C.; Dimache, M.; Sîngeap, A.-M.; Stoica, O.; Sfarti, C.; Stanciu, C. 2013: Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 117(3): 641-647

Varol, E.; Uysal, B.A.; Ozaydin, M. 2011: Platelet indices in patients with pulmonary arterial hypertension. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 17(6): E171-E174

Varol, E. 2014: Platelet indices in patients with unexplained recurrent miscarriage: related factors should be considered. Archives of Gynecology and Obstetrics 290(3): 407-408

Varol, E. 2013: Platelet indices in renovascular thrombosis after a renal transplant. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 11(3): 293

Varol, E.; Ozaydin, M. 2013: Platelet indices in retinal vein occlusion in hypertensive patients. Indian Journal of Ophthalmology 61(11): 692

Yalcinkaya, E.; Celik, M.; Bugan, B. 2013: Platelet indices should not be considered a stand-alone test for monitoring the disease progression. European Review for Medical and Pharmacological Sciences 17(19): 2693

Giovanetti, T.V.; do Nascimento, A.J.é; de Paula, J.P. 2011: Platelet indices: laboratory and clinical applications. Revista Brasileira de Hematologia e Hemoterapia 33(2): 164-165

Aggrey, A.A.; Srivastava, K.; Ture, S.; Field, D.J.; Morrell, C.N. 2013: Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria. Journal of Immunology 190(9): 4685-4691

Sowa, J.M.; Crist, S.A.; Ratliff, T.L.; Elzey, B.D. 2009: Platelet influence on T- and B-cell responses. Archivum Immunologiae et Therapiae Experimentalis 57(4): 235-241

Sørensen, B.; Ingerslev, J.ør. 2010: Platelet infusion supports recombinant factor VIIa in a patient with severe haemophilia a and inhibitor--clinical outcome and laboratory observations. Thrombosis and Haemostasis 103(6): 1275-1276

Desch, S.; Siegemund, A.; Scholz, U.; Adam, N.; Eitel, I.; de Waha, S.; Fürnau, G.; Lurz, P.; Wetzel, S.; Schuler, G.; Thiele, H. 2012: Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 101(2): 117-124

Alesci, S.; Krekeler, S.; Seifried, E.; Miesbach, W. 2012: Platelet inhibition and bleeding complications in patients with haemophilia/von Willebrand's disease and coronary artery disease. Haemophilia: the Official Journal of the World Federation of Hemophilia 18(5): E364-E365

Goldstein, M.R.; Mascitelli, L.; Pezzetta, F. 2010: Platelet inhibition and cancer promotion. Archives of Internal Medicine 170(21): 1943-1944

Blit, P.H.; McClung, W.G.; Brash, J.L.; Woodhouse, K.A.; Santerre, J.P. 2011: Platelet inhibition and endothelial cell adhesion on elastin-like polypeptide surface modified materials. Biomaterials 32(25): 5790-5800

Burcham, P.; Blais, D.; Firstenberg, M.S. 2011: Platelet inhibition and surgical bleeding. A plea for more science and evidence-based guidelines. Circulation Journal: Official Journal of the Japanese Circulation Society 75(12): 2751-2752

Alström, U.; Granath, F.; Oldgren, J.; Ståhle, E.; Tydén, H.; Siegbahn, A. 2009: Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery. Thrombosis Research 124(5): 572-577

Davlouros, P.; Mavronasiou, E.; Damelou, A.; Xanthopoulou, I.; Gizas, V.; Raptis, G.; Hahalis, G.; Alexopoulos, D. 2013: Platelet inhibition by IV glyceryl trinitrate in patients with stable coronary artery disease on dual antiplatelet therapy subjected to PCi. International Journal of Cardiology 168(3): 3069-3070

Christ, G.ün.; Hafner, T.; Siller-Matula, J.M.; Francesconi, M.; Grohs, K.; Wilhelm, E.; Podczeck-Schweighofer, A. 2013: Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy. Thrombosis Research 132(1): E36-E41

Nakagawa, I.; Wada, T.; Park, H.S.; Nishimura, F.; Yamada, S.; Nakagawa, H.; Kichikawa, K.; Nakase, H. 2014: Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis. Journal of Vascular Surgery 59(3): 761-767

Kim, I-Suk.; Jeong, Y-Hoon.; Park, Y.; Park, K-Soo.; Yun, S-Eun.; Park, J-Rang.; Hwang, S-Jae.; Koh, E-Ha.; Kwak, C.Hwan.; Hwang, J-Yong.; Kim, S. 2011: Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype. Jacc. Cardiovascular Interventions 4(4): 381-391

Srihirun, S.; Sriwantana, T.; Unchern, S.; Kittikool, D.; Noulsri, E.; Pattanapanyasat, K.; Fucharoen, S.; Piknova, B.; Schechter, A.N.; Sibmooh, N. 2012: Platelet inhibition by nitrite is dependent on erythrocytes and deoxygenation. Plos one 7(1): E30380

Aguiar, C. 2012: Platelet inhibition in acute coronary syndromes: a complex intervention that needs optimization. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 31(4): 275-277

Meyer, S. 2012: Platelet inhibition in clinical practice. Therapeutische Umschau. Revue Therapeutique 69(11): 631-633

Lippi, G.; Franchini, M.; Favaloro, E.J. 2010: Platelet inhibition with cangrelor. New England Journal of Medicine 362(11): 1049; Author Reply 1049

Wong, B.Y.L. 2013: Platelet inhibition with cangrelor during PCI. New England Journal of Medicine 369(4): 393

Harrington, R.A.; Stone, G.W.; McNulty, S.; White, H.D.; Lincoff, A.Michael.; Gibson, C.Michael.; Pollack, C.V.; Montalescot, G.; Mahaffey, K.W.; Kleiman, N.S.; Goodman, S.G.; Amine, M.; Angiolillo, D.J.; Becker, R.C.; Chew, D.P.; French, W.J.; Leisch, F.; Parikh, K.H.; Skerjanec, S.; Bhatt, D.L. 2009: Platelet inhibition with cangrelor in patients undergoing PCI. New England Journal of Medicine 361(24): 2318-2329

Serebruany, V.L. 2009: Platelet inhibition with prasugrel and increased cancer risks: potential causes and implications. American Journal of Medicine 122(5): 407-408

Stiefelhagen, P. 2014: Platelet inhibitor and oral anticoagulants. Discontinue antithrombotic drugs before colonoscopy?. MMW Fortschritte der Medizin 156(15): 22

Löser, C.; Zeymer, U.; Nast, A. 2013: Platelet inhibitors and anticoagulants: managing blood thinners in dermatosurgery. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 64(8): 553-557

Gebhard, C.; Beer, J. 2012: Platelet inhibitors in clinical practice. Therapeutische Umschau. Revue Therapeutique 69(11): 617-629

Wynn, R.L. 2010: Platelet inhibitors: update on clopidogrel (Plavix) and the recently approved prasugrel (Effient). General Dentistry 58(1): 7-9

Tempelhof, M.W.; Newby, L.K. 2008: Platelet inhibitors: what are the data in women?. Cardiology in Review 16(1): 23-29

Schiff, M.; Hochberg, M.C.; Oldenhof, J.; Brune, K. 2009: Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin. Current Medical Research and Opinion 25(10): 2471-2477

Hernández-Ruiz, L.; Sáez-Benito, A.; Pujol-Moix, N.; Rodríguez-Martorell, J.; Ruiz, F.A. 2009: Platelet inorganic polyphosphate decreases in patients with delta storage pool disease. Journal of Thrombosis and Haemostasis: Jth 7(2): 361-363

Prévost, N.; Kato, H.; Bodin, L.; Shattil, S.J. 2007: Platelet integrin adhesive functions and signaling. Methods in Enzymology 426: 103-115

Ma, Y.-Q.; Qin, J.; Plow, E.F. 2007: Platelet integrin alpha(IIb)beta(3): activation mechanisms. Journal of Thrombosis and Haemostasis: Jth 5(7): 1345-1352

Schmaier, A.A.; Kahn, M.L. 2009: Platelet integrin signaling: wherefore art thou?. Blood 114(13): 2571-2572

De Groot, P.G.; Urbanus, R.T.; Roest, M. 2012: Platelet interaction with the vessel wall. Handbook of Experimental Pharmacology 210: 87-110

Gitz, E.; Koopman, C.D.; Giannas, A.èk.; Koekman, C.A.; van den Heuvel, D.J.; Deckmyn, H.; Akkerman, J.-W.N.; Gerritsen, H.C.; Urbanus, R.T. 2013: Platelet interaction with von Willebrand factor is enhanced by shear-induced clustering of glycoprotein Ibα. Haematologica 98(11): 1810-1818

Smid, J.; Braun-Dullaeus, R.; Gawaz, M.; Langer, H.F. 2009: Platelet interactions as therapeutic targets for prevention of atherothrombosis. Future Cardiology 5(3): 285-296

White, J.G. 2010: Platelet interior imaging technologies. Blood 116(26): 6150-6151

Thornton, P.; McColl, B.W.; Greenhalgh, A.; Denes, A.; Allan, S.M.; Rothwell, N.J. 2010: Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood 115(17): 3632-3639

Bhatia, A.; Dey, P. 2013: Platelet internalization within the cancer cells: what is the significance?. Diagnostic Cytopathology 41(7): 659-660

Ivanov, P.; Gecheva, S.; Tsvyatkovska, T.; Izmailov, A.; Komsa-Penkova, R.; Kovacheva, K.; Konova, E.; Simeonova, M.; Tanchev, S. 2012: Platelet intregrin beta3 A1/A2 polymorphism in women with stillbirth. Akusherstvo i Ginekologiia 51(4): 8-12

Voorzanger-Rousselot, N.; Goehrig, D.; Facon, T.; Clézardin, P.; Garnero, P. 2009: Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma. British Journal of Haematology 145(2): 264-266

Sun, H.; Swaim, A.; Herrera, J.E.; Becker, D.; Becker, L.; Srivastava, K.; Thompson, L.E.; Shero, M.R.; Perez-Tamayo, A.; Suktitipat, B.; Mathias, R.; Contractor, A.; Faraday, N.; Morrell, C.N. 2009: Platelet kainate receptor signaling promotes thrombosis by stimulating cyclooxygenase activation. Circulation Research 105(6): 595-603

Habibi, A.; Esfandbod, M.; Ghafari, M.H.; Khashayar, P.; Najafi, A.; Moharari, R.S. 2011: Platelet kinetics after slow versus standard transfusions: a pilot study. Upsala Journal of Medical Sciences 116(3): 212-215

Everts, P.A.M.; Delawi, D.; Mahoney, C.B.; van Erp, A.; Overdevest, E.P.; van Zundert, A.é; Knape, J.T.A.; Dhert, W.J.A. 2010: Platelet leukocyte gel facilitates bone substitute growth and autologous bone growth in a goat model. Journal of Biomedical Materials Research. Part a 92(2): 746-753

Taguchi, H.; Kataoka, M.; Yanagisawa, R.; Kawakami, T.; Tamura, Y.; Fukuda, K.; Yoshino, H.; Satoh, T. 2012: Platelet level as a new prognostic factor for idiopathic pulmonary arterial hypertension in the era of combination therapy. Circulation Journal: Official Journal of the Japanese Circulation Society 76(6): 1494-1500

Josefsson, E.C.; White, M.J.; Dowling, M.R.; Kile, B.T. 2012: Platelet life span and apoptosis. Methods in Molecular Biology 788: 59-71

Laine, O.; Mäkelä, S.; Mustonen, J.; Helminen, M.; Vaheri, A.; Lassila, R.; Joutsi-Korhonen, L. 2011: Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(6): 468-472

Gavrish, A.S.; Kilimnik, E.N.; Kindzerskaia, O.L. 2012: Platelet link of homeostasis system at modeling of chronic stress situation. Tsitologiia i Genetika 46(4): 59-65

De Castro, J.; Rodríguez, M.C.; Martínez-Zorzano, V.S.; Llanillo, M.; Sánchez-Yagüe, J.ús. 2009: Platelet linoleic acid is a potential biomarker of advanced non-small cell lung cancer. Experimental and Molecular Pathology 87(3): 226-233

Dolegowska, B.; Lubkowska, A.; De Girolamo, L. 2012: Platelet lipidomic. Journal of Biological Regulators and Homeostatic Agents 26(2 Suppl. 1): 23s-33s

O'Donnell, V.B.; Murphy, R.C.; Watson, S.P. 2014: Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. Circulation Research 114(7): 1185-1203

Moroz, A.; Bittencourt, R.A.C.; Almeida, R.P.; Felisbino, S.ér.L.; Deffune, E. 2013: Platelet lysate 3D scaffold supports mesenchymal stem cell chondrogenesis: an improved approach in cartilage tissue engineering. Platelets 24(3): 219-225

Yamauchi, T.; Saito, H.; Ito, M.; Shichinohe, H.; Houkin, K.; Kuroda, S. 2014: Platelet lysate and granulocyte-colony stimulating factor serve safe and accelerated expansion of human bone marrow stromal cells for stroke therapy. Translational Stroke Research 5(6): 701-710

Müller, A.M.; Davenport, M.; Verrier, S.; Droeser, R.; Alini, M.; Bocelli-Tyndall, C.; Schaefer, D.J.; Martin, I.; Scherberich, A. 2009: Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Engineering. Part a 15(4): 869-875

Bieback, K. 2013: Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures. Transfusion Medicine and Hemotherapy: Offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhamatologie 40(5): 326-335

Leotot, J.; Coquelin, L.; Bodivit, G.; Bierling, P.; Hernigou, P.; Rouard, H.; Chevallier, N. 2013: Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation. Acta Biomaterialia 9(5): 6630-6640

Crespo-Diaz, R.; Behfar, A.; Butler, G.W.; Padley, D.J.; Sarr, M.G.; Bartunek, J.; Dietz, A.B.; Terzic, A. 2011: Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplantation 20(6): 797-811

Sandri, G.; Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Mori, M.; Cervio, M.; Riva, F.; Liakos, I.; Athanassiou, A.; Saporito, F.; Marini, L.; Caramella, C. 2015: Platelet lysate embedded scaffolds for skin regeneration. Expert Opinion on Drug Delivery 12(4): 525-545

Zaky, S.H.; Ottonello, A.; Strada, P.; Cancedda, R.; Mastrogiacomo, M. 2008: Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. Journal of Tissue Engineering and Regenerative Medicine 2(8): 472-481

Sandri, G.; Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Mori, M.; Del Fante, C.; Perotti, C.; Scudeller, L.; Caramella, C. 2011: Platelet lysate formulations based on mucoadhesive polymers for the treatment of corneal lesions. Journal of Pharmacy and Pharmacology 63(2): 189-198

Fekete, N.; Gadelorge, M.él.; Fürst, D.; Maurer, C.; Dausend, J.; Fleury-Cappellesso, S.; Mailänder, V.; Lotfi, R.; Ignatius, A.; Sensebé, L.; Bourin, P.; Schrezenmeier, H.; Rojewski, M.T. 2012: Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. CytoTherapy 14(5): 540-554

El Backly, R.; Ulivi, V.; Tonachini, L.; Cancedda, R.; Descalzi, F.; Mastrogiacomo, M. 2011: Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response. Tissue Engineering. Part a 17(13-14): 1787-1800

Ranzato, E.; Martinotti, S.; Volante, A.; Mazzucco, L.; Burlando, B. 2011: Platelet lysate modulates MMP-2 and MMP-9 expression, matrix deposition and cell-to-matrix adhesion in keratinocytes and fibroblasts. Experimental Dermatology 20(4): 308-313

Ranzato, E.; Mazzucco, L.; Patrone, M.; Burlando, B. 2009: Platelet lysate promotes in vitro wound scratch closure of human dermal fibroblasts: different roles of cell calcium, P38, ERK and PI3K/AKT. Journal of Cellular and Molecular Medicine 13(8b): 2030-2038

Jonsdottir-Buch, S.M.; Lieder, R.; Sigurjonsson, O.E. 2013: Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. Plos one 8(7): E68984

Hayon, Y.; Dashevsky, O.; Shai, E.; Varon, D.; Leker, R.R. 2013: Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke. Thrombosis and Haemostasis 110(2): 323-330

Polasek, J. 2009: Platelet lysosomal acid phosphatase enzyme activity as a marker of platelet procoagulant activity. Blood Transfusion 7(2): 155-156

Mohana Rao, V.; Sridevi, K.; Anandraj, M.P.J.S. 2012: Platelet m-calpain: a facile marker and STR polymorphism analysis for the identification of true carriers of Duchenne muscular dystrophy. Integrative Biology: Quantitative Biosciences from Nano to Macro 4(2): 202-208

Rowley, J.W.; Schwertz, Hörg.; Weyrich, A.S. 2012: Platelet mRNA: the meaning behind the message. Current Opinion in Hematology 19(5): 385-391

Gupta, A.K.; Sethi, B.B.; Trivedi, J.K. 1985: Platelet mao activity in chronic schizophrenia. Indian Journal of Psychiatry 27(4): 279-286

Sharma, I.; Kumar, A.; Chansouria, J.P. 1990: Platelet mao activity in subgroups of schizophrenia. Indian Journal of Psychiatry 32(4): 324-329

Ranucci, M.; Nano, G.; Pazzaglia, A.; Bianchi, P.; Casana, R.; Tealdi, D.G. 2007: Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. Journal of Cardiothoracic and Vascular Anesthesia 21(6): 851-854

Nelles, N.J.; Chandler, W.L. 2014: Platelet mapping assay interference due to platelet activation in heparinized samples. American Journal of Clinical Pathology 142(3): 331-338

Ravid, K. 2008: Platelet marginal bands: not so marginal. Blood 111(9): 4423

Cullen, A. 2013: Platelet margination in postpartum haemorrhage. British Journal of Anaesthesia 110(6): 1052-1053

Dalamaga, M.; Karmaniolas, K.; Lekka, A.; Antonakos, G.; Thrasyvoulides, A.; Papadavid, E.; Spanos, N.; Dionyssiou-Asteriou, A. 2010: Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. Disease Markers 29(1): 55-61

Zaccardi, F.; Rocca, B.; Pitocco, D.; Tanese, L.; Rizzi, A.; Ghirlanda, G. 2015: Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis. Diabetes/Metabolism Research and Reviews 31(4): 402-410

ten Berg, M.J.; van Solinge, W.W.; van den Bemt, P.M.L.A.; Huisman, A.; Schobben, A.F.A.M.; Egberts, T.C.G. 2009: Platelet measurements versus discharge diagnoses for identification of patients with potential drug-induced thrombocytopenia: a cross-sectional study in the Netherlands. Drug Safety 32(1): 69-76

Qiu, Y.; Brown, A.C.; Myers, D.R.; Sakurai, Y.; Mannino, R.G.; Tran, R.; Ahn, B.; Hardy, E.T.; Kee, M.F.; Kumar, S.; Bao, G.; Barker, T.H.; Lam, W.A. 2014: Platelet mechanosensing of substrate stiffness during clot formation mediates adhesion, spreading, and activation. Proceedings of the National Academy of Sciences of the United States of America 111(40): 14430-14435

Peerschke, E.I.B.; Yin, W.; Ghebrehiwet, B. 2008: Platelet mediated complement activation. Advances in Experimental Medicine and Biology 632: 81-91

Arutiunian, A.V.; Evsiukova, E.V.; Stepanov, M.G.; Kolesova, T.A.; Androsova, N.E. 2011: Platelet melatonin levels in healthy donors. Klinicheskaia Laboratornaia Diagnostika 5: 45-46

Nurden, A.T. 2007: Platelet membrane glycoproteins: a look back into the past and a view to the future. Thrombosis and Haemostasis 98(1): 49-54

Schaer, D.A.; Penn, J.; Jagpal, S.; Parikh, A. 2014: Platelet membrane potential: unable to pull the plug on sepsis. Critical Care 18(3): 428

Lewandrowski, U.; Wortelkamp, S.; Lohrig, K.; Zahedi, R.é P.; Wolters, D.A.; Walter, U.; Sickmann, A. 2009: Platelet membrane proteomics: a novel repository for functional research. Blood 114(1): E10-E19

Ahmad, S.S.; Walsh, P.N. 1994: Platelet membrane-mediated coagulation protease complex assembly. Trends in Cardiovascular Medicine 4(6): 271-278

Svensson Holm, A.-C.B.; Bengtsson, T.ör.; Grenegård, M.; Lindström, E.G. 2011: Platelet membranes induce airway smooth muscle cell proliferation. Platelets 22(1): 45-55

Hitzler, W.; Vamvakas, E.C. 2011: Platelet microRNA Profiles and the Effect of Pathogen Reduction on Platelet Function. Clinical Laboratory 57(7-8): 451-454

Stakos, D.A.; Gatsiou, A.; Stamatelopoulos, K.; Tselepis, A.D.; Stellos, K. 2013: Platelet microRNAs: from platelet biology to possible disease biomarkers and therapeutic targets. Platelets 24(8): 579-589

Curtis, A.M.; FitzGerald, G.A. 2013: Platelet microRNAs: Novy Mir* or mired in human complexity?. Circulation Research 112(4): 576-578

Warkentin, T.E. 2014: Platelet microparticle generation assay for detection of HIT antibodies: advance, retreat, or too soon to tell?. Thrombosis Research 133(6): 957-958

Mullier, F.; Minet, V.; Bailly, N.; Devalet, B.; Douxfils, J.; Chatelain, C.; Elalamy, I.; Dogné, J.M.; Chatelain, B. 2014: Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis. Thrombosis Research 133(6): 1068-1073

Darnige, L.; Helley, D.; Fischer, A.M.; Emmerich, J.; Smadja, D.M.; Fiessinger, J.N. 2010: Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation. Journal of Cellular and Molecular Medicine 14(1-2): 449-451

Forestier, M.; Reséndiz, J.C.; Pontiggia, L.; Lassila, R.; Beer, J.H. 2008: Platelet microparticle suppressing antibody against GP Ibalpha acts independently of the filamin cleavage and increases protein tyrosine phosphorylation. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 19(8): 801-806

Raturi, A.; Miersch, S.; Hudson, J.W.; Mutus, B. 2008: Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. Biochimica et Biophysica Acta 1778(12): 2790-2796

Dong, J-Fei. 2014: Platelet microparticles are not created equal. Blood 124(14): 2161-2162

Mause, S.F.; Ritzel, E.; Liehn, E.A.; Hristov, M.; Bidzhekov, K.; Müller-Newen, G.; Soehnlein, O.; Weber, C. 2010: Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 122(5): 495-506

Tantawy, A.A.G.; Matter, R.M.; Hamed, A.A.; Shams El Din El Telbany, M.A. 2010: Platelet microparticles in immune thrombocytopenic purpura in pediatrics. Pediatric Hematology and Oncology 27(4): 283-296

Faille, Dée.; Combes, Véry.; Mitchell, A.J.; Fontaine, A.; Juhan-Vague, Iène.; Alessi, M-Christine.; Chimini, G.; Fusaï, T.; Grau, G.E. 2009: Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 23(10): 3449-3458

Helley, D.; Banu, E.; Bouziane, A.; Banu, A.; Scotte, F.; Fischer, A-Marie.; Oudard, Séphane. 2009: Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. European Urology 56(3): 479-484

Burnouf, T.; Goubran, H.Alphonse.; Chou, M-Li.; Devos, D.; Radosevic, M. 2014: Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Reviews 28(4): 155-166

Pisetsky, D.S. 2011: Platelet microparticles: making blood a bad humor. Journal of Rheumatology 38(4): 590-592

Mause, S.F. 2013: Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis. Thrombosis and Haemostasis 109(1): 5-6

Doshi, N.; Orje, J.N.; Molins, B.; Smith, J.W.; Mitragotri, S.; Ruggeri, Z.M. 2012: Platelet mimetic particles for targeting thrombi in flowing blood. Advanced Materials 24(28): 3864-3869

Avila, C.; Huang, R.J.; Stevens, M.V.; Aponte, A.M.; Tripodi, D.; Kim, K.Y.; Sack, M.N. 2012: Platelet mitochondrial dysfunction is evident in type 2 diabetes in association with modifications of mitochondrial anti-oxidant stress proteins. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 120(4): 248-251

Sjövall, F.; Hansson, M.J.; Elmér, E. 2012: Platelet mitochondrial function in sepsis. Critical Care Medicine 40(1): 357; Author Reply 357-8

Zharikov, S.; Shiva, S. 2013: Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease. Biochemical Society Transactions 41(1): 118-123

Gründler, K.; Angstwurm, M.; Hilge, R.; Baumann, P.; Annecke, T.; Crispin, A.; Sohn, H.-Y.; Massberg, S.; Kraemer, B.F. 2014: Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcome. Critical Care 18(1): R31

Yamakawa, K.; Ogura, H.; Koh, T.; Ogawa, Y.; Matsumoto, N.; Kuwagata, Y.; Shimazu, T. 2013: Platelet mitochondrial membrane potential correlates with severity in patients with systemic inflammatory response syndrome. Journal of Trauma and Acute Care Surgery 74(2): 411-417; Discussion 418

Kuiper, G.J.A.J.M.; Lancé, M.D.; Smit-Fun, V.M.; Peeters, L.L.H.; Marcus, M.A.E. 2011: Platelet monitoring follow-up in a pregnant patient with HELLP syndrome. Platelets 22(2): 160-163

Tantry, U.S.; Gurbel, P.A. 2009: Platelet monitoring for PCI: is it really necessary?. Hamostaseologie 29(4): 368-375

Capodanno, D.; Angiolillo, D.J. 2009: Platelet monitoring for PCI: which test is the one to choose?. Hamostaseologie 29(4): 376-380

Gustavson, C.; Wass, C.; Mansson, J.-E.; Blennow, K.; Forsman, A.; Anckarsater, H.; Nilsson, T. 2010: Platelet monoamine oxidase B activity did not predict destructive personality traits or violent recidivism: a prospective study in male forensic psychiatric examinees. Neuropsychobiology 61(2): 87-96

Nedic, G.; Pivac, N.; Hercigonja, D.K.; Jovancevic, M.; Curkovic, K.D.; Muck-Seler, D. 2010: Platelet monoamine oxidase activity in children with attention-deficit/hyperactivity disorder. Psychiatry Research 175(3): 252-255

Wargelius, H.-L.; Fahlke, C.; Suomi, S.J.; Oreland, L.; Higley, J.D. 2010: Platelet monoamine oxidase activity predicts alcohol sensitivity and voluntary alcohol intake in rhesus monkeys. Upsala Journal of Medical Sciences 115(1): 49-55

Nurden, P.; Nurden, A.T.; La Marca, S.; Punzo, M.; Baronciani, L.; Federici, A.B. 2009: Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene. Haematologica 94(11): 1627-1629

Zvetkova, E.; Antonova, N.; Ivanov, I.; Savov, Y.; Gluhcheva, Y. 2010: Platelet morphological, functional and rheological properties attributable to addictions. Clinical Hemorheology and Microcirculation 45(2-4): 245-251

Latger-Cannard, Véronique.; Fenneteau, O.; Salignac, S.; Lecompte, T.Pierre.; Schlegel, N. 2013: Platelet morphology analysis. Methods in Molecular Biology 992: 207-225

Chaves, F. 2012: Platelet morphology: reliable technology doesn't require duplication. Mlo: Medical Laboratory Observer 44(8): 28; 30 32 Passim

Skorczewski, T.; Erickson, L.C.; Fogelson, A.L. 2013: Platelet motion near a vessel wall or thrombus surface in two-dimensional whole blood simulations. Biophysical Journal 104(8): 1764-1772

Aburima, A.; Naseem, K.M. 2014: Platelet myosin light chain phosphatase: keeping it together. Biochemical Society Transactions 42(2): 279-283

Tilan, J.U.; Everhart, L.M.; Abe, K.; Kuo-Bonde, L.; Chalothorn, D.; Kitlinska, J.; Burnett, M.Susan.; Epstein, S.E.; Faber, J.E.; Zukowska, Z. 2013: Platelet neuropeptide Y is critical for ischemic revascularization in mice. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(6): 2244-2255

Radhakrishnan, K. 2013: Platelet neutralization test. Methods in Molecular Biology 992: 349-351

Garelnabi, M.; Gupta, V.; Mallika, V.; Bhattacharjee, J. 2011: Platelet nitric oxide signaling system in patients with coronary artery disease. Annals of Vascular Diseases 4(2): 99-105

Rajappa, M.; Chandrashekar, L.; Sundar, I.; Munisamy, M.; Ananthanarayanan, P.H.; Thappa, D.M.; Toi, P.C. 2013: Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria. Clinical Chemistry and Laboratory Medicine 51(9): 1789-1794

Wang, B.; Wang, Y.-q.; Cao, S.-h.; Liang, Y. 2011: Platelet parameters and platelet Toll-like receptor 4 (TLR4) expression in patients with sepsis, and the effect of a joint treatment-plan integrating traditional Chinese and western medicine: a clinical study. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 23(10): 616-620

Smith, J.R.; Smith, K.F.; Brainard, B.M. 2014: Platelet parameters from an automated hematology analyzer in dogs with inflammatory clinical diseases. Veterinary Journal 201(3): 406-411

Sit, M.; Aktaş, G.ül.; Yilmaz, E.E.; Hakyemez, I.N.; Alçelik, A.; Küçükbayrak, A.ül. 2013: Platelet parameters in hepatic hydatid cysts. International Journal of Inflammation 2013: 593273

Nardi, M.A.; Gor, Y.; Feinmark, S.J.; Xu, F.; Karpatkin, S. 2007: Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase. Blood 110(6): 1989-1996

White, J.G.; Cocking-Johnson, D.; Krumwiede, M. 1990: Platelet particle processing: an example of surface sorting on single cells. Platelets 1(4): 205-211

Zlobina, G.P.; Brusov, O.S.; Morozova, M.A.; Beniashvili, A.G. 2009: Platelet peculiarities in chronic schizophrenic patients. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(10): 47-50

Mathewkutty, S.; McGuire, D.K. 2009: Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment. Expert Review of Cardiovascular Therapy 7(5): 541-549

Campbell, V.; Fosbury, E.; Bain, B.J. 2009: Platelet phagocytosis as a cause of pseudothrombocytopenia. American Journal of Hematology 84(6): 362

Senzel, L.; Chang, C. 2013: Platelet phagocytosis by neutrophils. Blood 122(9): 1543

Zuern, C.S.; Schwab, M.; Gawaz, M.; Geisler, T. 2010: Platelet pharmacogenomics. Journal of Thrombosis and Haemostasis: Jth 8(6): 1147-1158

Thijs, T.; Nuyttens, B.P.; Deckmyn, H.; Broos, K. 2010: Platelet physiology and antiplatelet agents. Clinical Chemistry and Laboratory Medicine 48(Suppl 1): S3-13

Zucker, M.B. 1990: Platelet physiology: a personal perspective. Platelets 1(1): 3-9

Eso, Y.; Marusawa, H.; Chiba, T. 2013: Platelet plays a role in the pathogenesis of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 144(5): 1140-1142

Ashavaid, T.F.; Todur, S.P.; Kondkar, A.A.; Nair, K.G.; Shalia, K.K.; Dalal, J.J.; Rajani, R.; Ponde, C.K. 2011: Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population. Platelets 22(2): 85-91

Mackman, N.; Gruber, A. 2010: Platelet polyphosphate: an endogenous activator of coagulation factor XIi. Journal of Thrombosis and Haemostasis: Jth 8(5): 865-867

Müller, F.; Mutch, N.J.; Schenk, W.A.; Smith, S.A.; Esterl, L.; Spronk, H.M.; Schmidbauer, S.; Gahl, W.A.; Morrissey, J.H.; Renné, T. 2009: Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139(6): 1143-1156

Kerbiriou-Nabias, D.èl. 2010: Platelet polyphosphates: new mediators linking thrombosis with inflammation. Medecine Sciences: M/S 26(4): 343-346

Müller, F.; Renné, T. 2011: Platelet polyphosphates: the nexus of primary and secondary hemostasis. Scandinavian Journal of Clinical and Laboratory Investigation 71(2): 82-86

Golubchik, P.; Mozes, T.; Vered, Y.; Weizman, A. 2009: Platelet poor plasma serotonin level in delinquent adolescents diagnosed with conduct disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33(7): 1223-1225

Pleass, R.J. 2009: Platelet power: sticky problems for sticky parasites?. Trends in Parasitology 25(7): 296-299

Schwertz, H.ör.; Weyrich, A.S. 2010: Platelet precursors display bipolar behavior. Journal of Cell Biology 191(4): 699-700

Ohto, H. 2011: Platelet preservation: past, present, and future. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 44(3): 269

Pradella, P.; Bonetto, S.; Turchetto, S.; Uxa, L.; Comar, C.; Zorat, F.; De Angelis, V.; Pozzato, G. 2011: Platelet production and destruction in liver cirrhosis. Journal of Hepatology 54(5): 894-900

Barsam, S.J.; Psaila, B.; Forestier, M.; Page, L.K.; Sloane, P.A.; Geyer, J.T.; Villarica, G.O.; Ruisi, M.M.; Gernsheimer, T.B.; Beer, J.H.; Bussel, J.B. 2011: Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood 117(21): 5723-5732

Morrow, T. 2008: Platelet production bolstered with romiplostim approval. Managed Care 17(10): 49-50

Kosaki, G. 2008: Platelet production by megakaryocytes: protoplatelet theory justifies cytoplasmic fragmentation model. International Journal of Hematology 88(3): 255-267

Petrosian, E.A.; Botashev, A.A.; Tereshchenko, O.A.; Laĭpanov, A.M.; Ivanov, V.V. 2010: Platelet production of nitric oxide in experimental bile peritonitis. Eksperimental'naia i Klinicheskaia Gastroenterologiia 10: 64-66

Lodise, T.P.; Fang, E.; Minassian, S.L.; Prokocimer, P.G. 2014: Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials. Antimicrobial Agents and ChemoTherapy 58(12): 7198-7204

Sak, M.Erdal.; Soydinç, H.Ender.; Ozler, A.; Evsen, M.Sıddık.; Turgut, Aülkadir.; Sak, S.; Gül, T. 2012: Platelet profile in patients with gestational diabetes: a retrospective study. Journal of the Turkish German Gynecological Association 13(4): 223-226

Martínez-Salazar, E.L.; Tobón-Castaño, A. 2014: Platelet profile is associated with clinical complications in patients with vivax and falciparum malaria in Colombia. Revista da Sociedade Brasileira de Medicina Tropical 47(3): 341-349

Sturm, A.; Hebestreit, H.; Koenig, C.; Walter, U.; Grossmann, R. 2010: Platelet proinflammatory activity in clinically stable patients with CF starts in early childhood. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 9(3): 179-186

Boulaftali, Y.; Ho-Tin-Noe, B.; Pena, A.; Loyau, Séphane.; Venisse, L.; François, Déborah.; Richard, B.; Arocas, Véronique.; Collet, J-Philippe.; Jandrot-Perrus, M.; Bouton, M-Christine. 2011: Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation 123(12): 1326-1334

Chen, W.-F.; Lee, J.-J.; Chang, C.-C.; Lin, K.-H.; Wang, S.-H.; Sheu, J.-R. 2013: Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets. Haematologica 98(5): 793-801

Maeda, N.Y.; Carvalho, J.ão.H.; Otake, A.éi.H.; Mesquita, S.M.F.; Bydlowski, S.ér.P.; Lopes, A.A. 2010: Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension. Thrombosis Research 125(1): 38-43

Wiisanen, M.E.; Moliterno, D.J. 2012: Platelet protease-activated receptor antagonism in cardiovascular medicine. Coronary Artery Disease 23(6): 375-379

Stavenuiter, F.; Davis, N.F.; Duan, E.; Gale, A.J.; Heeb, M.J. 2013: Platelet protein S directly inhibits procoagulant activity on platelets and microparticles. Thrombosis and Haemostasis 109(2): 229-237

Goswami, K.; Bhatla, B.D.; Shankar, R. 2000: Platelet protein damage by free radicals and glycationin vitro: the pathological consequences. Indian Journal of Clinical Biochemistry: Ijcb 15(1): 11-16

Van Nispen Tot Pannerden, H.E.; van Dijk, S.M.; Du, V.; Heijnen, H.F.G. 2009: Platelet protein disulfide isomerase is localized in the dense tubular system and does not become surface expressed after activation. Blood 114(21): 4738-4740

Jalagadugula, G.; Mao, G.; Kaur, G.; Dhanasekaran, D.N.; Rao, A.K. 2011: Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1. Arteriosclerosis Thrombosis and Vascular Biology 31(4): 921-927

Van der Meijden, P.E.; Heemskerk, J.W. 2012: Platelet protein shake as playmaker. Blood 120(15): 2931-2932

Volpi, E.; Giusti, L.; Ciregia, F.; Da Valle, Y.; Giannaccini, G.; Berti, S.; Clerico, A.; Lucacchini, A. 2012: Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention. Clinical Biochemistry 45(10-11): 758-765

Almog, N.; Klement, G.L. 2010: Platelet proteome and tumor dormancy: can platelets content serve as predictive biomarkers for exit of tumors from dormancy?. Cancers 2(2): 842-858

Della Corte, A.; Tamburrelli, C.; Crescente, M.; Giordano, L.; D'Imperio, M.; Di Michele, M.; Donati, M.B.; De Gaetano, G.; Rotilio, D.; Cerletti, C. 2012: Platelet proteome in healthy volunteers who smoke. Platelets 23(2): 91-105

Zufferey, A.; Fontana, P.; Reny, J-Luc.; Nolli, S.; Sanchez, J-Charles. 2012: Platelet proteomics. Mass Spectrometry Reviews 31(2): 331-351

Liu, Y.; Yin, H.; Chen, K. 2013: Platelet proteomics and its advanced application for research of blood stasis syndrome and activated blood circulation herbs of Chinese medicine. Science China. Life Sciences 56(11): 1000-1006

Parguiña, A.és.F.; García, A. 2012: Platelet proteomics in transfusion medicine: a reality with a challenging but promising future. Blood Transfusion 10(Suppl 2): S113-S114

Senis, Y.; García, A. 2012: Platelet proteomics: state of the art and future perspective. Methods in Molecular Biology 788: 367-399

Tynngård, N.; Trinks, M.; Berlin, G.ös. 2010: Platelet quality after washing: the effect of storage time before washing. Transfusion 50(12): 2745-2752

Maurer-Spurej, E.; Labrie, A.; Pittendreigh, C.; Chipperfield, K.; Smith, C.; Heddle, N.; Liu, Y.; Yi, Q.-L.; Barnett, M. 2009: Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion 49(11): 2276-2284

Valeri, C.Robert.; Ragno, G. 2007: Platelet radiolabeling procedure. Transfusion 47(5): 946

Lotta, L.A.; Lombardi, R.; Mariani, M.; Lancellotti, S.; De Cristofaro, R.; Hollestelle, M.J.; Canciani, M.T.; Mannucci, P.M.; Peyvandi, F. 2011: Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission. Journal of Thrombosis and Haemostasis: Jth 9(9): 1744-1751

Sibbing, D.; Braun, S.; Morath, T.; Mehilli, J.; Vogt, W.; Schömig, A.; Kastrati, A.; von Beckerath, N. 2009: Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. Journal of the American College of Cardiology 53(10): 849-856

Price, M.J. 2013: Platelet reactivity after coronary stenting. Lancet 382(9892): 583-584

Legrand, V.; Cuisset, T.; Chenu, P.; Vrolix, M.; Martinez, C.; Dens, J.; Gach, O.; Boland, J.; Claeys, M.J.; Magne, J.; Barbato, E.; Wijns, W. 2014: Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 10(2): 204-211

Staritz, P.; Kurz, K.; Stoll, M.; Giannitsis, E.; Katus, H.A.; Ivandic, B.T. 2009: Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene. International Journal of Cardiology 133(3): 341-345

Di Minno, M.N.D.; Iervolino, S.; Peluso, R.; Scarpa, R.; Di Minno, G. 2012: Platelet reactivity and disease activity in subjects with psoriatic arthritis. Journal of Rheumatology 39(2): 334-336

Bray, P.F. 2006: Platelet reactivity and genetics down on the pharm. Transactions of the American Clinical and Climatological Association 117: 103-111; Discussion: 111-112

Vila, P.M.; Zafar, M.U.; Badimon, J.J. 2009: Platelet reactivity and nonresponse to dual antiplatelet therapy: a review. Platelets 20(8): 531-538

Di Sciascio, G.; Mangiacapra, F. 2012: Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?. Journal of the American College of Cardiology 60(5): 378-380

Flood, K.; Peace, A.; Kent, E.; Tedesco, T.; Dicker, P.; Geary, M.; Malone, F.D.; Kenny, D. 2010: Platelet reactivity and pregnancy loss. American Journal of Obstetrics and Gynecology 203(3): 281.E1-5

Vaduganathan, M.; Alviar, C.L.; Arikan, M.E.; Tellez, A.; Guthikonda, S.; DeLao, T.; Granada, J.F.; Kleiman, N.S.; Ballantyne, C.M.; Lev, E.I. 2008: Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. American Heart Journal 156(5): 1002.E1-1002.E7

Perez de Prado, A.; Cuellas, C.; Diego, A.; de Miguel, A.; Fernandez-Vazquez, F. 2009: Platelet reactivity and stent thrombosis: still some issues to solve. Journal of the American College of Cardiology 54(7): 666-7; author reply 667-8

Darling, C.E.; Michelson, A.D.; Volturo, G.A.; Przyklenk, K. 2009: Platelet reactivity and the identification of acute coronary syndromes in the emergency department. Journal of Thrombosis and Thrombolysis 28(1): 31-37

Singla, A.; Bliden, K.P.; Jeong, Y.-H.; Abadilla, K.; Antonino, M.J.; Muse, W.C.; Mathew, D.P.; Bailon, O.; Tantry, U.S.; Gurbel, P.A. 2013: Platelet reactivity and thrombogenicity in postmenopausal women. Menopause 20(1): 57-63

Van Werkum, J.W.; Ten Berg, J.ën.M. 2008: Platelet reactivity as a risk-factor for stent thrombosis: can this be one of the currently available appropriate methods to determine platelet reactivity?. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 4 Suppl C: C11-C16

Louden, K.A. 2014: Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study. Bjog: An International Journal of Obstetrics and Gynaecology 121(12): 1580

Alexopoulos, D.; Xanthopoulou, I.; Storey, R.F.; Bliden, K.P.; Tantry, U.S.; Angiolillo, D.J.; Gurbel, P.A. 2014: Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis. American Heart Journal 168(4): 530-536

Alexandru, N.; Georgescu, A.; Amuzescu, M.; Zamfir, C.; Badila, A.; Popov, D. 2011: Platelet Reactivity in Chronic Venous Insufficiency. Clinical Laboratory 57(7-8): 527-534

Steblovnik, K.; Blinc, A.; Bozic-Mijovski, M.; Kranjec, I.; Melkic, E.; Noc, M. 2015: Platelet reactivity in comatose survivors of cardiac arrest undergoing percutaneous coronary intervention and hypothermia. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 10(12): 1418-1424

Scheinowitz, M.; Pakala, R.; Ben-Dor, I.; Lemesle, G.; Torguson, R.; Pichard, A.D.; Lindsay, J.; Waksman, R. 2011: Platelet reactivity in diabetic patients subjected to acute exercise stress test. Cardiovascular Revascularization Medicine: Including Molecular Interventions 12(1): 20-24

Cuisset, T.; Gaborit, B.én.éd.; Dubois, N.ém.; Quilici, J.; Loosveld, M.; Beguin, S.; Loundou, A.D.é; Moro, P.J.; Morange, P.E.; Alessi, M.-C.; Dutour, A.; Bonnet, J.-L. 2013: Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy. International Journal of Cardiology 168(1): 523-528

Bouganim, T.; Shapira, Y.; Sagie, A.; Vaturi, M.; Battler, A.; Kornowski, R.; Lev, E.I. 2009: Platelet reactivity in patients with a history of obstructive prosthetic valve thrombosis. American Journal of Cardiology 103(12): 1760-1763

Woo, J.S.; Kim, W.; Lee, S.R.; Jung, K.H.; Kim, W.S.; Lew, J.H.; Lee, T.W.; Lim, C.K. 2011: Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: results of the effect of platelet inhibition according to clopidogrel dose in patients with chronic kidney disease (PIANO-2 CKD) randomized study. American Heart Journal 162(6): 1018-1025

Montoro-García, S.; Shantsila, E.; Lip, G.Y.H. 2011: Platelet reactivity in prolonged stress disorders--a link with cardiovascular disease?. Psychoneuroendocrinology 36(2): 159-160

Mylotte, D.; Kavanagh, G.F.; Peace, A.J.; Tedesco, A.F.; Carmody, D.; O'Reilly, M.; Foley, D.P.; Thompson, C.J.; Agha, A.; Smith, D.; Kenny, D. 2012: Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control. Platelets 23(6): 439-446

Zufferey, A.; Reny, J.-L.; Combescure, C.; de Moerloose, P.; Sanchez, J.-C.; Fontana, P. 2011: Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients. Thrombosis and Haemostasis 106(3): 466-474

Breet, N.J.; ten Berg, J.M. 2014: Platelet reactivity is preferred over genotyping in monitoring efficacy of antiplatelet therapy. JACC. Cardiovascular Interventions 7(4): 448

Alexopoulos, D.; Xanthopoulou, I.; Stavrou, K.; Hahalis, G.; Davlouros, P. 2013: Platelet reactivity measurements reveal patient noncompliance during ticagrelor maintenance therapy. Canadian Journal of Cardiology 29(12): 1743.E13-14

Małek, L.A.; Bilińska, Z.T.; Sitkiewicz, D.; Kłopotowski, M.; Witkowski, A.; Ruzyłło, W. 2010: Platelet reactivity on aspirin, clopidogrel and abciximab in patients with acute coronary syndromes and reduced estimated glomerular filtration rate. Thrombosis Research 125(1): 67-71

Van Werkum, J.W.; Ten Berg, J.ën.M. 2011: Platelet reactivity over time: solid as a rock or not durable?. Thrombosis and Haemostasis 105(1): 3-4

Raison, C. 2013: Platelet reactivity test could predict risk of stent-associated adverse ischemic events. Expert Review of Molecular Diagnostics 13(7): 652

Steiner, S.; Moertl, D. 2013: Platelet reactivity tests for assessing antiplatelet drug response: what the clinician needs to know. Expert Review of Cardiovascular Therapy 11(8): 975-984

Gurbel, P.A.; Antonino, M.J.; Bliden, K.P.; Dichiara, J.; Suarez, T.A.; Singla, A.; Tantry, U.S. 2008: Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target. Platelets 19(8): 595-604

Frelinger, A.L. 2010: Platelet reactivity with prolonged aspirin treatment--steady going at 2 year. Circulation Journal: Official Journal of the Japanese Circulation Society 74(6): 1077-1078

Ostojic, L.; Zelenika, D.; Zotz, R.B.; Sucker, C.; Ostojic, Z.; Loncar, R. 2007: Platelet receptor HPA-1 polymorphism of alphaIIbbeta3 and 807 C/T polymorphism of alpha2beta1 and Buerger's disease. Angiology 58(2): 169-174

Gardiner, E.E.; Andrews, R.K. 2014: Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein Vi. Transfusion Medicine Reviews 28(2): 56-60

Daga, S.; Shepherd, J.G.; Callaghan, J.G.S.; Hung, R.K.Y.; Dawson, D.K.; Padfield, G.J.; Hey, S.Y.; Cartwright, R.A.; Newby, D.E.; Fitzgerald, J.R. 2011: Platelet receptor polymorphisms do not influence Staphylococcus aureus-platelet interactions or infective endocarditis. Microbes and Infection 13(3): 216-225

Farndale, R.W.; Slatter, D.A.; Siljander, P.R.-M.; Jarvis, G.E. 2007: Platelet receptor recognition and cross-talk in collagen-induced activation of platelets. Journal of Thrombosis and Haemostasis: Jth 5(Suppl 1): 220-229

Gardiner, E.E.; Al-Tamimi, M.; Andrews, R.K.; Berndt, M.C. 2012: Platelet receptor shedding. Methods in Molecular Biology 788: 321-339

Stegner, D.; Nieswandt, B. 2011: Platelet receptor signaling in thrombus formation. Journal of Molecular Medicine 89(2): 109-121

Kauskot, A.; Hoylaerts, M.F. 2012: Platelet receptors. Handbook of Experimental Pharmacology 2012(210): 23-57

Ozaki, Y.; Suzuki-Inoue, K.; Inoue, O. 2013: Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb-IX-V, and CLEC-2. Journal of Thrombosis and Haemostasis: Jth 11(Suppl 1): 330-339

Rivera, J.é; Lozano, M.ía.L.; Navarro-Núñez, L.; Vicente, V. 2009: Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 94(5): 700-711

Saboor, M.; Ayub, Q.; Ilyas, S.; Moinuddin 2013: Platelet receptors; an instrumental of platelet physiology. Pakistan Journal of Medical Sciences 29(3): 891-896

Doescher, A.; Petershofen, E.K.; Hertenstein, B.; Kraemer, D.; Casper, J.; Schmidt, Jörg-Peter.; Müller, T.H. 2015: Platelet recovery and survival measured in patients by quantitative polymerase chain reaction of mitochondrial DNA. Transfusion 55(1): 55-63

Prébet, T.; Ladaique, P.; Ferrando, M.; Chabannon, C.; Faucher, C.; De Lavallade, H.; El-Cheikh, J.; Furst, S.; Vey, N.; Stoppa, A-Marie.; Viens, P.; Blaise, D.; Mohty, M. 2010: Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation. Experimental Hematology 38(1): 55-60

Alatrash, G.; Pelosini, M.; Saliba, R.M.; Koca, E.; Rondon, G.; Andersson, B.S.; Chiattone, A.; Zhang, W.; Giralt, S.A.; Cernosek, A.M.; Kebriaei, P.; Alousi, A.M.; Popat, U.R.; Hosing, C.; Khouri, I.F.; Champlin, R.E.; de Lima, M.J. 2011: Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 17(12): 1841-1845

Liu, C.; Kallogjeri, D.; Dynis, M.; Grossman, B.J. 2013: Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura. Transfusion 53(5): 1096-1107

Devi, S.; Kuligowski, M.P.; Kwan, R.Y.Q.; Westein, E.; Jackson, S.P.; Kitching, A.R.; Hickey, M.J. 2010: Platelet recruitment to the inflamed glomerulus occurs via an alphaIIbbeta3/GPVI-dependent pathway. American Journal of Pathology 177(3): 1131-1142

McDonald, D.M.; O'Kane, F.; McConville, M.; Devine, A.B.; McVeigh, G.E. 2013: Platelet redox balance in diabetic patients with hypertension improved by n-3 fatty acids. Diabetes Care 36(4): 998-1005

Repossini, A.; Bloch, D.; Muneretto, C.; Piccoli, P.; Bisleri, G.; Beholz, S. 2012: Platelet reduction after stentless pericardial aortic valve replacement. Interactive Cardiovascular and Thoracic Surgery 14(4): 434-438

Arber, C.; Bertrand, G.; Halter, J.ör.; Boehlen, F.ço.; Kaplan, C.éc.; Gratwohl, A. 2007: Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay. British Journal of Haematology 139(1): 159-161

Kirwan, C.C.; Byrne, G.J.; Kumar, S.; McDowell, G. 2009: Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer. Journal of Angiogenesis Research 1: 7

Lippross, S.; Loibl, M.; Hoppe, S.; Meury, T.; Benneker, L.; Alini, M.; Verrier, S. 2011: Platelet released growth factors boost expansion of bone marrow derived CD34(+) and CD133(+) endothelial progenitor cells for autologous grafting. Platelets 22(6): 422-432

Baghai, M.; Tamura, N.; Beyersdorf, F.; Henze, M.; Prucker, O.; Rühe, J.ür.; Goto, S.; Zieger, B.; Heilmann, C. 2014: Platelet repellent properties of hydrogel coatings on polyurethane-coated glass surfaces. Asaio Journal 60(5): 587-593

Dieter, R.S.; Lopez, J.J.; Nanjundappa, A. 2011: Platelet resistance - much known and much more unknown. Journal of Invasive Cardiology 23(1): 14

Kumar, A.; Kao, J. 2009: Platelet resistance to antiplatelet drugs. Recent Patents on Cardiovascular Drug Discovery 4(2): 98-108

Anfossi, G.; Russo, I.; Trovati, M. 2006: Platelet resistance to the anti-aggregating agents in the insulin resistant states. Current Diabetes Reviews 2(4): 409-430

Jayachandran, M.; Miller, V.M.; Brunn, G.J.; Owen, W.G. 2010: Platelet response as a sentinel marker of toll-like receptor 4 activation in mice. Thrombosis Research 126(5): 414-417

Pignatti, F.; Flores, B.; Jonsson, B. 2012: Platelet response as the basis for approval in chronic immune (idiopathic) thrombocytopenic purpura (ITP): a regulatory perspective. American Journal of Hematology 87(10): 943-944

Munnix, I.C.A.; Cosemans, J.M.E.M.; Auger, J.M.; Heemskerk, J.W.M. 2009: Platelet response heterogeneity in thrombus formation. Thrombosis and Haemostasis 102(6): 1149-1156

Bhatt, D.L.; Kottke-Marchant, K.; Alexander, J.H.; Peacock, W.F.; Sabatine, M.S. 2009: Platelet response in practice: Applying new insights and tools for testing and treatment. Cleveland Clinic Journal of Medicine 76(Suppl 1): S24-S32

Scandellari, R.; Allemand, E.; Vettore, S.; Plebani, M.; Randi, M.L.; Fabris, F. 2009: Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene a antibodies. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 20(2): 108-113

Berent, R.; Auer, J.; Franklin, B.; Schmid, P.; von Duvillard, S.P. 2011: Platelet response to aspirin 50 and 100 mg in patients with coronary heart disease over a five-year period. American Journal of Cardiology 108(5): 644-650

Madsen, E.H.; Gehr, N.R.; Johannesen, N.L.; Schmidt, E.B.; Kristensen, S.ør.R. 2011: Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis. Platelets 22(7): 537-546

Morel, O.; Ohlmann, P.; Bareiss, P. 2007: Platelet response to aspirin and clopidogrel. Biochemical evaluation, clinical impact, and pharmacological modulation. Archives des Maladies du Coeur et des Vaisseaux 100(12): 992-1002

Yi, X.; Zhou, Q.; Lin, J.; Chi, L.; Han, Z. 2013: Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. Journal of Atherosclerosis and Thrombosis 20(1): 65-72

Schulz, S.; Sibbing, D.; Braun, S.; Morath, T.; Mehilli, J.; Massberg, S.; Byrne, R.A.; Schömig, A.; Kastrati, A. 2010: Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents. American Heart Journal 160(2): 355-361

Kim, D.A.; McClure, W.G.; Neighoff, J.B.; Vaidya, D.; Williams, M.S. 2014: Platelet response to serotonin in patients with stable coronary heart disease. American Journal of Cardiology 114(2): 181-186

Milicic, D.; Lovric, D.; Skoric, B.; Narancic-Skoric, K.; Gornik, I.; Sertic, J. 2011: Platelet response to standard aspirin and clopidogrel treatment correlates with long-term outcome in patients with acute ST-elevation myocardial infarction. International Journal of Cardiology 153(2): 227-229

Goldstein, L.S. 1949: Platelet response to vitamin B complex in the newborn period. New York State Journal of Medicine 49(10): 1191

Kakinoki, S.; Yui, N.; Yamaoka, T. 2013: Platelet responses to dynamic biomaterial surfaces with different poly(ethylene glycol) and polyrotaxane molecular architectures constructed on gold substrates. Journal of Biomaterials Applications 28(4): 544-551

Liang, X.M.; Han, S.J.; Reems, J-Anna.; Gao, D.; Sniadecki, N.J. 2010: Platelet retraction force measurements using flexible post force sensors. Lab on a Chip 10(8): 991-998

Mehta, S.; Watson, J.T. 2008: Platelet rich concentrate: basic science and current clinical applications. Journal of Orthopaedic Trauma 22(6): 432-438

Deepak, B.S.; Nandini, D.B. 2014: Platelet rich concentrates: a quick healer. Journal of Pharmacy and Bioallied Sciences 6(2): 133-134

Sambhav, J.; Rohit, R.; Ranjana, M.; Shalabh, M. 2014: Platelet rich fibrin (Prf) and β-tricalcium phosphate with coronally advanced flap for the management of grade-Ii furcation defect. Ethiopian Journal of Health Sciences 24(3): 269-272

Hotwani, K.; Sharma, K. 2014: Platelet rich fibrin - a novel acumen into regenerative endodontic therapy. Restorative Dentistry and Endodontics 39(1): 1-6

Panda, S.; Ramamoorthi, S.; Jayakumar, N.D.; Sankari, M.; Varghese, S.S. 2014: Platelet rich fibrin and alloplast in the treatment of intrabony defect. Journal of Pharmacy and Bioallied Sciences 6(2): 127-131

Panda, S.; Jayakumar, N.D.; Sankari, M.; Varghese, S.S.; Kumar, D.S. 2014: Platelet rich fibrin and xenograft in treatment of intrabony defect. Contemporary Clinical Dentistry 5(4): 550-554

Gigante, A.; Del Torto, M.; Manzotti, S.; Cianforlini, M.; Busilacchi, A.; Davidson, P.A.; Greco, F.; Mattioli-Belmonte, M. 2012: Platelet rich fibrin matrix effects on skeletal muscle lesions: an experimental study. Journal of Biological Regulators and Homeostatic Agents 26(3): 475-484

Desarda, H.Megharaj.; Gurav, A.N.; Gaikwad, S.P.; Inamdar, S.P. 2013: Platelet rich fibrin: a new hope for regeneration in aggressive periodontitis patients: report of two cases. Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research 24(5): 627-630

Hall, M.P.; Ward, J.P.; Cardone, D.A. 2013: Platelet rich placebo? Evidence for platelet rich plasma in the treatment of tendinopathy and augmentation of tendon repair. Bulletin of the Hospital for Joint Disease 71(1): 54-59

Banfi, G. 2012: Platelet rich plasma. Journal of Biological Regulators and Homeostatic Agents 26(2 Suppl. 1): 1

Sánchez, M.; Delgado, D.; Sánchez, P.; Fiz, N.ás.; Azofra, J.; Orive, G.; Anitua, E.; Padilla, S. 2014: Platelet rich plasma and knee surgery. Biomed Research International 2014: 890630

Del Buono, A.; Papalia, R.; Denaro, V.; Maccauro, G.; Maffulli, N. 2011: Platelet rich plasma and tendinopathy: state of the art. International Journal of Immunopathology and Pharmacology 24(1 Suppl 2: 79-83

Peng, Y.; Huang, S.; Wu, Y.; Cheng, B.; Nie, X.; Liu, H.; Ma, K.; Zhou, J.; Gao, D.; Feng, C.; Yang, S.; Fu, X. 2013: Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments. Stem Cells and Development 22(24): 3236-3251

El Backly, R.M.; Zaky, S.H.; Canciani, B.; Saad, M.M.; Eweida, A.M.; Brun, F.; Tromba, G.; Komlev, V.S.; Mastrogiacomo, M.; Marei, M.K.; Cancedda, R. 2014: Platelet rich plasma enhances osteoconductive properties of a hydroxyapatite-β-tricalcium phosphate scaffold (Skelite) for late healing of critical size rabbit calvarial defects. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery 42(5): E70-E79

Mehrannia, M.; Vaezi, M.; Yousefshahi, F.; Rouhipour, N. 2014: Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report. Canadian Journal of Diabetes 38(1): 5-8

Abate, M.; Di Gregorio, P.; Schiavone, C.; Salini, V.; Tosi, U.; Muttini, A. 2012: Platelet rich plasma in tendinopathies: how to explain the failure. International Journal of Immunopathology and Pharmacology 25(2): 325-334

Longo, F.; Guida, A.; Aversa, C.; Pavone, E.; Di Costanzo, G.; Ramaglia, L.; Ionna, F. 2014: Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature. International Journal of Dentistry 2014: 298945

Sampson, S.; Gerhardt, M.; Mandelbaum, B. 2008: Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Current Reviews in Musculoskeletal Medicine 1(3-4): 165-174

Elgazzar, R.F.; Mutabagani, M.A.; Abdelaal, S.E.; Sadakah, A.A. 2008: Platelet rich plasma may enhance peripheral nerve regeneration after cyanoacrylate reanastomosis: a controlled blind study on rats. International Journal of Oral and Maxillofacial Surgery 37(8): 748-755

Andia, I.; Sánchez, M.; Maffulli, N. 2011: Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice?. Expert Opinion on Biological Therapy 11(4): 509-518

Andia, I. 2014: Platelet rich plasma therapies: a great potential to be harnessed. Muscles Ligaments and Tendons Journal 4(1): 1-2

Galliera, E.; Corsi, M.M.; Banfi, G. 2012: Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. Journal of Biological Regulators and Homeostatic Agents 26(2 Suppl 1: 35s-42s

Rutkowski, J.L.; Johnson, D.A.; Radio, N.M.; Fennell, J.W. 2010: Platelet rich plasma to facilitate wound healing following tooth extraction. Journal of Oral Implantology 36(1): 11-23

Monto, R.R. 2012: Platelet rich plasma treatment for chronic Achilles tendinosis. Foot and Ankle International 33(5): 379-385

Tonk, G.; Kumar, A.; Gupta, A. 2014: Platelet rich plasma versus laser therapy in lateral epicondylitis of elbow. Indian Journal of Orthopaedics 48(4): 390-393

Acosta-Olivo, C.; Esponda-Colmenares, F.; Vilchez-Cavazos, F.él.; Lara-Arias, J.; Mendoza-Lemus, O.; Ramos-Morales, T. 2014: Platelet rich plasma versus oral paracetamol for the treatment of early knee osteoarthritis. Preliminary study. Cirugia y Cirujanos 82(2): 163-169

Mei-Dan, O.; Laver, L.; Nyska, M.; Mann, G. 2011: Platelet rich plasma--a new biotechnology for treatment of sports injuries. Harefuah 150(5): 453-457; 490

De La Mata, J.é 2013: Platelet rich plasma. a new treatment tool for the rheumatologist?. Reumatologia Clinica 9(3): 166-171

Perdisa, F.; Filardo, G.; Di Matteo, B.; Marcacci, M.; Kon, E. 2014: Platelet rich plasma: a valid augmentation for cartilage scaffolds? a systematic review. Histology and Histopathology 29(7): 805-814

Wang, H.-L.; Avila, G. 2007: Platelet rich plasma: myth or reality?. European Journal of Dentistry 1(4): 192-194

Griffin, X.L.; Wallace, D.; Parsons, N.; Costa, M.L. 2012: Platelet rich therapies for long bone healing in adults. Cochrane Database of Systematic Reviews 7: Cd009496

Randriamboavonjy, V.; Pistrosch, F.; Bölck, B.; Schwinger, R.H.G.; Dixit, M.; Badenhoop, K.; Cohen, R.A.; Busse, R.; Fleming, I. 2008: Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation 117(1): 52-60

Padayatty, J.; Grigoropoulos, N.; Gilligan, D.; Follows, G.A. 2010: Platelet satellitism. European Journal of Haematology 84(4): 366

Mourad, S.de.Carvalho.; Takihi, I.Yoko.; Sandes, A.Freire. 2013: Platelet satellitism. Revista Brasileira de Hematologia e Hemoterapia 35(4): 293

Latger-Cannard, V.ér.; Debourgogne, A.; Montagne, K.; Plénat, F.ço.; Lecompte, T. 2009: Platelet satellitism and lympho-agglutination as presenting finding in marginal zone B-cell lymphoma. European Journal of Haematology 83(1): 81-82

Bobba, R.K.; Doll, D.C. 2012: Platelet satellitism as a cause of spurious thrombocytopenia. Blood 119(18): 4100

Kopcinovic, L.M.; Pavic, M. 2012: Platelet satellitism in a trauma patient. Biochemia Medica 22(1): 130-134

Ye, S.; Huang, Y.; Joshi, S.; Zhang, J.; Yang, F.; Zhang, G.; Smyth, S.S.; Li, Z.; Takai, Y.; Whiteheart, S.W. 2014: Platelet secretion and hemostasis require syntaxin-binding protein STXBP5. Journal of Clinical Investigation 124(10): 4517-4528

Nakamura, L.; Sandrock-Lang, K.; Speckmann, C.; Vraetz, T.; Bührlen, M.; Ehl, S.; Heemskerk, J.W.M.; Zieger, B. 2013: Platelet secretion defect in a patient with stromal interaction molecule 1 deficiency. Blood 122(22): 3696-3698

Sandrock, K.; Nakamura, L.; Vraetz, T.; Beutel, K.; Ehl, S.; Zieger, B. 2010: Platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5). Blood 116(26): 6148-6150

White, G.C.; Rompietti, R. 2007: Platelet secretion: indiscriminately spewed forth or highly orchestrated?. Journal of Thrombosis and Haemostasis: Jth 5(10): 2006-2008

Kasperek, K.; Lombeck, I.; Kiem, J.; Iyengar, G.V.; Wang, Y.X.; Feinendegen, L.E.; Bremer, H.J. 1982: Platelet selenium in children with normal and low selenium intake. Biological Trace Element Research 4(1): 29-34

Paul S. Hartley 2007: Platelet Senescence and Death. Clinical Laboratory 53(3-4): 157-166

Dasgupta, S.K.; Argaiz, E.R.; Mercado, J.E.C.; Maul, H.O.E.; Garza, J.; Enriquez, A.B.; Abdel-Monem, H.; Prakasam, A.; Andreeff, M.; Thiagarajan, P. 2010: Platelet senescence and phosphatidylserine exposure. Transfusion 50(10): 2167-2175

Dowling, M.R.; Josefsson, E.C.; Henley, K.J.; Hodgkin, P.D.; Kile, B.T. 2010: Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood 116(10): 1776-1778

Brusov, O.S.; Faktor, M.I.; Zlobina, G.P.; Dupin, A.M.; Katasonov, A.B.; Dmitriev, A.D.; Pavlova, E.V.; Beniashvili, A.G.; Morozova, M.A. 2007: Platelet serotonergic parameters and clinical symptoms of psychosis in patients with episodic progressive schizophrenia. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 107(4): 17-24

Schäfer, A.; Scheurlen, M.; Seufert, J.; Keicher, C.; Weissbrich, B.; Rieger, P.; Kraus, M.R. 2010: Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression. Journal of Hepatology 52(1): 10-15

Ruljancic, N.; Mihanovic, M.; Cepelak, I.; Bakliza, A.; Curkovic, K.D. 2013: Platelet serotonin and magnesium concentrations in suicidal and non-suicidal depressed patients. Magnesium Research 26(1): 9-17

Mimica, N.; Mück-Seler, D.; Pivac, N.; Mustapić, M.; Dezeljin, M.; Stipcević, T.; Presecki, P.; Radonić, E.; Folnegović-Smalc, V. 2008: Platelet serotonin and monoamine oxidase in Alzheimer's disease with psychotic features. Collegium Antropologicum 32(Suppl 1): 119-122

Llinás, S.G.; Caballero, A.J.; Peñalver, J.C.; Valdés, R. 2014: Platelet serotonin concentration and clinical status in alcohol withdrawal syndrome, preliminary results. Medicc Review 16(1): 37-42

Stipcevic, T.; Kusacic-Kuna, S.; Dezeljin, M.; Dodig, D.; Korsic, M.; Pivac, N.; Muck-Seler, D. 2009: Platelet serotonin concentration and monoamine oxidase activity in hypothyroid patients. Hormone Research 71(4): 207-212

Muck-Seler, D.; Presecki, P.; Mimica, N.; Mustapic, M.; Pivac, N.; Babic, A.; Nedic, G.; Folnegovic-Smalc, V. 2009: Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33(7): 1226-1231

Gall, V.; Kosec, V.; Vranes, H.S.ć; Jukić, M.; Filipović-Djaković, I.; Vuković, A. 2011: Platelet serotonin concentration at term pregnancy and after birth: physiologic values for Croatian population. Collegium Antropologicum 35(3): 715-718

Hercigonja Novkovic, V.; Rudan, V.; Pivac, N.; Nedic, G.; Muck-Seler, D. 2009: Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder. Neuropsychobiology 59(1): 17-22

Ulrich, S.; Huber, L.C.; Fischler, M.; Treder, U.; Maggiorini, M.; Eberli, F.R.; Speich, R. 2011: Platelet serotonin content and transpulmonary platelet serotonin gradient in patients with pulmonary hypertension. Respiration; International Review of Thoracic Diseases 81(3): 211-216

Sarac, H.; Markeljevic, J.; Mokrovic, G.; Erdeljic, V.; Bozina, N.; Cicin-Sain, L. 2012: Platelet serotonin in primary Sjögren's syndrome: level and relation with disease activity. Journal of Neuroimmunology 251(1-2): 87-89

Ghosh, D. 2008: Platelet serotonin level and its correlation with finger length relation. Indian Journal of Psychiatry 50(4): 253-256

Dupuis, L.; Spreux-Varoquaux, O.; Bensimon, G.; Jullien, P.; Lacomblez, L.; Salachas, F.ço.; Bruneteau, G.ël.; Pradat, P.-F.ço.; Loeffler, J.-P.; Meininger, V. 2010: Platelet serotonin level predicts survival in amyotrophic lateral sclerosis. Plos one 5(10): E13346

Banović, M.; Bordukalo-Niksić, T.; Balija, M.; Cicin-Sain, L.; Jernej, B. 2010: Platelet serotonin transporter (5HTt): physiological influences on kinetic characteristics in a large human population. Platelets 21(6): 429-438

Sigurdh, J.; Allard, P.; Spigset, O.; Hägglöf, B. 2013: Platelet serotonin transporter and 5-HT2A receptor binding in adolescents with eating disorders. International Journal of Neuroscience 123(5): 333-338

Kang, E.-H.; Shim, H.-B.; Kim, K.-J.; Park, J.-E.; Lee, I.-S.; Yu, B.-H. 2010: Platelet serotonin transporter function after short-term paroxetine treatment in patients with panic disorder. Psychiatry Research 176(2-3): 250-253

Kang, E.-H.; Lee, I.-S.; Park, J.-E.; Kim, K.-J.; Yu, B.-H. 2010: Platelet serotonin transporter function and heart rate variability in patients with panic disorder. Journal of Korean Medical Science 25(4): 613-618

Scharinger, C.; Rabl, U.; Kasess, C.H.; Meyer, B.M.; Hofmaier, T.; Diers, K.; Bartova, L.; Pail, G.; Huf, W.; Uzelac, Z.; Hartinger, B.; Kalcher, K.; Perkmann, T.; Haslacher, H.; Meyer-Lindenberg, A.; Kasper, S.; Freissmuth, M.; Windischberger, C.; Willeit, M.äu.; Lanzenberger, R.; Esterbauer, H.; Brocke, B.; Moser, E.; Sitte, H.H.; Pezawas, L. 2014: Platelet serotonin transporter function predicts default-mode network activity. Plos one 9(3): E92543

Fisar, Z.; Kalisová, L.; Paclt, I.; Anders, M.; Vevera, J. 2008: Platelet serotonin uptake in drug-naïve depressive patients before and after treatment with citalopram. Psychiatry Research 161(2): 185-194

Aslan, J.E.; Itakura, A.; Gertz, J.M.; McCarty, O.J.T. 2012: Platelet shape change and spreading. Methods in Molecular Biology 788: 91-100

Crook, M. 1990: Platelet sialic Acid and its significance to platelet life-spans. Platelets 1(3): 167

Stalker, T.J.; Newman, D.K.; Ma, P.; Wannemacher, K.M.; Brass, L.F. 2012: Platelet signaling. Handbook of Experimental Pharmacology 2012(210): 59-85

Lombardi, F.; De Chaumont, C.án.; Shields, D.C.; Moran, N. 2012: Platelet signalling networks: pathway perturbation demonstrates differential sensitivity of ADP secretion and fibrinogen binding. Platelets 23(1): 17-25

Boughton, B.J.; Macwhannell, A.; Simpson, A.; Hawker, R. 1990: Platelet size and adenine nucleotides in patients undergoing bone marrow ablation: a useful model for studying platelet ageing. Platelets 1(1): 21-24

Chesnutt, J.K.W.; Han, H.-C. 2013: Platelet size and density affect shear-induced thrombus formation in tortuous arterioles. Physical Biology 10(5): 056003

Noris, P.; Klersy, C.; Zecca, M.; Arcaini, L.; Pecci, A.; Melazzini, F.; Terulla, V.; Bozzi, V.; Ambaglio, C.; Passamonti, F.; Locatelli, F.; Balduini, C.L. 2009: Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. Journal of Thrombosis and Haemostasis: Jth 7(12): 2131-2136

Watts, E. 1990: Platelet size does not change in the thrombocytosis of prolonged exercise. Platelets 1(2): 89-90

Aksoy, S.; Kilickap, S.; Hayran, M.; Harputluoglu, H.; Koca, E.; Dede, D.S.; Erman, M.; Turker, A. 2008: Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. International Journal of Laboratory Hematology 30(3): 214-219

Falet, H.é 2012: Platelet size: finding the right balance. Blood 119(12): 2702-2703

Fernández Bello, I.; Álvarez, M.ía.T.; López-Longo, F.J.; Arias-Salgado, E.G.; Martín, M.ón.; Jiménez-Yuste, V.íc.; Rodríguez de la Rúa, A.; Butta, N.V. 2012: Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients. Thrombosis and Haemostasis 107(1): 88-98

Arachiche, A.; de la Fuente, M.ía.; Nieman, M.T. 2014: Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse platelets. Plos one 9(5): E97724

Eder, A.F.; Moroff, G. 2010: Platelet storage and adverse transfusion outcomes: old platelets?. Transfusion 50(11): 2288-2291

Del Proposto, G.; Cerrone, P.; Sansone, L.; Daniele, N.; Sinopoli, S.; Lanti, A.; Ferraro, A.S.; Adorno, G.; Isacchi, G. 2012: Platelet storage and flow cytometry, an interesting couple. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 47(1): 121-122

Hornsey, V.S.; McColl, K.; Drummond, O.; Macgregor, I.R.; Prowse, C.V. 2008: Platelet storage in Fresenius/NPBi polyolefin and BTHC-PVC bags: a direct comparison. Transfusion Medicine 18(4): 223-227

Thon, J.N.; Schubert, P.; Devine, D.V. 2008: Platelet storage lesion: a new understanding from a proteomic perspective. Transfusion Medicine Reviews 22(4): 268-279

Bayraktaroglu, Z.; Yilmaz, N.; Cicek, H.K.; Karafak, A.; Gül, E. 2007: Platelet storage time and cytokine (IL-2R, IL-8, TNF-alpha) levels. Eastern Mediterranean Health Journal 13(1): 79-84

White, J.G.; Thomas, A. 2009: Platelet structural pathology in a patient with the X-linked GATA-1, R216Q mutation. Platelets 20(1): 41-49

Mininkova, A.I. 2010: Platelet structure and functions (a review of literature). Part 1. Klinicheskaia Laboratornaia Diagnostika 2010(11): 21-26

Frankhauser, P.; Baranyai, R.; Ahrens, T.; Schloss, P.; Deuschle, M.; Lederbogen, F. 2008: Platelet surface P-selectin expression is highly correlated with serotonin transporter density in human subjects. Thrombosis and Haemostasis 100(6): 1201-1203

Bahou, W.F. 2012: Platelet systems biology using integrated genetic and proteomic platforms. Thrombosis Research 129(Suppl 1): S38-S45

Farías, G.; Pérez, P.; Slachevsky, A.; Maccioni, R.B. 2012: Platelet tau pattern correlates with cognitive status in Alzheimer's disease. Journal of Alzheimer's Disease: Jad 31(1): 65-69

Tomlinson, M.G. 2009: Platelet tetraspanins: small but interesting. Journal of Thrombosis and Haemostasis: Jth 7(12): 2070-2073

Angiolillo, D.J.; Capodanno, D.; Goto, S. 2010: Platelet thrombin receptor antagonism and atherothrombosis. European Heart Journal 31(1): 17-28

Bravo, C.; Majó, J.; Ruiz, F.; Muntaner, L.; Monforte, V.íc.; Solé, J.; Maestre, J.é; Morell, F.; Roman, A. 2009: Platelet thromboembolism after lung transplantation. Journal of Transplantation 2009: 650703

Zucker, H.D. 1949: Platelet thrombosis in human hemostasis; a histologic study of skin wounds in normal and purpuric individuals. Blood 4(5): 631-645

Zucker, H.D. 1948: Platelet thrombosis in human hemostatis; a histologic study of skin wounds in normal and in purpuric individuals. American Journal of Pathology 24(3): 705

Lopez, L.R.; Guyer, K.E.; Torre, I.G.D.L.; Pitts, K.R.; Matsuura, E.; Ames, P.R. 2014: Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. World Journal of Diabetes 5(2): 115-127

Bouchard, B.A.; Krudysz-Amblo, J.; Butenas, S. 2012: Platelet tissue factor is not expressed transiently after platelet activation. Blood 119(18): 4338-9; author reply 4339-41

Maroney, S.A.; Mast, A.E. 2012: Platelet tissue factor pathway inhibitor modulates intravascular coagulation. Thrombosis Research 129(Suppl 2): S21-S22

Gerrits, A.J.; Koekman, C.A.; van Haeften, T.W.; Akkerman, J.W.N. 2010: Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes 59(6): 1487-1495

Key, N.S. 2008: Platelet tissue factor: how did it get there and is it important?. Seminars in Hematology 45(2 Suppl 1: S16-S20

Mackman, N.; Luther, T. 2013: Platelet tissue factor: to be or not to be. Thrombosis Research 132(1): 3-5

Raungkaewmanee, S.; Tangjitgamol, S.; Manusirivithaya, S.; Srijaipracharoen, S.; Thavaramara, T. 2012: Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. Journal of Gynecologic Oncology 23(4): 265-273

Akkaya, E.; Gul, M.; Ugur, M. 2014: Platelet to lymphocyte ratio: a simple and valuable prognostic marker for acute coronary syndrome. International Journal of Cardiology 177(2): 597-598

Lood, C.; Amisten, S.; Gullstrand, B.; Jönsen, A.; Allhorn, M.; Truedsson, L.; Sturfelt, G.; Erlinge, D.; Bengtsson, A.A. 2010: Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type i interferon system is strongly associated with vascular disease. Blood 116(11): 1951-1957

Senzel, L.; Gnatenko, D.V.; Bahou, W.F. 2007: Platelet transcriptome and cardiovascular disease. Future Cardiology 3(4): 391-398

Cid, J.; Harm, S.K.; Yazer, M.H. 2013: Platelet transfusion - the art and science of compromise. Transfusion Medicine and Hemotherapy: Offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhamatologie 40(3): 160-171

Wenzel, F.; Günther, W.; Baertl, A.; Gruber, W.; Sorg, R.üd.V.; Haas, R.; Giers, G.ün. 2012: Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia. Transfusion 52(6): 1213-1220

Chambost, H. 2014: Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 21(4-5): 210-215

Kim, J.; Yi, N.-J.; Shin, W.Y.; Kim, T.; Lee, K.U.; Suh, K.-S. 2010: Platelet transfusion can be related to liver regeneration after living donor liver transplantation. World Journal of Surgery 34(5): 1052-1058

Pereboom, I.T.A.; de Boer, M.T.; Haagsma, E.B.; Hendriks, H.G.D.; Lisman, T.; Porte, R.J. 2009: Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesthesia and Analgesia 108(4): 1083-1091

Ueda, Y. 2010: Platelet transfusion for patients with haematological diseases--indications and transfusion triggers. Japanese Journal of Clinical Hematology 51(10): 1523-1530

Thiele, T.; Sümnig, A.; Hron, G.; Müller, C.; Althaus, K.; Schroeder, H.W.S.; Greinacher, A. 2012: Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. Journal of Thrombosis and Haemostasis: Jth 10(5): 968-971

Maruyama, T.; Murata, S.; Takahashi, K.; Tamura, T.; Nozaki, R.; Ikeda, N.; Fukunaga, K.; Oda, T.; Sasaki, R.; Ohkohchi, N. 2013: Platelet transfusion improves liver function in patients with chronic liver disease and cirrhosis. Tohoku Journal of Experimental Medicine 229(3): 213-220

Paraskeva, A.; Vassiliou, I.; Vlachos, S. 2008: Platelet transfusion in a patient with thrombotic thrombocytopenic purpura presenting for splenectomy--a case report. Middle East Journal of Anaesthesiology 19(5): 1129-1134

McGrath, T.; Koch, C.G.; Xu, M.; Li, L.; Mihaljevic, T.; Figueroa, P.; Blackstone, E.H. 2008: Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes. Annals of Thoracic Surgery 86(2): 543-553

Christensen, R.D. 2011: Platelet transfusion in the neonatal intensive care unit: benefits, risks, alternatives. Neonatology 100(3): 311-318

Josephson, C.D.; Su, L.L.; Christensen, R.D.; Hillyer, C.D.; Castillejo, M.-I.és.; Emory, M.R.; Lin, Y.; Hume, H.; Easley, K.; Poterjoy, B.; Sola-Visner, M. 2009: Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 123(1): 278-285

Hatakeyama, N.; Hori, T.; Yamamoto, M.; Inazawa, N.; Iesato, K.; Miyazaki, T.; Ikeda, H.; Tsutsumi, H.; Suzuki, N. 2011: Platelet transfusion refractoriness attributable to HLA antibodies produced by donor-derived cells after allogeneic bone marrow transplantation from one HLA-antigen-mismatched mother. Pediatric Transplantation 15(8): E177-E182

Marktel, S.; Napolitano, S.; Zino, E.; Cappelli, B.; Chiesa, R.; Poli, F.; Crocchiolo, R.; Ronchi, P.; Rossini, S.; Ciceri, F.; Roncarolo, M.G.; Fleischhauer, K. 2010: Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation. Pediatric Transplantation 14(3): 393-401

McVey, M.; Cserti-Gazdewich, C.M. 2010: Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HLA. Transfusion Medicine 20(5): 346-353

Podda, G.M.; Ricci, S. 2015: Platelet transfusion strategy for hematologic cancers. Internal and Emergency Medicine 10(1): 81-82

Slichter, S.J. 2007: Platelet transfusion therapy. Hematology/Oncology Clinics of North America 21(4): 697-729 Vii

Thiagarajan, P.; Afshar-Kharghan, V. 2013: Platelet transfusion therapy. Hematology/Oncology Clinics of North America 27(3): 629-643

Razzaghi, A.; Barkun, A.N. 2012: Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review. Journal of Clinical Gastroenterology 46(6): 482-486

Strauss, R.G. 2013: Platelet transfusion volume reduction: it can be done, but why do it?. Transfusion 53(12): 3029-3031

Kaufman, R.M.; Djulbegovic, B.; Gernsheimer, T.; Kleinman, S.; Tinmouth, A.T.; Capocelli, K.E.; Cipolle, M.D.; Cohn, C.S.; Fung, M.K.; Grossman, B.J.; Mintz, P.D.; O'Malley, B.A.; Sesok-Pizzini, D.A.; Shander, A.; Stack, G.E.; Webert, K.E.; Weinstein, R.; Welch, B.G.; Whitman, G.J.; Wong, E.C.; Tobian, A.A.R. 2015: Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 162(3): 205-213

Kumar, A.; Mhaskar, R.; Grossman, B.J.; Kaufman, R.M.; Tobian, A.A.R.; Kleinman, S.; Gernsheimer, T.; Tinmouth, A.T.; Djulbegovic, B. 2015: Platelet transfusion: a systematic review of the clinical evidence. Transfusion 55(5): 1116-1127; Quiz 1115

Washington, C.W.; Schuerer, D.J.E.; Grubb, R.L. 2011: Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. Journal of Trauma 71(2): 358-363

Holbro, A.; Infanti, L.; Sigle, J.ör.; Buser, A. 2013: Platelet transfusion: basic aspects. Swiss Medical Weekly 143: W13885

Andreu, G.; Vasse, J.; Tardivel, R.; Semana, G. 2009: Platelet transfusion: products, indications, dose, threshold and efficacy. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 16(2): 118-133

Stroncek, D.F.; Rebulla, P. 2007: Platelet transfusions. Lancet 370(9585): 427-438

Karkouti, K.; Wijeysundera, D.N.; Beattie, W.Scott. 2007: Platelet transfusions as a risk factor in cardiac surgery. Transfusion 47(9): 1739-40; author reply 1740

Lieberman, L.; Bercovitz, R.S.; Sholapur, N.S.; Heddle, N.M.; Stanworth, S.J.; Arnold, D.M. 2014: Platelet transfusions for critically ill patients with thrombocytopenia. Blood 123(8): 1146-1151; Quiz 1280

Cid, J.; Carbassé, G.; Pereira, A.; Sanz, C.; Mazzara, R.; Escolar, G.és.; Lozano, M. 2011: Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients. Transfusion 51(6): 1163-1169

Perkins, J.D. 2008: Platelet transfusions have a negative impact on liver transplant survival. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 14(5): 701-702

Palo, R.; Capraro, L.; Hanhela, R.; Koivuranta, M.; Nikkinen, L.; Salmenperä, M.; Salonen, I.; Sjövall, S.; Tienhaara, A.; Vähämurto, M.; Mäki, T. 2010: Platelet transfusions in adult patients with particular reference to patients undergoing surgery. Transfusion Medicine 20(1): 30-37

Verma, A.; Pandey, P.; Khetan, D.; Chaudhary, R. 2008: Platelet transfusions in clinical practice at a multidisciplinary hospital in North India. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 39(1): 29-35

Estcourt, L.J.; Birchall, J.; Lowe, D.; Grant-Casey, J.; Rowley, M.; Murphy, M.F. 2012: Platelet transfusions in haematology patients: are we using them appropriately?. Vox Sanguinis 103(4): 284-293

Hopkins, C.K.; Goldfinger, D. 2008: Platelet transfusions in heparin-induced thrombocytopenia: a report of four cases and review of the literature. Transfusion 48(10): 2128-2132

Strauss, R.G. 2010: Platelet transfusions in neonates: questions and answers. Expert Review of Hematology 3(1): 7-9

Rubinstein, P. 2010: Platelet transfusions to HLA-immunized recipients: how to be or not to be matched. Transfusion 50(11): 2292-2294

Blajchman, M.A. 2008: Platelet transfusions: an historical perspective. Hematology. American Society of Hematology. Education Program 2008: 197

Refaai, M.A.; Phipps, R.P.; Spinelli, S.L.; Blumberg, N. 2011: Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thrombosis Research 127(4): 287-291

Spiess, B.D. 2010: Platelet transfusions: the science behind safety, risks and appropriate applications. Best Practice and Research. Clinical Anaesthesiology 24(1): 65-83

Blumberg, N.; Heal, J.M.; Phillips, G.L. 2010: Platelet transfusions: trigger, dose, benefits, and risks. F1000 Medicine Reports 2: 5

Bark, D.L.; Ku, D.N. 2013: Platelet transport rates and binding kinetics at high shear over a thrombus. Biophysical Journal 105(2): 502-511

Larsen, S.B.øj.; Grove, E.L.; Hvas, A.-M.; Kristensen, S.D. 2014: Platelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation. Plos one 9(1): E85566

Arellano-Rodrigo, E.; Alvarez-Larrán, A.; Reverter, J.-C.; Colomer, D.; Villamor, N.; Bellosillo, B.; Cervantes, F. 2009: Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden. American Journal of Hematology 84(2): 102-108

Smith, G.S. 1971: Platelet typing. California Medicine 114(5): 76

Daniele, S.; Da Pozzo, E.; Abelli, M.; Panighini, A.; Pini, S.; Gesi, C.; Lari, L.; Cardini, A.; Cassano, G.B.; Martini, C. 2012: Platelet uptake of GABA and glutamate in patients with bipolar disorder. Bipolar Disorders 14(3): 301-308

Belen, F.B.; Okur, A.; Kulali, F.; Egritas, O.; Kocak, U.; Kaya, Z.; Altuntas, N.; Yenicesu, I. 2012: Platelet usage trends in a tertiary care hospital - could it be less and less expensive?. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 47(1): 101-106

Verma, A.; Agarwal, P. 2009: Platelet utilization in the developing world: strategies to optimize platelet transfusion practices. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 41(2): 145-149

Pieczarka, E.M.; Yamaguchi, M.; Wellman, M.L.; Judith Radin, M. 2014: Platelet vacuoles in a dog with severe nonregenerative anemia: evidence of platelet autophagy. Veterinary Clinical Pathology 43(3): 326-329

Unlu, B.S.; Keles, I.; Acay, A. 2014: Platelet values measurement. what we know about it?. Journal of Obstetrics and Gynaecology Research 40(7): 1955

Ueno, K.; Nomura, Y.; Hashiguchi, T.; Masuda, K.; Morita, Y.; Hazeki, D.; Eguchi, T.; Maruyama, I.; Kawano, Y. 2010: Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. British Journal of Haematology 148(2): 285-292

Zalsman, G.; Aslanov-Farbstein, D.; Rehavi, M.; Roz, N.; Vermeiren, R.; Laor, N.; Weizman, A.; Toren, P. 2011: Platelet vesicular monoamine transporter 2 density in the disruptive behavior disorders. Journal of Child and Adolescent Psychopharmacology 21(4): 341-344

D'Amelio, P.; Cristofaro, M.A.; De Vivo, E.; Ravazzoli, M.; Grosso, E.; Di Bella, S.; Aime, M.; Cotto, N.; Silvagno, F.; Isaia, G.; Pescarmona, G.P. 2012: Platelet vitamin D receptor is reduced in osteoporotic patients. Panminerva Medica 54(3): 225-231

Schwartz, D.; Sharkey, L.; Armstrong, P.J.; Knudson, C.; Kelley, J. 2014: Platelet volume and plateletcrit in dogs with presumed primary immune-mediated thrombocytopenia. Journal of Veterinary Internal Medicine 28(5): 1575-1579

Oge, T.; Yalcin, O.T.; Ozalp, S.S.; Isikci, T. 2013: Platelet volume as a parameter for platelet activation in patients with endometrial cancer. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 33(3): 301-304

Ercan, V. 2015: Platelet volume evaluation in patients with sepsis: associated factors should be considered. African Health Sciences 13(4): 1174-1175

Varol, E.; Peker, R.O. 2013: Platelet volume in cervicocephalic artery dissections. Irish Journal of Medical Science 182(1): 151-152

Kim, Y.Gi.; Suh, J-Won.; Yoon, C-Hwan.; Oh, I-Young.; Cho, Y-Seok.; Youn, T-Jin.; Chae, I-Ho.; Choi, D-Ju. 2014: Platelet volume indices are associated with high residual platelet reactivity after antiplatelet therapy in patients undergoing percutaneous coronary intervention. Journal of Atherosclerosis and Thrombosis 21(5): 445-453

Xu, R-Long.; Zheng, Z-Jing.; Ma, Y-Jun.; Hu, Y-Ping.; Zhuang, S-Hong. 2013: Platelet volume indices have low diagnostic efficiency for predicting bone marrow failure in thrombocytopenic patients. Experimental and Therapeutic Medicine 5(1): 209-214

Mahdavi-Zafarghandi, R.; Shakiba, B.; Keramati, M.Reza.; Tavakkoli, M. 2014: Platelet volume indices in patients with varicocele. Clinical and Experimental Reproductive Medicine 41(2): 92-95

Shihong, I.; Morris, D.; Konkle, B.A. 2009: Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Haemophilia: the Official Journal of the World Federation of Hemophilia 15(1): 131-134

McGrath, R.T.; McRae, E.; Smith, O.P.; O'Donnell, J.S. 2010: Platelet von Willebrand factor--structure, function and biological importance. British Journal of Haematology 148(6): 834-843

Lenting, P.J.; Denis, C.éc.V. 2013: Platelet von Willebrand factor: sweet resistance. Blood 122(25): 4006-4007

Grossman, F.; Manji, H.K.; Potter, W.Z. 1993: Platelet α2-adrenoreceptors in depression: a critical examination. Journal of Psychopharmacology 7(1 Suppl): 4-18

Bennett, J.S. 2014: Platelet αIIbβ3 activation: filling in the pieces. Blood 123(20): 3065-3067

Ludwig, R.J.; Bergmann, P.; Garbaraviciene, J.; von Stebut, E.; Radeke, H.H.; Gille, J.; Diehl, S.; Hardt, K.; Henschler, R.; Kaufmann, R.; Pfeilschifter, J.M.; Boehncke, W-Henning. 2010: Platelet, not endothelial, P-selectin expression contributes to generation of immunity in cutaneous contact hypersensitivity. American Journal of Pathology 176(3): 1339-1345

Mantur, M.; Koper, O. 2008: Platelet- derived growth factor--the construction, role and it's receptors. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(140): 173-176

Jin, Q.; Ma, P.X.; Giannobile, W.V. 2010: Platelet-Derived Growth Factor Delivery via Nanofibrous Scaffolds for Soft-Tissue Repair. Advances in Skin and Wound Care 1: 375-381

Kilvaer, T.Karsten.; Valkov, A.; Sorbye, S.W.; Donnem, T.; Smeland, E.; Bremnes, R.Martin.; Busund, L-Tove. 2010: Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival. Sarcoma 2010: 751304

Edgecombe, M.; Scrutton, M.C.; Kerry, R. 1993: Platelet-Platelet Contact is Required to Observe Guanylate Cyclase Activation in Stimulated Platelets. Platelets 4(3): 141-149

Jayalakshmi, K.B.; Agarwal, S.; Singh, M.P.; Vishwanath, B.T.; Krishna, A.; Agrawal, R. 2012: Platelet-Rich Fibrin with β-Tricalcium Phosphate-A Noval Approach for Bone Augmentation in Chronic Periapical Lesion: A Case Report. Case Reports in Dentistry 2012: 902858

Sarkarat, F.; Kalantar Motamedi, M.H.; Jahanbani, J.; Sepehri, D.; Kahali, R.; Nematollahi, Z. 2014: Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws. Trauma Monthly 19(2): E17196

Soares, R.P.; Aires, F.T.; Bernardo, W.M. 2010: Platelet-Rich Plasma in knee injuries. Revista da Associacao Medica Brasileira 56(3): 263

Saluja, H.; Dehane, V.; Mahindra, U. 2011: Platelet-Rich fibrin: a second generation platelet concentrate and a new friend of oral and maxillofacial surgeons. Annals of Maxillofacial Surgery 1(1): 53-57

Koupenova, M.; Vitseva, O.; MacKay, C.R.; Beaulieu, L.M.; Benjamin, E.J.; Mick, E.; Kurt-Jones, E.A.; Ravid, K.; Freedman, J.E. 2014: Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood 124(5): 791-802

Shim, K.; Anderson, P.J.; Tuley, E.A.; Wiswall, E.; Sadler, J.E. 2008: Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood 111(2): 651-657

Jalil, J.; Jantan, I.; Ghani, A.A.; Murad, S. 2012: Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King. Molecules 17(9): 10893-10901

Kikuchi, M.; Shirasaki, H.; Himi, T. 2008: Platelet-activating factor (PAF) increases NO production in human endothelial cells-real-time monitoring by DAR-4M AM. Prostaglandins Leukotrienes and Essential Fatty Acids 78(4-5): 305-309

Ogura, M.; Furukawa, M.; Tada, N.; Ikeda, H.; Yamashita, T. 2008: Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. Auris Nasus Larynx 35(3): 338-343

Nordin, N.; Jalil, J.; Jantan, I.; Murad, S. 2012: Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum. Pharmaceutical Biology 50(3): 284-290

Giaginis, C.; Kourou, E.; Giagini, A.; Goutas, N.; Patsouris, E.; Kouraklis, G.; Theocharis, S. 2014: Platelet-activating factor (PAF) receptor expression is associated with histopathological stage and grade and patients' survival in gastric adenocarcinoma. Neoplasma 61(3): 309-317

Singh, P.; Singh, I.N.; Mondal, S.C.; Singh, L.; Garg, V.K. 2013: Platelet-activating factor (PAF)-antagonists of natural origin. Fitoterapia 84: 180-201

De Castro, S.H.; Faria Neto, H.C.d.C.; Gomes, M.d.B. 2007: Platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with type 1 diabetes mellitus. Arquivos Brasileiros de Cardiologia 88(2): 179-184

Tsoukatos, D.C.; Brochériou, I.; Moussis, V.; Panopoulou, C.P.; Christofidou, E.D.; Koussissis, S.; Sismanidis, S.; Ninio, E.; Siminelakis, S. 2008: Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery. Journal of Lipid Research 49(10): 2240-2249

Denizot, Y. 2010: Platelet-activating factor and acute myelogenous leukemia. Experimental Hematology 38(6): 435; Author Reply 435-6

Braquet, P.; Rola-Pleszcynski, M. 1987: Platelet-activating factor and cellular immune responses. Immunology Today 8(11): 345-351

Michelotto, P.V.; Muehlmann, L.A.; Zanatta, A.L.; Bieberbach, E.W.R.; Fernandes, L.C.; Nishiyama, A. 2010: Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race training. Journal of Veterinary Internal Medicine 24(2): 414-419

McHowat, J.; Gullickson, G.; Hoover, R.G.; Sharma, J.; Turk, J.; Kornbluth, J. 2011: Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung. American Journal of Physiology. Cell Physiology 300(4): C825-C832

Tsuda, M.; Tozaki-Saitoh, H.; Inoue, K. 2011: Platelet-activating factor and pain. Biological and Pharmaceutical Bulletin 34(8): 1159-1162

Lee, I.S.; Jung, K.Y.; Oh, S.R.; Kim, D.S.; Kim, J.H.; Lee, J.J.; Lee, H.K.; Lee, S.H.; Kim, E.H.; Cheong, C. 1997: Platelet-activating factor antagonistic activity and(13) C NMR assignment of pregomisin and chamigrenal from Schisandra chinensis. Archives of Pharmacal Research 20(6): 633-636

Halickman, I.; Bastien, Y.; Zhuang, Q.; Mazer, M.B.; Toledano, B.; Mazer, B.D. 2005: Platelet-activating factor antagonists decrease follicular dendritic-cell stimulation of human B lymphocytes. Allergy Asthma and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology 1(2): 49-57

Simmons, C.; Ingham, V.; Williams, A.; Bate, C. 2014: Platelet-activating factor antagonists enhance intracellular degradation of amyloid-β42 in neurons via regulation of cholesterol ester hydrolases. Alzheimer's Research and Therapy 6(2): 15

Gomez, F.P.; Rodriguez-Roisin, R. 2000: Platelet-activating factor antagonists: current status in asthma. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 14(1): 21-30

Singh, T.P.; Huettner, B.; Koefeler, H.; Mayer, G.; Bambach, I.; Wallbrecht, K.; Schön, M.P.; Wolf, P. 2011: Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. American Journal of Pathology 178(2): 699-708

Rivera, J.; Sellers, R.S.; Zeng, W.; van Rooijen, N.; Casadevall, A.; Goldman, D.L. 2014: Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage. Journal of Biological Chemistry 289(10): 7131-7141

Reyes-Quiroz, M.ía.E.; Alba, G.; Santa-María, C.; Saenz, J.; Geniz, I.; Jiménez, J.; Ramírez, R.; Martín-Nieto, J.é; Pintado, E.; Sobrino, F. 2014: Platelet-activating factor downregulates the expression of liver X receptor-α and its target genes in human neutrophils. Febs Journal 281(3): 970-982

Kim, K.-J.; Cho, K.-D.; Jang, K.Y.; Kim, H.-A.; Kim, H.-K.; Lee, H.-K.; Im, S.-Y. 2014: Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation. Immunology 143(1): 21-32

Soliman, A.; Michelsen, K.S.; Karahashi, H.; Lu, J.; Meng, F.J.; Qu, X.; Crother, T.R.; Rabizadeh, S.; Chen, S.; Caplan, M.S.; Arditi, M.; Jilling, T. 2010: Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. Plos one 5(10): E15044

Drolet, A.-M.; Thivierge, M.; Turcotte, S.; Hanna, D.; Maynard, B.; Stankovà, J.; Rola-Pleszczynski, M. 2011: Platelet-activating factor induces Th17 cell differentiation. Mediators of Inflammation 2011: 913802

Feuerherm, A.J.; Jørgensen, K.M.; Sommerfelt, R.M.; Eidem, L.E.; Lægreid, A.; Johansen, B. 2013: Platelet-activating factor induces proliferation in differentiated keratinocytes. Molecular and Cellular Biochemistry 384(1-2): 83-94

Liu, S.X.L.; Tian, R.; Baskind, H.; Hsueh, W.; De Plaen, I.G. 2009: Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 297(1): G76-G81

Mrówczyńska, L.; Hägerstrand, H. 2009: Platelet-activating factor interaction with the human erythrocyte membrane. Journal of Biochemical and Molecular Toxicology 23(5): 345-348

Karantonis, H.C.; Gribilas, G.; Stamoulis, I.; Giaginis, C.; Spiliopoulou, C.; Kouraklis, G.; Demopoulos, C.; Theocharis, S.E. 2010: Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis. Digestive Diseases and Sciences 55(2): 276-284

Chen, H.; Zheng, P.; Zhu, H.; Zhu, J.; Zhao, L.; El Mokhtari, N.E.; Eberhard, J.ör.; Lins, M.; Jepsen, S.ør. 2010: Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. Clinical Oral Investigations 14(6): 629-636

Sirangelo, I.; Giovane, A.; Maritato, R.; D'Onofrio, N.; Iannuzzi, C.; Giordano, A.; Irace, G.; Balestrieri, M.L. 2014: Platelet-activating factor mediates the cytotoxicity induced by W7FW14F apomyoglobin amyloid aggregates in neuroblastoma cells. Journal of Cellular Biochemistry 115(12): 2116-2122

Muñoz-Cano, R.; Valero, A.; Roca-Ferrer, J.; Bartra, J.; Sanchez-Lopez, J.; Mullol, J.; Picado, C. 2013: Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients. American Journal of Rhinology and Allergy 27(2): E48-E52

Kihara, Y.; Yanagida, K.; Masago, K.; Kita, Y.; Hishikawa, D.; Shindou, H.; Ishii, S.; Shimizu, T. 2008: Platelet-activating factor production in the spinal cord of experimental allergic encephalomyelitis mice via the group IVA cytosolic phospholipase A2-lyso-PAFAT axis. Journal of Immunology 181(7): 5008-5014

De Oliveira, S.I.; Andrade, L.N.S.; Onuchic, A.C.; Nonogaki, S.; Fernandes, P.íc.D.; Pinheiro, M.ôn.C.; Rohde, C.B.S.; Chammas, R.; Jancar, S. 2010: Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. Bmc Cancer 10: 200

Yao, Y.; Harrison, K.A.; Al-Hassani, M.; Murphy, R.C.; Rezania, S.; Konger, R.L.; Travers, J.B. 2012: Platelet-activating factor receptor agonists mediate xeroderma pigmentosum a photosensitivity. Journal of Biological Chemistry 287(12): 9311-9321

Musto, A.E.; Samii, M. 2011: Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. Epilepsia 52(3): 551-561

Madeira, M.F.M.; Queiroz-Junior, C.M.; Costa, G.M.; Werneck, S.M.C.; Cisalpino, D.; Garlet, G.P.; Teixeira, M.M.; Silva, T.íl.A.; Souza, D.G. 2013: Platelet-activating factor receptor blockade ameliorates Aggregatibacter actinomycetemcomitans-induced periodontal disease in mice. Infection and Immunity 81(11): 4244-4251

Smani, Y.; Docobo-Pérez, F.; López-Rojas, R.; Domínguez-Herrera, J.; Ibáñez-Martínez, J.é; Pachón, J.ón. 2012: Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells. Journal of Biological Chemistry 287(32): 26901-26910

Lacerda-Queiroz, N.; Rodrigues, D.H.; Vilela, M.ár.C.; Rachid, M.A.; Soriani, F.M.; Sousa, L.ân.P.; Campos, R.D.L.; Quesniaux, V.F.J.; Teixeira, M.M.; Teixeira, A.L. 2012: Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. American Journal of Pathology 180(1): 246-255

Shin, S.H.; Song, H.Y.; Kim, M.Y.; Do, E.K.; Kim, K.H.; Kim, J.H. 2010: Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 26(4-5): 689-698

Garcia, C.C.; Russo, R.C.; Guabiraba, R.; Fagundes, C.T.; Polidoro, R.B.; Tavares, L.P.; Salgado, A.Paula.C.; Cassali, G.D.; Sousa, Lândia.P.; Machado, A.V.; Teixeira, M.M. 2010: Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. Plos Pathogens 6(11): E1001171

Castor, M.G.M.; Rezende, B.ár.M.; Resende, C.B.; Bernardes, P.T.T.; Cisalpino, D.; Vieira, A.él.T.; Souza, D.G.; Silva, T.íl.A.; Teixeira, M.M.; Pinho, V. 2012: Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality. Journal of Leukocyte Biology 91(4): 629-639

Yang, Y.; Yin, J.; Baumgartner, W.; Samapati, R.; Solymosi, E.A.; Reppien, E.; Kuebler, W.M.; Uhlig, S. 2010: Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. European Respiratory Journal 36(2): 417-427

Renteria, L.S.; Cruz, E.; Ibe, B.O. 2013: Platelet-activating factor synthesis and receptor-mediated signaling are downregulated in ovine newborn lungs: relevance in postnatal pulmonary adaptation and persistent pulmonary hypertension of the newborn. Journal of Developmental Origins of Health and Disease 4(6): 458-469

Bansal, A.S.; Chee, R.; Sumar, N. 2008: Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. New England Journal of Medicine 358(14): 1515-1516 Author Reply 1516-1517

Borthakur, A.; Bhattacharyya, S.; Alrefai, W.A.; Tobacman, J.K.; Ramaswamy, K.; Dudeja, P.K. 2010: Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflammatory Bowel Diseases 16(4): 593-603

Sharif, N.A.; Wiernas, T.K. 2010: Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cells. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 26(1): 21-29

Moriguchi, S.; Shioda, N.; Yamamoto, Y.; Fukunaga, K. 2010: Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region. Neuroscience 166(4): 1158-1166

Xu, J.; Krüger, B.; Vernunft, A.; Löhrke, B.; Viergutz, T. 2009: Platelet-activating factor-stimulated production of reactive oxygen species in ovarian granulosa cells from periovulatory follicles. CYTOMETRY. Part A: the Journal of the International Society for Analytical Cytology 75(8): 658-664

Agrawal, V.; Jaiswal, M.K.; Ilievski, V.; Beaman, K.D.; Jilling, T.; Hirsch, E. 2014: Platelet-activating factor: a role in preterm delivery and an essential interaction with Toll-like receptor signaling in mice. Biology of Reproduction 91(5): 119

Mazereeuw, G.; Herrmann, N.; Xu, H.; Figeys, D.; Oh, P.I.; Bennett, S.A.L.; Lanctôt, K.L. 2014: Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. Journal of Neuroinflammation 11: 119

Demler, C.; Bühler, B.; Menin, L.; Stöcklin, R.; Wilmer, M.; Ernst, B.; Perchuc, A.M. 2010: Platelet-active substances in the venom of Bothrops moojeni snake-a novel evaluation method using whole blood aggregometry. Platelets 21(1): 20-28

Gupalo, E.; Kuk, C.; Qadura, M.; Buriachkovskaia, L.; Othman, M. 2013: Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors. Platelets 24(5): 383-391

Lapchak, P.H.; Ioannou, A.; Kannan, L.; Rani, P.; Dalle Lucca, J.J.; Tsokos, G.C. 2012: Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury. Plos one 7(2): E32260

Falet, H.é; Marchetti, M.P.; Hoffmeister, K.M.; Massaad, M.J.; Geha, R.S.; Hartwig, J.H. 2009: Platelet-associated IgAs and impaired GPVi responses in platelets lacking WIP. Blood 114(21): 4729-4737

Enomoto, M.; Yamane, T.; Hino, M.; Ohnishi, M.; Tamori, A.; Kawada, N. 2008: Platelet-associated IgG for the diagnosis of immune thrombocytopaenic purpura during peginterferon alpha and ribavirin treatment for chronic hepatitis C. Liver International: Official Journal of the International Association for the Study of the Liver 28(9): 1314-1315

Cervi, D.; Yip, T.-T.; Bhattacharya, N.; Podust, V.N.; Peterson, J.; Abou-Slaybi, A.; Naumov, G.N.; Bender, E.; Almog, N.; Italiano, J.E.; Folkman, J.; Klement, G.L. 2008: Platelet-associated PF-4 as a biomarker of early tumor growth. Blood 111(3): 1201-1207

Radziwon-Balicka, A.; Moncada de la Rosa, C.; Jurasz, P. 2012: Platelet-associated angiogenesis regulating factors: a pharmacological perspective. Canadian Journal of Physiology and Pharmacology 90(6): 679-688

Cooper, N.; Stasi, R.; Cunningham-Rundles, S.; Cesarman, E.; McFarland, J.G.; Bussel, J.B. 2012: Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. British Journal of Haematology 158(4): 539-547

Licht, C.; Pluthero, F.G.; Li, L.; Christensen, H.; Habbig, S.; Hoppe, B.; Geary, D.F.; Zipfel, P.F.; Kahr, W.H.A. 2009: Platelet-associated complement factor H in healthy persons and patients with atypical HUS. Blood 114(20): 4538-4545

Lopez-Vilchez, I.; Galan, A.M.; Hernandez, M.R.; Caballo, C.; Roque, M.; Diaz-Ricart, M.; White, J.G.; Escolar, G. 2012: Platelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro. Thrombosis Research 130(6): E294-E300

Kerrigan, S.W.; Cox, D. 2010: Platelet-bacterial interactions. Cellular and Molecular Life Sciences: Cmls 67(4): 513-523

Riyahi-Alam, N.; Alibabaei, N.; Takavar, A.; Sohrabi, M.; Fard-Esfahani, A.; Oghabian, M.A.; Bakhtiary, M. 2006: Platelet-based MPLE denoising of SPECT images: phantom and patient study. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2006: 4787-4790

Stellos, K.; Bigalke, B.; Stakos, D.; Henkelmann, N.; Gawaz, M. 2010: Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication. Journal of Thrombosis and Haemostasis: Jth 8(1): 205-207

Gewirtz, J.; Thornton, M.A.; Rauova, L.; Poncz, M. 2008: Platelet-delivered factor VIIi provides limited resistance to anti-factor VIIi inhibitors. Journal of Thrombosis and Haemostasis: Jth 6(7): 1160-1166

Kligman, M.D.; Zyromski, N.J.; McCullough, D.G.; Gunning, W.T. 2009: Platelet-dense granule deficiency causes postoperative hemorrhage in patients receiving enoxaparin: a novel observation with dramatic clinical implications. American Journal of Surgery 197(3): 365-370

Elzey, B.D.; Schmidt, N.W.; Crist, S.A.; Kresowik, T.P.; Harty, J.T.; Nieswandt, B.; Ratliff, T.L. 2008: Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood 111(7): 3684-3691

Rahman, M.; Zhang, S.; Chew, M.; Ersson, A.; Jeppsson, B.; Thorlacius, H. 2009: Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Annals of Surgery 250(5): 783-790

Chatterjee, M.; Gawaz, M. 2013: Platelet-derived CXCL12 (SDF-1α): basic mechanisms and clinical implications. Journal of Thrombosis and Haemostasis: Jth 11(11): 1954-1967

Wang, L.; Wu, Y.; Zhou, J.; Ahmad, S.S.; Mutus, B.; Garbi, N.; Hämmerling, G.ün.; Liu, J.; Essex, D.W. 2013: Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin. Blood 122(22): 3642-3650

Khachigian, L.M.; Chesterman, C.N. 1993: Platelet-derived Growth Factor and its Receptor: Structure and Roles in Normal Growth and Pathology. Platelets 4(6): 304-315

Hartwig, H.; Drechsler, M.; Lievens, D.; Kramp, B.; von Hundelshausen, P.; Lutgens, E.; Weber, C.; Döring, Y.; Soehnlein, O. 2014: Platelet-derived PF4 reduces neutrophil apoptosis following arterial occlusion. Thrombosis and Haemostasis 111(3): 562-564

Nakanishi, T.; Inaba, M.; Inagaki-Katashiba, N.; Tanaka, A.; Vien, P.T.X.; Kibata, K.; Ito, T.; Nomura, S. 2015: Platelet-derived RANK ligand enhances CCL17 secretion from dendritic cells mediated by thymic stromal lymphopoietin. Platelets 26(5): 425-431

Wolfort, R.M.; Manriquez, R.; Stokes, K.Y.; Granger, D.Neil. 2011: Platelet-derived RANTES mediates hypercholesterolemia-induced superoxide production and endothelial dysfunction: retraction. Arteriosclerosis Thrombosis and Vascular Biology 31(4): E7

Wang, Y.; Fang, C.; Gao, H.; Bilodeau, M.L.; Zhang, Z.; Croce, K.; Liu, S.; Morooka, T.; Sakuma, M.; Nakajima, K.; Yoneda, S.; Shi, C.; Zidar, D.; Andre, P.; Stephens, G.; Silverstein, R.L.; Hogg, N.; Schmaier, A.H.; Simon, D.I. 2014: Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis. Journal of Clinical Investigation 124(5): 2160-2171

Stark, R.J.; Aghakasiri, N.; Rumbaut, R.E. 2012: Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia. Plos one 7(7): E41254

Motovska, Z.; Odvodyova, D.; Karpisek, M.; Hrabakova, H.; Kocka, V.; Simkova, I.; Katina, S.; Widimsky, P. 2011: Platelet-derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically significant degenerative aortic stenosis. International Journal of Cardiology 152(2): 273-275

Morales-Ibanez, O.; Bataller, R.ón. 2011: Platelet-derived chemokines: new targets to treat liver fibrosis. Journal of Hepatology 54(3): 581-583

Flad, H.-D.; Brandt, E. 2010: Platelet-derived chemokines: pathophysiology and therapeutic aspects. Cellular and Molecular Life Sciences: Cmls 67(14): 2363-2386

Hemalatha, T.; Tiwari, M.; Balachandran, C.; Manohar, B.M.; Puvanakrishnan, R. 2009: Platelet-derived endothelial cell growth factor mediates angiogenesis and antiapoptosis in rat aortic endothelial cells. Biochemistry and Cell Biology 87(6): 883-893

Azevedo, L.C.P.; Janiszewski, M.; Pontieri, V.; Pedro, M.d.A.; Bassi, E.ão.; Tucci, P.J.é F.; Laurindo, F.R.M. 2007: Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Critical Care 11(6): R120

Gambim, M.H.; do Carmo, A.d.O.; Marti, L.; Veríssimo-Filho, S.; Lopes, L.R.; Janiszewski, M. 2007: Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Critical Care 11(5): R107

Mazzucco, L.; Borzini, P.; Gope, R. 2010: Platelet-derived factors involved in tissue repair-from signal to function. Transfusion Medicine Reviews 24(3): 218-234

Kowarik, M.; Onofri, C.; Colaco, T.; Stalla, G.K.; Renner, U. 2010: Platelet-derived growth factor (PDGF) and PDGF receptor expression and function in folliculostellate pituitary cells. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 118(2): 113-120

Maheswaranathan, M.; Gole, H.K.A.; Fernandez, I.; Lassègue, B.; Griendling, K.K.; San Martín, A. 2011: Platelet-derived growth factor (PDGF) regulates Slingshot phosphatase activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells. Journal of Biological Chemistry 286(41): 35430-35437

Ding, W.; Knox, T.R.; Tschumper, R.C.; Wu, W.; Schwager, S.M.; Boysen, J.C.; Jelinek, D.F.; Kay, N.E. 2010: Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch. Blood 116(16): 2984-2993

Belizon, A.; Balik, E.; Horst, P.K.; Shantha Kumara, H.M.C.; Nasar, A.; Whelan, R.L. 2009: Platelet-derived growth factor (subtype BB) is elevated in patients with colorectal carcinoma. Diseases of the Colon and Rectum 52(6): 1166-1171

Yao, H.; Duan, M.; Hu, G.; Buch, S. 2011: Platelet-derived growth factor B chain is a novel target gene of cocaine-mediated Notch1 signaling: implications for HIV-associated neurological disorders. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31(35): 12449-12454

Vindrieux, D.; Gras, B.; Garcia-Belinchon, M.; Mourah, S.; Lebbe, C.él.; Augert, A.; Bernard, D. 2013: Platelet-derived growth factor B induces senescence and transformation in normal human fibroblasts. Aging 5(7): 531-538

Scotti, L.; Parborell, F.; Irusta, G.; De Zuñiga, I.; Bisioli, C.; Pettorossi, H.; Tesone, M.; Abramovich, D. 2014: Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients. Molecular Reproduction and Development 81(8): 748-756

Zhang, Y.; Ma, Y.; Wu, C.; Miron, R.J.; Cheng, X. 2016: Platelet-derived growth factor BB gene-released scaffolds: biosynthesis and characterization. Journal of Tissue Engineering and Regenerative Medicine 10(10): E372-E381

Hu, Y.; Cheng, P.; Ma, J.-C.; Xue, Y.-X.; Liu, Y.-H. 2013: Platelet-derived growth factor BB mediates the glioma-induced migration of bone marrow-derived mesenchymal stem cells by promoting the expression of vascular cell adhesion molecule-1 through the PI3K, P38 MAPK and NF-κB pathways. Oncology Reports 30(6): 2755-2764

Hata, N.; Shinojima, N.; Gumin, J.; Yong, R.; Marini, F.; Andreeff, M.; Lang, F.F. 2010: Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery 66(1): 144-156; Discussion: 156-157

Hiram-Bab, S.; Katz, L.S.; Shapira, H.; Sandbank, J.; Gershengorn, M.C.; Oron, Y. 2014: Platelet-derived growth factor BB mimics serum-induced dispersal of pancreatic epithelial cell clusters. Journal of Cellular Physiology 229(6): 743-751

Cheng, P.; Gao, Z.-Q.; Liu, Y.-H.; Xue, Y.-X. 2009: Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1. Neuroscience Letters 451(1): 52-56

Lange, S.; Heger, J.; Euler, G.; Wartenberg, M.; Piper, H.M.; Sauer, H. 2009: Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovascular Research 81(1): 159-168

Marzouk, K.M.; Gamal, A.Y.; Al-Awady, A.A.; Sharawy, M.M. 2008: Platelet-derived growth factor BB treated osteoprogenitors inhibit bone regeneration. Journal of Oral Implantology 34(5): 242-247

Ruffini, F.; Tentori, L.; Dorio, A.S.; Arcelli, D.; D'Amati, G.; D'Atri, S.; Graziani, G.; Lacal, P.M. 2013: Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness. Oncology Reports 30(6): 2887-2896

Fredriksson, L.; Nilsson, I.; Su, E.J.; Andrae, J.; Ding, H.; Betsholtz, C.; Eriksson, U.; Lawrence, D.A. 2012: Platelet-derived growth factor C deficiency in C57BL/6 mice leads to abnormal cerebral vascularization, loss of neuroependymal integrity, and ventricular abnormalities. American Journal of Pathology 180(3): 1136-1144

Suo, G.; Jiang, Y.; Cowan, B.; Wang, J.Y.J. 2009: Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth. Biology of Reproduction 81(4): 749-758

Moriya, J.; Wu, X.; Zavala-Solorio, J.; Ross, J.; Liang, X.H.; Ferrara, N. 2014: Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice. Journal of Vascular Surgery 59(5): 1402-9.E1-4

Peng, F.; Yao, H.; Akturk, H.K.; Buch, S. 2012: Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta. Plos one 7(10): E47572

Berasain, C.; Avila, M.A. 2013: Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts. Hepatology 58(3): 853-855

Watts, E.J.; Rose, M.T. 2010: Platelet-derived growth factor acts via both the Rho-kinase and p38 signaling enzymes to stimulate contraction in an in vitro model of equine wound healing. Domestic Animal Endocrinology 38(4): 253-259

Yao, L.-M.; Fan, X.-Y. 2009: Platelet-derived growth factor and lung fibrosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 27(6): 375-377

Hutton, D.L.; Moore, E.M.; Gimble, J.M.; Grayson, W.L. 2013: Platelet-derived growth factor and spatiotemporal cues induce development of vascularized bone tissue by adipose-derived stem cells. Tissue Engineering. Part a 19(17-18): 2076-2086

Rosengren, S.; Corr, M.; Boyle, D.L. 2010: Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes. Arthritis Research and Therapy 12(2): R65

Ito, I.; Fixman, E.D.; Asai, K.; Yoshida, M.; Gounni, A.S.; Martin, J.G.; Hamid, Q. 2009: Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 39(9): 1370-1380

Kaigler, D.; Avila, G.; Wisner-Lynch, L.; Nevins, M.L.; Nevins, M.; Rasperini, G.; Lynch, S.E.; Giannobile, W.V. 2011: Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Expert Opinion on Biological Therapy 11(3): 375-385

Kameda, H.; Suzuki, M.; Takeuchi, T. 2007: Platelet-derived growth factor as a therapeutic target for systemic autoimmune diseases. Drug Target Insights 2: 239-247

Galimberti, S.; Ferreri, M.I.; Simi, P.; Azzarà, A.; Baratè, C.; Fazzi, R.; Cecconi, N.; Cervetti, G.; Guerrini, F.; Petrini, M. 2009: Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype. British Journal of Haematology 147(5): 763-766

Liu, C.; Zhao, W.; Meng, W.; Zhao, T.; Chen, Y.; Ahokas, R.A.; Liu, H.; Sun, Y. 2014: Platelet-derived growth factor blockade on cardiac remodeling following infarction. Molecular and Cellular Biochemistry 397(1-2): 295-304

Cardoso, L.E.M.; Little, P.J.; Ballinger, M.L.; Chan, C.K.; Braun, K.R.; Potter-Perigo, S.; Bornfeldt, K.E.; Kinsella, M.G.; Wight, T.N. 2010: Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways. Journal of Biological Chemistry 285(10): 6987-6995

Ye, J.Yu.; Chan, G.Chi.Fung.; Qiao, L.; Lian, Q.; Meng, F.Yi.; Luo, X.Qun.; Khachigian, L.M.; Ma, M.; Deng, R.; Chen, J.Liang.; Chong, B.H.; Yang, M. 2010: Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway. Haematologica 95(10): 1745-1753

Majumdar, K.; Radotra, B.D.; Vasishta, R.K.; Pathak, A. 2009: Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas. Surgical Neurology 72(1): 54-60

Westermark, B. 2014: Platelet-derived growth factor in glioblastoma-driver or biomarker?. Upsala Journal of Medical Sciences 119(4): 298-305

Si, Y.; Wang, J.; Guan, J.; Han, Q.; Hui, Y. 2013: Platelet-derived growth factor induced alpha-smooth muscle actin expression by human retinal pigment epithelium cell. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 29(3): 310-318

Luo, Y.; Zhang, M.; Zhang, J.; Zhang, J.; Chen, C.; Chen, Y.E.; Xiong, J.-W.; Zhu, X. 2011: Platelet-derived growth factor induces Rad expression through Egr-1 in vascular smooth muscle cells. Plos one 6(4): E19408

Frenckner, B.ör.; Broomé, M.; Lindström, M.; Radell, P. 2008: Platelet-derived growth factor inhibition--a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?. Journal of Pediatric Surgery 43(10): 1928-1931

Bax, N.A.M.; Lie-Venema, H.; Vicente-Steijn, R.; Bleyl, S.B.; Van Den Akker, N.M.S.; Maas, S.; Poelmann, R.E.; Gittenberger-de Groot, A.C. 2009: Platelet-derived growth factor is involved in the differentiation of second heart field-derived cardiac structures in chicken embryos. Developmental Dynamics: An Official Publication of the American Association of Anatomists 238(10): 2658-2669

McKeown, L.; Moss, N.K.; Turner, P.; Li, J.; Heath, N.; Burke, D.; O'Regan, D.; Gilthorpe, M.S.; Porter, K.E.; Beech, D.J. 2012: Platelet-derived growth factor maintains stored calcium through a nonclustering Orai1 mechanism but evokes clustering if the endoplasmic reticulum is stressed by store depletion. Circulation Research 111(1): 66-76

Lu, J.; Zhu, Y.; Feng, W.; Pan, Y.; Li, S.; Han, D.; Liu, L.; Xie, X.; Wang, G.; Li, M. 2014: Platelet-derived growth factor mediates interleukin-13-induced collagen i production in mouse airway fibroblasts. Journal of Biosciences 39(4): 693-700

Yang, J.; Liu, X.; Nyland, S.B.; Zhang, R.; Ryland, L.K.; Broeg, K.; Baab, K.T.; Jarbadan, N.R.; Irby, R.; Loughran, T.P. 2010: Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood 115(1): 51-60

Penmatsa, V.; Ruslinda, A.R.; Beidaghi, M.; Kawarada, H.; Wang, C. 2013: Platelet-derived growth factor oncoprotein detection using three-dimensional carbon microarrays. Biosensors and Bioelectronics 39(1): 118-123

Edqvist, P.-H.D.; Niklasson, M.; Vidal-Sanz, M.; Hallböök, F.; Forsberg-Nilsson, K. 2012: Platelet-derived growth factor over-expression in retinal progenitors results in abnormal retinal vessel formation. Plos one 7(8): E42488

Rizvi, S.; Mertens, J.C.; Bronk, S.F.; Hirsova, P.; Dai, H.; Roberts, L.R.; Kaufmann, S.H.; Gores, G.J. 2014: Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. Journal of Biological Chemistry 289(33): 22835-22849

Nevins, M.; Kao, R.T.; McGuire, M.K.; McClain, P.K.; Hinrichs, J.E.; McAllister, B.S.; Reddy, M.S.; Nevins, M.L.; Genco, R.J.; Lynch, S.E.; Giannobile, W.V. 2013: Platelet-derived growth factor promotes periodontal regeneration in localized osseous defects: 36-month extension results from a randomized, controlled, double-masked clinical trial. Journal of Periodontology 84(4): 456-464

Matsuo, K.; Nishimura, M.; Komurov, K.; Shahzad, M.M.K.; Ali-Fehmi, R.; Roh, J.-W.; Lu, C.; Cody, D.D.; Ram, P.T.; Loizos, N.; Coleman, R.L.; Sood, A.K. 2014: Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma. Gynecologic Oncology 132(1): 166-175

Tamborini, E.; Rossi, S.; Tarantino, E.; Mauro, V.; Dei Tos, A.P.; Pilotti, S. 2012: Platelet-derived growth factor receptor alpha expression improves the diagnostic assessment of gastrointestinal stromal tumours. Histopathology 61(6): 1240-1245

Xu, S.; Zhou, Y.; Yang, S.; Ren, Y.; Zhang, C.; Quan, C.; Gao, M.; He, C.; Chen, H.; Hhan, J.; Chen, J.; Liang, Y.; Yang, J.; Sun, L.; Yin, X.; Liu, J.; Zhang, X. 2010: Platelet-derived growth factor receptor alpha gene mutations in vitiligo vulgaris. Acta Dermato-Venereologica 90(2): 131-135

Liu, K.-W.; Hu, B.; Cheng, S.-Y. 2011: Platelet-derived growth factor receptor alpha in glioma: a bad seed. Chinese Journal of Cancer 30(9): 590-602

Kanamoto, T.; Rimayanti, U.; H, O.; Kiuchi, Y. 2011: Platelet-derived growth factor receptor alpha is associated with oxidative stress-induced retinal cell death. Current Eye Research 36(4): 336-340

Hacker, T.A.; Griffin, M.O.; Guttormsen, B.; Stoker, S.; Wolff, M.R. 2007: Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo. Journal of Invasive Cardiology 19(6): 269-274

Wang, Y.; Mandal, D.; Wang, S.; Kleinerman, E.S.; Pollock, R.E.; Lev, D.; Hayes-Jordan, A. 2010: Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. Cancer 116(16): 3892-3902

Wiens, K.M.; Lee, H.L.; Shimada, H.; Metcalf, A.E.; Chao, M.Y.; Lien, C.-L. 2010: Platelet-derived growth factor receptor beta is critical for zebrafish intersegmental vessel formation. Plos one 5(6): E11324

Mathey, S.; Graeser, M.K.; Zu Eulenburg, C.; Woelber, L.; Trillsch, F.; Jaenicke, F.; Müller, V.; Milde-Langosch, K.; Mahner, S. 2013: Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer. Oncology 85(2): 69-77

Mellgren, A.M.; Smith, C.L.; Olsen, G.S.; Eskiocak, B.; Zhou, B.; Kazi, M.N.; Ruiz, F.R.; Pu, W.T.; Tallquist, M.D. 2008: Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circulation Research 103(12): 1393-1401

Basciani, S.; De Luca, G.; Dolci, S.; Brama, M.; Arizzi, M.; Mariani, S.; Rosano, G.; Spera, G.; Gnessi, L. 2008: Platelet-derived growth factor receptor beta-subtype regulates proliferation and migration of gonocytes. Endocrinology 149(12): 6226-6235

Feng, J.; He, W.; Song, Y.; Wang, Y.; Simpson, R.J.; Zhang, X.; Luo, G.; Wu, J.; Huang, C. 2014: Platelet-derived growth factor receptor beta: a novel urinary biomarker for recurrence of non-muscle-invasive bladder cancer. Plos one 9(5): E96671

Koos, B.ör.; Paulsson, J.; Jarvius, M.; Sanchez, B.C.; Wrede, B.; Mertsch, S.; Jeibmann, A.; Kruse, A.; Peters, O.; Wolff, J.E.A.; Galla, H.-J.; Söderberg, O.; Paulus, W.; Ostman, A.; Hasselblatt, M. 2009: Platelet-derived growth factor receptor expression and activation in choroid plexus tumors. American Journal of Pathology 175(4): 1631-1637

Mathew, P.; Thall, P.F.; Bucana, C.D.; Oh, W.K.; Morris, M.J.; Jones, D.M.; Johnson, M.M.; Wen, S.; Pagliaro, L.C.; Tannir, N.M.; Tu, S.-M.; Meluch, A.A.; Smith, L.; Cohen, L.; Kim, S.-J.; Troncoso, P.; Fidler, I.J.; Logothetis, C.J. 2007: Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(19): 5816-5824

Zhang, Y.Y.; Cui, Y.Z.; Luan, J.; Zhou, X.Y.; Zhang, G.L.; Han, J.X. 2012: Platelet-derived growth factor receptor kinase inhibitor AG-1295 promotes osteoblast differentiation in MC3T3-E1 cells via the Erk pathway. Bioscience Trends 6(3): 130-135

Yamamoto, S.; Fukumoto, E.; Yoshizaki, K.; Iwamoto, T.; Yamada, A.; Tanaka, K.; Suzuki, H.; Aizawa, S.; Arakaki, M.; Yuasa, K.; Oka, K.; Chai, Y.; Nonaka, K.; Fukumoto, S. 2008: Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression. Journal of Biological Chemistry 283(34): 23139-23149

Kumar, A.; Salimath, B.P.; Stark, G.B.ör.; Finkenzeller, G.ün. 2010: Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells. Tissue Engineering. Part a 16(3): 983-993

Dai, Y. 2010: Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature. Expert Opinion on Therapeutic Patents 20(7): 885-897

Kurahashi, M.; Nakano, Y.; Hennig, G.W.; Ward, S.M.; Sanders, K.M. 2012: Platelet-derived growth factor receptor α-positive cells in the tunica muscularis of human colon. Journal of Cellular and Molecular Medicine 16(7): 1397-1404

Suzuki, S.; Heldin, C.-H.; Heuchel, R.L. 2007: Platelet-derived growth factor receptor-beta, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma. Bmc Cancer 7: 224

Koh, B.H.; Roy, R.; Hollywood, M.A.; Thornbury, K.D.; McHale, N.G.; Sergeant, G.P.; Hatton, W.J.; Ward, S.M.; Sanders, K.M.; Koh, S.D. 2012: Platelet-derived growth factor receptor-α cells in mouse urinary bladder: a new class of interstitial cells. Journal of Cellular and Molecular Medicine 16(4): 691-700

Kurahashi, M.; Mutafova-Yambolieva, V.; Koh, S.D.; Sanders, K.M. 2014: Platelet-derived growth factor receptor-α-positive cells and not smooth muscle cells mediate purinergic hyperpolarization in murine colonic muscles. American Journal of Physiology. Cell Physiology 307(6): C561-C570

Overbeek, M.J.; Boonstra, A.; Voskuyl, A.E.; Vonk, M.C.; Vonk-Noordegraaf, A.; van Berkel, M.P.A.; Mooi, W.J.; Dijkmans, B.A.C.; Hondema, L.S.; Smit, E.F.; Grünberg, K. 2011: Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Research and Therapy 13(2): R61

Donica, C.L.; Cui, Y.; Shi, S.; Gutstein, H.B. 2014: Platelet-derived growth factor receptor-β antagonism restores morphine analgesic potency against neuropathic pain. Plos one 9(5): E97105

Seeger, H.; Braun, N.; Latus, J.; Alscher, M.D.; Fritz, P.; Edenhofer, I.; Biegger, D.; Lindenmeier, M.; Wüthrich, R.P.; Segerer, S. 2014: Platelet-derived growth factor receptor-β expression in human peritoneum. NEPHRON. Clinical Practice 128(1-2): 178-184

Suciu, L.C.; Popescu, B.O.; Kostin, S.; Popescu, L.M. 2012: Platelet-derived growth factor receptor-β-positive telocytes in skeletal muscle interstitium. Journal of Cellular and Molecular Medicine 16(4): 701-707

French, W.J.; Creemers, E.E.; Tallquist, M.D. 2008: Platelet-derived growth factor receptors direct vascular development independent of vascular smooth muscle cell function. Molecular and Cellular Biology 28(18): 5646-5657

Ball, S.G.; Shuttleworth, C.A.; Kielty, C.M. 2010: Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization. Expert Opinion on Biological Therapy 10(1): 57-71

Yokoyama, Y.; Mori, S.; Hamada, Y.; Hieda, M.; Kawaguchi, N.; Shaker, M.; Tao, Y.; Yoshidome, K.; Tsujimoto, M.; Matsuura, N. 2011: Platelet-derived growth factor regulates breast cancer progression via β-catenin expression. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 78(5): 253-260

Lopatina, T.; Bruno, S.; Tetta, C.; Kalinina, N.; Porta, M.; Camussi, G. 2014: Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Communication and Signaling: Ccs 12: 26

Carosa, E.; Castri, A.; Forcella, C.; Sebastiani, G.; Di Sante, S.; Gravina, G.L.; Ronchi, P.; Cesarini, V.; Dolci, S.; Di Stasi, S.; Lenzi, A.; Jannini, E.A. 2014: Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells. Journal of Sexual Medicine 11(7): 1675-1684

Beazely, M.A.; Lim, A.; Li, H.; Trepanier, C.; Chen, X.; Sidhu, B.; Macdonald, J.F. 2009: Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons. Journal of Biological Chemistry 284(12): 8054-8063

Liu, K.-W.; Hu, B.; Cheng, S.-Y. 2011: Platelet-derived growth factor signaling in human malignancies. Chinese Journal of Cancer 30(9): 581-584

Donovan, J.; Abraham, D.; Norman, J. 2013: Platelet-derived growth factor signaling in mesenchymal cells. Frontiers in Bioscience 18(1): 106-119

Noskovičová, N.; Petřek, M.; Eickelberg, O.; Heinzelmann, K. 2015: Platelet-derived growth factor signaling in the lung. from lung development and disease to clinical studies. American Journal of Respiratory Cell and Molecular Biology 52(3): 263-284

Kurahashi, M.; Niwa, Y.; Cheng, J.; Ohsaki, Y.; Fujita, A.; Goto, H.; Fujimoto, T.; Torihashi, S. 2008: Platelet-derived growth factor signals play critical roles in differentiation of longitudinal smooth muscle cells in mouse embryonic gut. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 20(5): 521-531

Eisel, F.; Boosen, M.; Beck, M.; Heide, H.; Wittig, I.; Beck, K.-F.; Pfeilschifter, J. 2013: Platelet-derived growth factor triggers PKA-mediated signalling by a redox-dependent mechanism in rat renal mesangial cells. Biochemical Pharmacology 85(1): 101-108

Porsch, H.; Mehić, M.; Olofsson, B.; Heldin, P.; Heldin, C.-H. 2014: Platelet-derived growth factor β-receptor, transforming growth factor β type i receptor, and CD44 protein modulate each other's signaling and stability. Journal of Biological Chemistry 289(28): 19747-19757

McGowan, S.E.; McCoy, D.M. 2013: Platelet-derived growth factor-A and sonic hedgehog signaling direct lung fibroblast precursors during alveolar septal formation. American Journal of Physiology. Lung Cellular and Molecular Physiology 305(3): L229-L239

Abe, H.; Hino, R.; Fukayama, M. 2013: Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer. Virchows Archiv: An International Journal of Pathology 462(5): 523-531

Lederle, W.; Linde, N.; Heusel, J.; Bzyl, J.; Woenne, E.C.; Zwick, S.; Skobe, M.; Kiessling, F.; Fusenig, N.E.; Mueller, M.M. 2010: Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. American Journal of Pathology 176(2): 981-994

Farrer, R.G.; Farrer, J.R.; DeVries, G.H. 2013: Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14. Journal of Biological Chemistry 288(16): 11066-11073

Tokuda, H.; Takai, S.; Hanai, Y.; Harada, A.; Matsushima-Nishiwaki, R.; Akamatsu, S.; Ohta, T.; Kozawa, O. 2007: Platelet-derived growth factor-BB amplifies PGF2alpha-stimulated VEGF synthesis in osteoblasts: function of phosphatidylinositol 3-kinase. Prostaglandins Leukotrienes and Essential Fatty Acids 77(3-4): 187-193

Shen, W.; Li, L.; Song, B.; Li, W.; Zhou, Z.; Guo, R. 2013: Platelet-derived growth factor-BB increases expression of connexin 43 in an extracellular-regulated protein kinase-dependent manner in bladder smooth muscle cells. International Journal of Urology: Official Journal of the Japanese Urological Association 20(1): 123-130

Hassan, M.I.; Boosen, M.; Schaefer, L.; Kozlowska, J.; Eisel, F.; von Knethen, A.; Beck, M.; Hemeida, R.A.M.; El-Moselhy, M.A.M.; Hamada, F.M.A.; Beck, K.-F.; Pfeilschifter, J. 2012: Platelet-derived growth factor-BB induces cystathionine γ-lyase expression in rat mesangial cells via a redox-dependent mechanism. British Journal of Pharmacology 166(8): 2231-2242

Cui, Y.; Sun, Y.-W.; Lin, H.-S.; Su, W.-M.; Fang, Y.; Zhao, Y.; Wei, X.-Q.; Qin, Y.-H.; Kohama, K.; Gao, Y. 2014: Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK pathways. Molecular and Cellular Biochemistry 393(1-2): 255-263

Pan, D.-B.; Ke, Y.-S.; Liu, W.-J.; Wei, Y.-Q.; Tang, J.; Cao, H. 2010: Platelet-derived growth factor-BB inhibited p21(WAF1) expression partially through transforming growth factor-beta signalling system in vascular smooth muscle cell. Zhonghua Xin Xue Guan Bing Za Zhi 38(2): 160-165

He, J.-L. 2014: Platelet-derived growth factor-BB is involved in mesenchymal stem cell secretome-induced neuroprotection of retinal ganglion cells. Brain: a Journal of Neurology 137(Part 5): E276

Malabanan, K.P.; Sheahan, A.V.; Khachigian, L.M. 2012: Platelet-derived growth factor-BB mediates cell migration through induction of activating transcription factor 4 and tenascin-C. American Journal of Pathology 180(6): 2590-2597

Krzystek-Korpacka, M.; Neubauer, K.; Matusiewicz, M. 2009: Platelet-derived growth factor-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel disease. Clinical Biochemistry 42(16-17): 1602-1609

Gamal, A.Y.; El-Shal, O.S.A.; El-Aasara, M.M.; Fakhry, E.M. 2011: Platelet-derived growth factor-BB release profile in gingival crevicular fluid after use of marginal periosteal pedicle graft as an autogenous guided tissue membrane to treat localized intrabony defects. Journal of Periodontology 82(2): 272-280

Chao, J.; Yang, L.; Yao, H.; Buch, S. 2014: Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on Neuroimmune Pharmacology 9(2): 259-268

Yao, H.; Duan, M.; Yang, L.; Buch, S. 2012: Platelet-derived growth factor-BB restores human immunodeficiency virus Tat-cocaine-mediated impairment of neurogenesis: role of TRPC1 channels. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(29): 9835-9847

Van Steensel, L.; Paridaens, D.; Dingjan, G.M.; van Daele, P.L.A.; van Hagen, P.M.; Kuijpers, R.W.A.M.; van den Bosch, W.A.; Drexhage, H.A.; Hooijkaas, H.; Dik, W.A. 2010: Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy. Investigative Ophthalmology and Visual Science 51(2): 1002-1007

Hurst, N.J.; Najy, A.J.; Ustach, C.V.; Movilla, L.; Kim, H.-R.C. 2012: Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression. Biochemical Journal 441(3): 909-918

Son, D.; Na, Y.R.; Hwang, E.-S.; Seok, S.H. 2014: Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation. Journal of Biological Chemistry 289(9): 6225-6235

Ahmad, A.; Wang, Z.; Kong, D.; Ali, R.; Ali, S.; Banerjee, S.; Sarkar, F.H. 2011: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. Breast Cancer Research and Treatment 126(1): 15-25

Park, Y.-K.; Jang, B.-C.; Choi, M. 2013: Platelet-derived growth factor-D induces expression of cyclooxygenase-2 in rat mesangial cells through activation of PI3K/PKB and PKCs. International Journal of Molecular Medicine 31(2): 447-452

Wang, Y.; Hu, C.; Dong, R.; Huang, X.; Qiu, H. 2011: Platelet-derived growth factor-D promotes ovarian cancer invasion by regulating matrix metalloproteinases 2 and 9. Asian Pacific Journal of Cancer Prevention: Apjcp 12(12): 3367-3370

Kumar, A.; Hou, X.; Lee, C.; Li, Y.; Maminishkis, A.; Tang, Z.; Zhang, F.; Langer, H.F.; Arjunan, P.; Dong, L.; Wu, Z.; Zhu, L.Y.; Wang, L.; Min, W.; Colosi, P.; Chavakis, T.; Li, X. 2010: Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation. Journal of Biological Chemistry 285(20): 15500-15510

Zhang, Z.-W.; Yanamoto, H.; Nagata, I.; Miyamoto, S.; Nakajo, Y.; Xue, J.-H.; Iihara, K.; Kikuchi, H. 2010: Platelet-derived growth factor-induced severe and chronic vasoconstriction of cerebral arteries: proposed growth factor explanation of cerebral vasospasm. Neurosurgery 66(4): 728

Jurek, A.; Heldin, C.-H.; Lennartsson, J. 2011: Platelet-derived growth factor-induced signaling pathways interconnect to regulate the temporal pattern of Erk1/2 phosphorylation. Cellular Signalling 23(1): 280-287

Peng, F.; Yao, H.; Bai, X.; Zhu, X.; Reiner, B.C.; Beazely, M.; Funa, K.; Xiong, H.; Buch, S. 2010: Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. Journal of Biological Chemistry 285(28): 21615-21624

Faraone, D.; Aguzzi, M.S.; Toietta, G.; Facchiano, A.M.; Facchiano, F.; Magenta, A.; Martelli, F.; Truffa, S.; Cesareo, E.; Ribatti, D.; Capogrossi, M.C.; Facchiano, A. 2009: Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo. Neoplasia 11(8): 732-742

Plemel, J.R.; Chojnacki, A.; Sparling, J.S.; Liu, J.; Plunet, W.; Duncan, G.J.; Park, S.E.; Weiss, S.; Tetzlaff, W. 2011: Platelet-derived growth factor-responsive neural precursors give rise to myelinating oligodendrocytes after transplantation into the spinal cords of contused rats and dysmyelinated mice. Glia 59(12): 1891-1910

Osman, N.; Getachew, R.; Thach, L.; Wang, H.; Su, X.; Zheng, W.; Little, P.J. 2014: Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation. Cellular Signalling 26(5): 912-916

Cui, H.-K.; Yan, R.-F.; Ding, X.-L.; Zhao, P.; Wu, Q.-W.; Wang, H.-P.; Qin, H.-X.; Tu, J.-F.; Yang, R.-M. 2014: Platelet-derived growth factor-β expression in rabbit models of cerebral vasospasm following subarachnoid hemorrhage. Molecular Medicine Reports 10(3): 1416-1422

Tran, T.A.; Kinch, L.; Peña-Llopis, S.; Kockel, L.; Grishin, N.; Jiang, H.; Brugarolas, J. 2013: Platelet-derived growth factor/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1/Tsc2-dependent inhibition of TORC1. Molecular and Cellular Biology 33(19): 3762-3779

Fiset, C.él. 2013: Platelet-derived growth factor: a promising therapeutic target for atrial fibrillation. Heart Rhythm 10(7): 1052-1053

Aricò, A.; Guadagnin, E.; Ferraresso, S.; Gelain, M.E.; Iussich, S.; Rütgen, B.C.; Mazzariol, S.; Marconato, L.; Aresu, L. 2014: Platelet-derived growth factors and receptors in Canine Lymphoma. Journal of Comparative Pathology 151(4): 322-328

Demoulin, J.-B.; Montano-Almendras, C.P. 2012: Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis. American Journal of Blood Research 2(1): 44-56

Schallmoser, K.; Rohde, E.; Bartmann, C.; Obenauf, A.C.; Reinisch, A.; Strunk, D. 2009: Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Bio-Medical Materials and Engineering 19(4-5): 271-276

Cheng, X.; Tsao, C.; Sylvia, V.L.; Cornet, D.; Nicolella, D.P.; Bredbenner, T.L.; Christy, R.J. 2014: Platelet-derived growth-factor-releasing aligned collagen-nanoparticle fibers promote the proliferation and tenogenic differentiation of adipose-derived stem cells. Acta Biomaterialia 10(3): 1360-1369

De la Motte, C.; Nigro, J.; Vasanji, A.; Rho, H.; Kessler, S.; Bandyopadhyay, S.; Danese, S.; Fiocchi, C.; Stern, R. 2009: Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. American Journal of Pathology 174(6): 2254-2264

Zhang, X.; McGeoch, S.C.; Johnstone, A.M.; Holtrop, G.; Sneddon, A.A.; MacRury, S.M.; Megson, I.L.; Pearson, D.W.M.; Abraham, P.; De Roos, B.; Lobley, G.E.; O'Kennedy, N. 2014: Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. Journal of Thrombosis and Thrombolysis 37(4): 455-463

Nagy, Béla.; Szuk, T.; Debreceni, Ió.Beke.; Kappelmayer, János. 2010: Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone. Platelets 21(2): 147-151

Kaptan, Kürşat.; Beyan, C.; Ifran, A.; Pekel, A. 2008: Platelet-derived microparticle levels in women with recurrent spontaneous abortion. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 102(3): 271-274

Siljander, P.R.M. 2011: Platelet-derived microparticles - an updated perspective. Thrombosis Research 127 Suppl. 2: S30-S33

Toth, B.; Liebhardt, S.; Steinig, K.; Ditsch, N.; Rank, A.; Bauerfeind, I.; Spannagl, M.; Friese, K.; Reininger, A.J. 2008: Platelet-derived microparticles and coagulation activation in breast cancer patients. Thrombosis and Haemostasis 100(4): 663-669

Li, X.; Cong, H. 2009: Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. Texas Heart Institute Journal 36(2): 134-139

Shan, L-Yang.; Li, J-Zhao.; Zu, L-Yun.; Niu, C-Guang.; Ferro, A.; Zhang, Y-Dong.; Zheng, L-min.; Ji, Y. 2013: Platelet-derived microparticles are implicated in remote ischemia conditioning in a rat model of cerebral infarction. Cns Neuroscience and Therapeutics 19(12): 917-925

Hanafusa, N.; Satonaka, H.; Doi, K.; Yatomi, Y.; Noiri, E.; Fujita, T. 2010: Platelet-derived microparticles are removed by a membrane plasma separator. Asaio Journal 56(4): 323-325

Nomura, S.; Fujita, S.; Nakanishi, T.; Yokoi, T.; Shimamoto, K.; Miyamoto, R.; Ito, T. 2012: Platelet-derived microparticles cause CD154-dependent activation of dendritic cells. Platelets 23(1): 81-82

Skeppholm, M.; Mobarrez, F.; Malmqvist, K.; Wallén, Håkan. 2012: Platelet-derived microparticles during and after acute coronary syndrome. Thrombosis and Haemostasis 107(6): 1122-1129

Meyer, A.D.; Gelfond, J.A.L.; Wiles, A.A.; Freishtat, R.J.; Rais-Bahrami, K. 2015: Platelet-derived microparticles generated by neonatal extracorporeal membrane oxygenation systems. Asaio Journal 61(1): 37-42

Koiou, E.; Tziomalos, K.; Katsikis, I.; Papadakis, E.; Kandaraki, E.A.; Panidis, D. 2013: Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 29(3): 250-253

Dashevsky, O.; Varon, D.; Brill, A. 2009: Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. International Journal of Cancer 124(8): 1773-1777

Kniewallner, K.M.; Grimm, N.; Humpel, C. 2014: Platelet-derived nerve growth factor supports the survival of cholinergic neurons in organotypic rat brain slices. Neuroscience Letters 574: 64-69

Dees, C.; Akhmetshina, A.; Zerr, P.; Reich, N.; Palumbo, K.; Horn, A.; Jüngel, A.; Beyer, C.; Krönke, G.; Zwerina, J.; Reiter, R.; Alenina, N.; Maroteaux, L.; Gay, S.; Schett, G.; Distler, O.; Distler, J.ör.H.W. 2011: Platelet-derived serotonin links vascular disease and tissue fibrosis. Journal of Experimental Medicine 208(5): 961-972

Lesurtel, Mël.; Clavien, P-Alain. 2014: Platelet-derived serotonin: translational implications for liver regeneration. Hepatology 60(1): 30-33

Iino, J.; Osada, M.; Kurano, M.; Kaneko, M.; Ohkawa, R.; Satoh, Y.; Okubo, S.; Ozaki, Y.; Tozuka, M.; Tsuno, N.H.; Yatomi, Y. 2014: Platelet-derived sphingosine 1-phosphate induces migration of Jurkat T cells. Lipids in Health and Disease 13: 150

Seta, N.; Okazaki, Y.; Miyazaki, H.; Kato, T.; Kuwana, M. 2013: Platelet-derived stromal cell-derived factor-1 is required for the transformation of circulating monocytes into multipotential cells. Plos one 8(9): E74246

Zaslavsky, A.; Baek, K.-H.; Lynch, R.C.; Short, S.; Grillo, J.; Folkman, J.; Italiano, J.E.; Ryeom, S. 2010: Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood 115(22): 4605-4613

Kopp, H.-G.; Placke, T.; Salih, H.R. 2009: Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Research 69(19): 7775-7783

Chuah, M.K.; Vandendriessche, T. 2012: Platelet-directed gene therapy overcomes inhibitory antibodies to factor VIIi. Journal of Thrombosis and Haemostasis: Jth 10(8): 1566-1569

Berger, J.S. 2009: Platelet-directed therapies and coronary artery bypass grafting. American Journal of Cardiology 104(5 Suppl): 44c-48c

Wei, Y.-S.; Lan, Y.; Liu, Y.-G.; Meng, L.-Q.; Xu, Q.-Q.; Xie, H.-Y. 2009: Platelet-endothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with ischemic stroke. Dna and Cell Biology 28(3): 151-158

McCormick, M.E.; Goel, R.; Fulton, D.; Oess, S.; Newman, D.; Tzima, E. 2011: Platelet-endothelial cell adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression. Arteriosclerosis Thrombosis and Vascular Biology 31(3): 643-649

Faille, D.ée.; El-Assaad, F.; Alessi, M.-C.; Fusai, T.; Combes, V.ér.; Grau, G.E. 2009: Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thrombosis and Haemostasis 102(6): 1093-1102

You, T.-M.; Choi, B.-H.; Zhu, S.-J.; Jung, J.-H.; Lee, S.-H.; Huh, J.-Y.; Lee, H.-J.; Li, J. 2007: Platelet-enriched fibrin glue and platelet-rich plasma in the repair of bone defects adjacent to titanium dental implants. International Journal of Oral and Maxillofacial Implants 22(3): 417-422

Hamilton, B.H.; Best, T.M. 2011: Platelet-enriched plasma and muscle strain injuries: challenges imposed by the burden of proof. Clinical Journal of Sport Medicine: Official Journal of the Canadian Academy of Sport Medicine 21(1): 31-36

Kraus, E.; Kraus, K.; Obser, T.; Oyen, F.; Klemm, U.; Schneppenheim, R.; Brehm, M.A. 2014: Platelet-free shear flow assay facilitates analysis of shear-dependent functions of VWF and ADAMTS13. Thrombosis Research 134(6): 1285-1291

Sucker, C.; Zotz, R.B.; Kurt, M.; Feindt, P.; Litmathe, J. 2010: Platelet-function analyzer closure times indicate shear stress-induced hemostatic abnormalities in patients with aortic valve stenosis and correlate with perioperative transfusion requirements. Perfusion 25(3): 153-158

Wassmer, S.Crocodile.; Taylor, T.; Maclennan, C.Alexander.; Kanjala, M.; Mukaka, M.; Molyneux, M.Edward.; Grau, G.Emile. 2008: Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia. Journal of Infectious Diseases 197(1): 72-78

Wang, Y.; Zhang, H. 2008: Platelet-induced inhibition of tumor cell growth. Thrombosis Research 123(2): 324-330

Panova-Noeva, M.; Marchetti, M.; Spronk, H.M.; Russo, L.; Diani, E.; Finazzi, G.; Finazzi, G.; Salmoiraghi, S.; Rambaldi, A.; Rambaldi, A.; Barbui, T.; Barbui, T.; Ten Cate, H.; Ten Cate, H.; Falanga, A. 2011: Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera. American Journal of Hematology 86(4): 337-342

Liu, X.; Zhang, F.; Wang, Q.; Gao, J.; Meng, J.; Wang, S.; Yang, Z.; Jiang, L. 2014: Platelet-inspired multiscaled cytophilic interfaces with high specificity and efficiency toward point-of-care cancer diagnosis. Small 10(22): 4677-4683

Kunapuli, S.P.; Colman, R.W. 1993: Platelet-kininogen Interactions. Platelets 4(2): 61-65

De Luca, G.; Santagostino, M.; Secco, G.G.; Cassetti, E.; Giuliani, L.; Coppo, L.; Schaffer, A.; Fundaliotis, A.; Iorio, S.; Venegoni, L.; Bellomo, G.; Marino, P. 2010: Platelet-large cell ratio and the extent of coronary artery disease: results from a large prospective study. Journal of Thrombosis and Thrombolysis 30(4): 426-433

Verdoia, M.; Barbieri, L.; Schaffer, A.; Cassetti, E.; Marino, P.; Bellomo, G.; Sinigaglia, F.; De Luca, G. 2015: Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization. Heart and Vessels 30(1): 20-27

Von Hentig, N.; Förster, A.-K.; Kuczka, K.; Klinkhardt, U.; Klauke, S.; Gute, P.; Staszewski, S.; Harder, S.; Graff, J. 2008: Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors. Journal of Antimicrobial ChemoTherapy 62(5): 1118-1121

Irving, P.M.; Macey, M.G.; Feakins, R.M.; Knowles, C.H.; Frye, J.N.; Liyanage, S.H.; Dorudi, S.; Williams, N.S.; Rampton, D.S. 2008: Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis. European Journal of Gastroenterology and Hepatology 20(4): 283-289

Chakroun, T.; Abdelkefi, S.; Bouslama, M.; Houissa, B.; Zaier, M.; Miled, A.; Kortas, M.; Yacoub, S. 2008: Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 15(4): 148-153

Ghasemzadeh, M.; Hosseini, E. 2013: Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state. Thrombosis Research 131(3): 191-197

Maugeri, N.; Baldini, M.; Ramirez, G.A.; Rovere-Querini, P.; Manfredi, A.A. 2012: Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. Thrombosis Research 129(3): 267-273

Totani, L.; Evangelista, V. 2010: Platelet-leukocyte interactions in cardiovascular disease and beyond. Arteriosclerosis Thrombosis and Vascular Biology 30(12): 2357-2361

Franks, Z.G.; Campbell, R.A.; Weyrich, A.S.; Rondina, M.T. 2010: Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke. Annals of the new York Academy of Sciences 1207: 11-17

Alberti, S.; Angeloni, G.; Tamburrelli, C.; Pampuch, A.; Izzi, B.; Messano, L.; Parisi, Q.; Santamaria, M.; Donati, M.Benedetta.; de Gaetano, G.; Cerletti, C. 2009: Platelet-leukocyte mixed conjugates in patients with atrial fibrillation. Platelets 20(4): 235-241

Anselmo, A.C.; Modery-Pawlowski, C.Lynn.; Menegatti, S.; Kumar, S.; Vogus, D.R.; Tian, L.L.; Chen, M.; Squires, T.M.; Sen Gupta, A.; Mitragotri, S. 2014: Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. Acs Nano 8(11): 11243-11253

Zhu, G.; Xu, H.; Liu, Y.; Xi, C.; Yang, J.; Shen, X.; Zhu, J.; Yang, J. 2013: Platelet-like nickel hydroxide: synthesis and the transferring to nickel oxide as a gas sensor. Journal of Colloid and Interface Science 412: 100-106

Chen, Y.-G.; Lin, C.-S.; Shen, C.-H.; Chian, C.-F. 2012: Platelet-lowering therapy with anagrelide as an adjuvant therapy for treatment of primary pulmonary neoplasm-associated extreme thrombocytosis. Japanese Journal of Clinical Oncology 42(8): 761-763

Li, N. 2008: Platelet-lymphocyte cross-talk. Journal of Leukocyte Biology 83(5): 1069-1078

Koseoglu, H.I.; Altunkas, F.; Kanbay, A.; Doruk, S.; Etikan, I.; Demir, O. 2015: Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. Journal of Thrombosis and Thrombolysis 39(2): 179-185

Riem Vis, P.W.; Bouten, C.V.C.; Sluijter, J.P.G.; Pasterkamp, G.; van Herwerden, L.A.; Kluin, J. 2010: Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering. Tissue Engineering. Part a 16(4): 1317-1327

Lucchini, G.; Introna, M.; Dander, E.; Rovelli, A.; Balduzzi, A.; Bonanomi, S.; Salvadè, A.; Capelli, C.; Belotti, D.; Gaipa, G.; Perseghin, P.; Vinci, P.; Lanino, E.; Chiusolo, P.; Orofino, M.G.; Marktel, S.; Golay, J.; Rambaldi, A.; Biondi, A.; D'Amico, G.; Biagi, E. 2010: Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 16(9): 1293-1301

Bell, J.D.; Thomas, T.C.; Lass, E.; Ai, J.; Wan, H.; Lifshitz, J.; Baker, A.J.; Macdonald, R.L. 2014: Platelet-mediated changes to neuronal glutamate receptor expression at sites of microthrombosis following experimental subarachnoid hemorrhage. Journal of Neurosurgery 121(6): 1424-1431

von Hundelshausen, P.; Koenen, R.R.; Weber, C. 2009: Platelet-mediated enhancement of leukocyte adhesion. Microcirculation 16(1): 84-96

Jiang, L.; Song, X.H.; Liu, P.; Zeng, C.L.; Huang, Z.S.; Zhu, L.J.; Jiang, Y.Z.; Ouyang, H.W.; Hu, H. 2012: Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension. Cell Transplantation 21(7): 1463-1475

Wright, B.; Gibson, T.; Spencer, J.; Lovegrove, J.A.; Gibbins, J.M. 2010: Platelet-mediated metabolism of the common dietary flavonoid, quercetin. Plos one 5(3): E9673

Dienava-Verdoold, I.; Marchetti, M.R.; te Boome, L.C.J.; Russo, L.; Falanga, A.; Koene, H.R.; Mertens, K.; Brinkman, H.J.M. 2012: Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies. Thrombosis and Haemostasis 107(3): 468-476

Brodsky, M.A.; Machovec, K.A.; Chambers, B.P.; Nielsen, V.G. 2011: Platelet-mediated thrombolysis in patients with δ-storage pool deficiency: a thrombelastographic analysis. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(7): 610-612

Granada, J.F.; Price, M.J.; French, P.A.; Steinhubl, S.R.; Cutlip, D.E.; Becker, R.C.; Smyth, S.S.; Dauerman, H.L. 2011: Platelet-mediated thrombosis and drug-eluting stents. CIRCULATION. Cardiovascular Interventions 4(6): 629-637

Dixon, J.T.; Gozal, E.; Roberts, A.M. 2012: Platelet-mediated vascular dysfunction during acute lung injury. Archives of Physiology and Biochemistry 118(2): 72-82

Rondina, M.T.; Carlisle, M.; Fraughton, T.; Brown, S.M.; Miller, R.R.; Harris, E.S.; Weyrich, A.S.; Zimmerman, G.A.; Supiano, M.A.; Grissom, C.K. 2015: Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 70(2): 225-231

Kopp, C.W.; Gremmel, T.; Steiner, S.; Seidinger, D.; Minar, E.; Maurer, G.; Huber, K. 2011: Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction. Platelets 22(7): 530-536

Hamdan, A.A.-S.; Loty, S.; Isaac, J.; Bouchard, P.; Berdal, A.; Sautier, J.-M. 2009: Platelet-poor plasma stimulates the proliferation but inhibits the differentiation of rat osteoblastic cells in vitro. Clinical Oral Implants Research 20(6): 616-623

Wisman, P.P.; Roest, M.; Asselbergs, F.W.; de Groot, P.G.; Moll, F.L.; van der Graaf, Y.; de Borst, G.J. 2014: Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis: Jth 12(5): 736-747

Peddinghaus, M.E.; Tormey, C.A. 2009: Platelet-related bleeding: an update on diagnostic modalities and therapeutic options. Clinics in Laboratory Medicine 29(2): 175-191

Rusak, T.; Piszcz, Jław.; Misztal, T.; Brańska-Januszewska, J.; Tomasiak, M. 2014: Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis. Thrombosis Research 134(1): 192-198

Knehtl, M.; Ponikvar, R.; Buturovic-Ponikvar, J. 2013: Platelet-related hemostasis before and after hemodialysis with five different anticoagulation methods. International Journal of Artificial Organs 36(10): 717-724

Carr, B.I.; Lin, C.-Y.; Lu, S.-N. 2014: Platelet-related phenotypic patterns in hepatocellular carcinoma patients. Seminars in Oncology 41(3): 415-421

Tohidnezhad, M.; Varoga, D.; Wruck, C.J.; Brandenburg, L.O.; Seekamp, A.; Shakibaei, M.; Sönmez, T.T.; Pufe, T.; Lippross, S. 2011: Platelet-released growth factors can accelerate tenocyte proliferation and activate the anti-oxidant response element. Histochemistry and Cell Biology 135(5): 453-460

Verrier, S.; Meury, T.R.; Kupcsik, L.; Heini, P.; Stoll, T.; Alini, M. 2010: Platelet-released supernatant induces osteoblastic differentiation of human mesenchymal stem cells: potential role of BMP-2. European Cells and Materials 20: 403-414

Pietrzak, W.S.; An, Y.H.; Kang, Q.K.; Demos, H.A.; Ehrens, K.H. 2007: Platelet-rich and platelet-poor plasma: development of an animal model to evaluate hemostatic efficacy. Journal of Craniofacial Surgery 18(3): 559-567

Hunter, P.J. 2013: Platelet-rich blood clots. Biophysical Journal 104(8): 1641

Parsons, P.; Butcher, A.; Hesselden, K.; Ellis, K.; Maughan, J.; Milner, R.; Scott, M.; Alley, C.; Watson, J.T.; Horner, A. 2008: Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair. Journal of Orthopaedic Trauma 22(9): 595-604

Garin, P.; Peerbaccus, Y.; Mullier, F.; Gheldof, D.; Dogne, J.-M.; Putz, L.; Van Damme, J.P. 2014: Platelet-rich fibrin (PRF): an autologous packing material for middle ear microsurgery. B-Ent 10(1): 27-34

Lekovic, V.; Milinkovic, I.; Aleksic, Z.; Jankovic, S.; Stankovic, P.; Kenney, E.B.; Camargo, P.M. 2012: Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects. Journal of Periodontal Research 47(4): 409-417

Ruga, E.; Gallesio, C.; Boffano, P. 2011: Platelet-rich fibrin and piezoelectric surgery: a safe technique for the prevention of periodontal complications in third molar surgery. Journal of Craniofacial Surgery 22(5): 1951-1955

Kulkarni, M.R.; Thomas, B.S.; Varghese, J.M.; Bhat, G.S. 2014: Platelet-rich fibrin as an adjunct to palatal wound healing after harvesting a free gingival graft: a case series. Journal of Indian Society of Periodontology 18(3): 399-402

Visser, L.C.; Arnoczky, S.P.; Caballero, O.; Egerbacher, M. 2010: Platelet-rich fibrin constructs elute higher concentrations of transforming growth factor-β1 and increase tendon cell proliferation over time when compared to blood clots: a comparative in vitro analysis. Veterinary Surgery: Vs 39(7): 811-817

Horii, K.; Kanayama, T.; Miyamoto, H.; Kohgo, T.; Tsuchimochi, T.; Shigetomi, T.; Yokoi, M. 2014: Platelet-rich fibrin has a healing effect on chemotherapy-induced mucositis in hamsters. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 117(4): 445-453

Antuña, S.; Barco, R.úl.; Martínez Diez, J.é M.; Sánchez Márquez, J.é M. 2013: Platelet-rich fibrin in arthroscopic repair of massive rotator cuff tears: a prospective randomized pilot clinical trial. Acta Orthopaedica Belgica 79(1): 25-30

Boudet, C. 2014: Platelet-rich fibrin in mesh exposure repair. Dentistry Today 33(1): 112-113

Eren, G.ül.; Atilla, G.ül. 2014: Platelet-rich fibrin in the treatment of localized gingival recessions: a split-mouth randomized clinical trial. Clinical Oral Investigations 18(8): 1941-1948

Ranganathan, A.T.; Chandran, C.R. 2014: Platelet-rich fibrin in the treatment of periodontal bone defects. Journal of Contemporary Dental Practice 15(3): 372-375

Shubhashini, N.; Kumar, R.V.; Shija, A.S.; Razvi, S. 2013: Platelet-rich fibrin in treatment of periapical lesions: a novel therapeutic option. Chinese Journal of Dental Research: the Official Journal of the Scientific Section of the Chinese Stomatological Association 16(1): 79-82

Huang, F.-M.; Yang, S.-F.; Zhao, J.-H.; Chang, Y.-C. 2010: Platelet-rich fibrin increases proliferation and differentiation of human dental pulp cells. Journal of Endodontics 36(10): 1628-1632

Kang, Y.-H.; Jeon, S.H.; Park, J.-Y.; Chung, J.-H.; Choung, Y.-H.; Choung, H.-W.; Kim, E.-S.; Choung, P.-H. 2011: Platelet-rich fibrin is a Bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Engineering. Part a 17(3-4): 349-359

Theodoropoulos, J. 2011: Platelet-rich fibrin matrix augmentation did not improve recovery and healing more than nonaugmented rotator cuff repair. Journal of Bone and Joint Surgery. American Volume 93(22): 2125

Sclafani, A.P.; Saman, M. 2012: Platelet-rich fibrin matrix for facial plastic surgery. Facial Plastic Surgery Clinics of North America 20(2): 177-186 Vi

Sclafani, A.P. 2010: Platelet-rich fibrin matrix for improvement of deep nasolabial folds. Journal of Cosmetic Dermatology 9(1): 66-71

Gassling, V.; Douglas, T.; Warnke, P.H.; Açil, Y.; Wiltfang, J.ör.; Becker, S.T. 2010: Platelet-rich fibrin membranes as scaffolds for periosteal tissue engineering. Clinical Oral Implants Research 21(5): 543-549

Chang, I.-C.; Tsai, C.-H.; Chang, Y.-C. 2010: Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. Journal of Biomedical Materials Research. Part a 95(1): 327-332

Habesoglu, M.; Oysu, C.; Sahin, S.; Sahin-Yilmaz, A.; Korkmaz, D.; Tosun, A.; Karaaslan, A. 2014: Platelet-rich fibrin plays a role on healing of acute-traumatic ear drum perforation. Journal of Craniofacial Surgery 25(6): 2056-2058

Li, Q.; Pan, S.; Dangaria, S.J.; Gopinathan, G.; Kolokythas, A.; Chu, S.; Geng, Y.; Zhou, Y.; Luan, X. 2013: Platelet-rich fibrin promotes periodontal regeneration and enhances alveolar bone augmentation. Biomed Research International 2013: 638043

Lara, F.J.P.ér.; Serrano, A.M.; Moreno, J.U.; Carmona, J.H.án.; Marquez, M.F.; Pérez, L.R.; del Rey Moreno, A.; Muñoz, H.O. 2015: Platelet-rich fibrin sealant as a treatment for complex perianal fistulas: a multicentre study. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 19(2): 360-368

Danielsen, P.L.; Agren, M.S.; Jorgensen, L.N. 2010: Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. Annals of Surgery 251(5): 825-831

Mishra, N.; Narang, I.; Mittal, N. 2013: Platelet-rich fibrin-mediated revitalization of immature necrotic tooth. Contemporary Clinical Dentistry 4(3): 412-415

Eshghpour, M.; Majidi, M.Reza.; Nejat, A.Hossein. 2012: Platelet-rich fibrin: an autologous fibrin matrix in surgical procedures: a case report and review of literature. Iranian Journal of Otorhinolaryngology 24(69): 197-202

Sunitha Raja, V.; Munirathnam Naidu, E. 2008: Platelet-rich fibrin: evolution of a second-generation platelet concentrate. Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research 19(1): 42-46

Pal, U.S.; Mohammad, S.; Singh, R.K.; Das, S.; Singh, N.; Singh, M. 2012: Platelet-rich growth factor in oral and maxillofacial surgery. National Journal of Maxillofacial Surgery 3(2): 118-123

Mishra, A. 2010: Platelet-rich plasma. Orthopedics 33(7): 486-487

Saucedo, J.M.; Yaffe, M.A.; Berschback, J.C.; Hsu, W.K.; Kalainov, D.M. 2012: Platelet-rich plasma. Journal of Hand Surgery 37(3): 587-589; Quiz 590

Dohan Ehrenfest, D.M.; Del Corso, M.; Inchingolo, F.; Sammartino, G.; Charrier, J.-B. 2010: Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in human cell cultures: growth factor release and contradictory results. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 110(4): 418

Kanthan, S.R.; Kavitha, G.; Addi, S.; Choon, D.S.K.; Kamarul, T. 2011: Platelet-rich plasma (PRP) enhances bone healing in non-united critical-sized defects: a preliminary study involving rabbit models. Injury 42(8): 782-789

Hamid, M.S.A.; Yusof, A.; Mohamed Ali, M.R. 2014: Platelet-rich plasma (PRP) for acute muscle injury: a systematic review. Plos one 9(2): E90538

Giovanini, A.F.; Gonzaga, C.C.; Zielak, J.ão.C.; Deliberador, T.M.; Kuczera, J.; Göringher, I.; de Oliveira Filho, M.A.; Baratto-Filho, F.; Urban, C.íc.A. 2011: Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-β levels and modulates the co-expression between collagen IIi and α-smooth muscle actin. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 29(3): 457-463

Martin, J.I.; Merino, J.; Atilano, L.; Areizaga, L.M.; Gomez-Fernandez, M.C.; Burgos-Alonso, N.; Andia, I. 2013: Platelet-rich plasma (PRP) in chronic epicondylitis: study protocol for a randomized controlled trial. Trials 14: 410

Battaglia, M.; Guaraldi, F.; Vannini, F.; Buscio, T.; Buda, R.; Galletti, S.; Giannini, S. 2011: Platelet-rich plasma (PRP) intra-articular ultrasound-guided injections as a possible treatment for hip osteoarthritis: a pilot study. Clinical and Experimental Rheumatology 29(4): 754

Roubelakis, M.G.; Trohatou, O.; Roubelakis, A.; Mili, E.; Kalaitzopoulos, I.; Papazoglou, G.; Pappa, K.I.; Anagnou, N.P. 2014: Platelet-rich plasma (PRP) promotes fetal mesenchymal stem/stromal cell migration and wound healing process. Stem Cell Reviews and Reports 10(3): 417-428

Nakamura, S.; Ishihara, M.; Takikawa, M.; Murakami, K.; Kishimoto, S.; Nakamura, S.; Yanagibayashi, S.; Kubo, S.; Yamamoto, N.; Kiyosawa, T. 2010: Platelet-rich plasma (PRP) promotes survival of fat-grafts in rats. Annals of Plastic Surgery 65(1): 101-106

Kon, E.; Filardo, G.; Di Martino, A.; Marcacci, M. 2011: Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 19(4): 516-527

Marques, L.ís.F.; Stessuk, T.; Camargo, I.C.C.; Sabeh Junior, N.; dos Santos, L.éi.; Ribeiro-Paes, J.ão.T. 2015: Platelet-rich plasma (PRP): methodological aspects and clinical applications. Platelets 26(2): 101-113

Wu, W.; Zhang, J.; Dong, Q.; Liu, Y.; Mao, T.; Chen, F. 2009: Platelet-rich plasma - a promising cell carrier for micro-invasive articular cartilage repair. Medical Hypotheses 72(4): 455-457

Getgood, A.; Henson, F.; Brooks, R.; Fortier, L.A.; Rushton, N. 2011: Platelet-rich plasma activation in combination with biphasic osteochondral scaffolds-conditions for maximal growth factor production. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 19(11): 1942-1947

Nakamura, N. 2013: Platelet-rich plasma added to the patellar tendon harvest site during anterior cruciate ligament reconstruction enhanced healing. Journal of Bone and Joint Surgery. American Volume 95(10): 942

Mariani, E.; Filardo, G.; Canella, V.; Berlingeri, A.; Bielli, A.; Cattini, L.; Landini, M.P.; Kon, E.; Marcacci, M.; Facchini, A. 2014: Platelet-rich plasma affects bacterial growth in vitro. CytoTherapy 16(9): 1294-1304

Feng, Y.; Sun, Y.; Jia, W.; Zhang, C. 2010: Platelet-rich plasma and 1,25(OH)2 vitamin D3 synergistically stimulate osteogenic differentiation of adult human mesenchymal stem cells. Biotechnology Letters 32(5): 635-642

Griffeth, R.J.; García-Párraga, D.; Mellado-López, M.; Crespo-Picazo, J.L.; Soriano-Navarro, M.; Martinez-Romero, A.; Moreno-Manzano, V. 2014: Platelet-rich plasma and adipose-derived mesenchymal stem cells for regenerative medicine-associated treatments in bottlenose dolphins (Tursiops truncatus). Plos one 9(9): E108439

Keskiner, I.; Alkan, A.; Acikgoz, G.; Arpak, N.; Kaplan, S.; Arslan, H. 2014: Platelet-rich plasma and autogenous bone graft combined with guided tissue regeneration in periodontal fenestration defects in dogs. International Journal of Periodontics and Restorative Dentistry 34(6): E112-E120

Gentile, P.; D'angiolino, A.; Giusti, D.; Bocchini, I.; Di Pasquali, C.; Curcio, B.C.; Cervelli, V. 2012: Platelet-rich plasma and blood components for non-transfusion use: technical and medicolegal aspects. Medicine Science and the Law 52(4): 234-239

Malhotra, A.; Pelletier, M.; Oliver, R.; Christou, C.; Walsh, W.R. 2014: Platelet-rich plasma and bone defect healing. Tissue Engineering. Part a 20(19-20): 2614-2633

Akça, K.ç; Cehreli, M.; Demiralp, B.; Güzel, E.; Dağdeviren, A. 2007: Platelet-rich plasma and bone healing: a histologic study in titanium bone chambers. International Journal of Periodontics and Restorative Dentistry 27(4): 387-392

Moroz, A.; Deffune, E. 2013: Platelet-rich plasma and chronic wounds: remaining fibronectin may influence matrix remodeling and regeneration success. CytoTherapy 15(11): 1436-1439

Nair, M.B.; Varma, H.K.; John, A. 2009: Platelet-rich plasma and fibrin glue-coated bioactive ceramics enhance growth and differentiation of goat bone marrow-derived stem cells. Tissue Engineering. Part a 15(7): 1619-1631

Yu, S.; Wang, Y.; Dong, Q. 2008: Platelet-rich plasma and its applications in orthopedics field. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(7): 880-883

Monto, R.R. 2013: Platelet-rich plasma and plantar fasciitis. Sports Medicine and Arthroscopy Review 21(4): 220-224

Mazzucco, L.; Balbo, V.; Cattana, E.; Borzini, P. 2008: Platelet-rich plasma and platelet gel preparation using Plateltex. Vox Sanguinis 94(3): 202-208

Gassling, V.L.W.; Açil, Y.; Springer, I.N.; Hubert, N.; Wiltfang, J.ör. 2009: Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 108(1): 48-55

Sammartino, G.; Tia, M.; Gentile, E.; Marenzi, G.; Claudio, P.Paolo. 2009: Platelet-rich plasma and resorbable membrane for prevention of periodontal defects after deeply impacted lower third molar extraction. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 67(11): 2369-2373

Dimauro, I.; Grasso, L.; Fittipaldi, S.; Fantini, C.; Mercatelli, N.; Racca, S.; Geuna, S.; Di Gianfrancesco, A.; Caporossi, D.; Pigozzi, F.; Borrione, P. 2014: Platelet-rich plasma and skeletal muscle healing: a molecular analysis of the early phases of the regeneration process in an experimental animal model. Plos one 9(7): E102993

Creaney, L. 2011: Platelet-rich plasma and the biological complexity of tissue regeneration. British Journal of Sports Medicine 45(8): 611

Mishra, A.; Randelli, P.; Barr, C.; Talamonti, T.; Ragone, V.; Cabitza, P. 2012: Platelet-rich plasma and the upper extremity. Hand Clinics 28(4): 481-491

Klaassen, M.A.; Pietrzak, W.S. 2011: Platelet-rich plasma application and heterotopic bone formation following total hip arthroplasty. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 24(6): 257-261

Kabiri, A.; Esfandiari, E.; Esmaeili, A.; Hashemibeni, B.; Pourazar, A.; Mardani, M. 2014: Platelet-rich plasma application in chondrogenesis. Advanced Biomedical Research 3: 138

Kaux, J.-F.ço.; Crielaard, J.-M. 2013: Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthopaedica Belgica 79(1): 10-15

Wang, P.; Qu, Y.; Man, Y. 2010: Platelet-rich plasma as a scaffold for injectable soft-tissue augmentation. CytoTherapy 12(5): 701-702

Dragoo, J.L.; Wasterlain, A.S.; Braun, H.J.; Nead, K.T. 2014: Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. American Journal of Sports Medicine 42(3): 610-618

Wetzel, R.J.; Patel, R.M.; Terry, M.A. 2013: Platelet-rich plasma as an effective treatment for proximal hamstring injuries. Orthopedics 36(1): E64-E70

Castricini, R.; Longo, U.G.; De Benedetto, M.; Panfoli, N.; Pirani, P.; Zini, R.; Maffulli, N.; Denaro, V. 2011: Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. American Journal of Sports Medicine 39(2): 258-265

Arnoczky, S.P. 2011: Platelet-rich plasma augmentation of rotator cuff repair: letter. American Journal of Sports Medicine 39(6): Np8

Gonzales, V.K.; de Mulder, E.L.W.; de Boer, T.; Hannink, G.; van Tienen, T.G.; van Heerde, W.L.; Buma, P. 2013: Platelet-rich plasma can replace fetal bovine serum in human meniscus cell cultures. Tissue Engineering. Part C Methods 19(11): 892-899

Yin, Z.; Yang, X.; Jiang, Y.; Xing, L.; Xu, Y.; Lu, Y.; Ding, P.; Ma, J.; Xu, Y.; Gui, J. 2014: Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study. Journal of Biomaterials Applications 28(7): 1039-1050

Hakimi, M.; Jungbluth, P.; Thelen, S.; Betsch, M.; Linhart, W.; Flohé, S.; Windolf, J.; Wild, M. 2011: Platelet-rich plasma combined with autologous cancellous bone : An alternative therapy for persistent non-union?. Der Unfallchirurg 114(11): 998-1006